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                                                Abstract 
 
Ischaemia of the liver followed by reperfusion results in endothelial and 
parenchymal injury through a complex cascade of events. This often occurs in 
human liver transplantation as well as with major liver resections and is referred 
to as Ischaemia Reperfusion (IR) Injury. Bucillamine is a low molecular weight 
thiol antioxidant that is capable of rapidly entering cells. 
 
This thesis evaluates the effect of Bucillamine on both the early and late phases 
of liver warm IR injury with the hypothesis that beneficial effects are induced 
could be due to its action as a free radical scavenger. The drug was evaluated in 
an in vivo lobar liver ischemia reperfusion model as previously described. Male 
Sprague –Dawley rats were subjected to 45 mins of partial hepatic (70 %) 
ischaemia followed by 3 hrs of reperfusion to investigate the early phase of 
hepatic IR and 24 hrs of reperfusion to study the late phase of hepatic IR. 
Changes to the microcirculation, leucocyte adherence and apoptosis were 
assessed by intra-vital microscopy. Hepatocellular injury was assessed by 
standard liver function tests. Expression of pro and antiapoptotic gene 
expression was studied by RT-PCR. Oxidative stress was assessed by 
measuring plasma and hepatic F2 isoprostane levels and tissue glutathione 
levels. Cytokine response was assessed by measuring serum CINC-1 levels.  
Bucillamine improved liver sinusoidal perfusion, reduced leukocyte adherence 
and apoptosis in both the early and late phases of IR injury. Hepatocellular injury   5
was reduced. There was no difference in the level of tissue glutathione or tissue 
and plasma F2 isoprostane levels.  
 
This study shows that the hepato protective effect of Bucillamine in warm Liver 
ischemia reperfusion injury is not by direct replenishment of Glutathione level; 
however, it is through decreased neutrophil activation and recruitment. A clinical 
trial could hence be undertaken in the future to study its efficacy. 
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Introduction 
Liver Transplantation and liver resection surgery have increased dramatically due 
to the excellent outcomes they offer in patients with chronic liver disease and 
liver cancers. Both procedures involve a period of ischaemia and reperfusion to 
the liver which initiates an inflammatory cascade resulting in liver and remote 
organ injury. When severe these changes can be fatal. Reactive oxygen species 
(ROS) have a central role to play in Ischaemia –Reperfusion injury (IR). 
 
ROS activate cytokines, macrophages and other components of the inflammatory 
pathway(Entman  et  al.  1991;  Jaeschke  and  Farhood  1991a;  Le  et  al.  1997). 
When generated in large numbers they can also cause direct oxidative damage 
to the cells through iron mediated reactions(Horwitz et al. 1998). Thiol donors are 
antioxidants  which  can  interrupt  redox  signalling  pathway  and  thereby  reduce 
cytokine and macrophage activation(Sano et al. 2001). In addition, thiol donors 
can protect against oxidative injury by replenishing intracellular glutathione and 
other endogenous thiol compounds(Ceconi et al. 1988a). 
 
1.1 Pathophysiology of Liver I/R 
 
1.1.1 Effects of ischaemia in the Liver: 
In aerobic cells the energy necessary to maintain cell integrity is supplied by the 
mitochondrial  system  through  complete  reduction  of  oxygen  to  water  with  the 
concomitant production of ATP through oxidative phosphorylation (Chazouilleres   19
et al. 1993). When oxygen supply to cells becomes insufficient as a result of 
ischaemia  or  hypoxia,  mitochondrial  respiratory  chain  function  alters  and  the 
reduction-oxidation  (redox)  state  of  the  mitochondrial  enzymes  becomes 
reduced.  This  causes  inhibition  of  the  mitochondrial  ATP  synthase  with  the 
subsequent reduction of oxidative phosphorylation(Gonzalez-Flecha et al. 1993). 
Reduction  of  cellular  ATP  causes  disturbances    in  the  cell  membrane  ion 
translocation  by  inhibition  of  the  ATP-dependent  sodium  (Na
+)/potassium  (K
+) 
ATPase,  resulting  in  sodium  influx  and  intracellular  sodium  and  calcium  
accumulation  with  cell  swelling,  cytoskeleton  disorganization,  cellular  acidosis, 
decreased cellular phosphocreatinine and glutathione, and finally results in cell 
death(Blum et al. 1991).  
 
Intracellular calcium accumulation is thought to be a crucial step in the transition 
to  irreversible  damage  with  ischaemic  injury(Dhar  et  al.  1996).  It  occurs 
secondary to calcium release from the intracellular stores and inhibition of the 
ATP-dependent  calcium  pumps  in  the  plasma  membrane  and  endoplasmic 
reticulum. The increased cytosolic calcium causes activation of cell membrane 
phospholipases  resulting  in  phospholipid  degradation  and  cell  membrane 
disruption(Farber  1981).  Calcium  also  activates  tissue  proteases  such  as 
xanthine oxidase (XO) which play a role in oxygen free radical production and 
reperfusion injury(Ishii et al. 1990). Calpains are proteases that are capable of 
degrading  cytoskeletal  proteins  such  as  spectrin.  There  is  experimental 
evidence, that calpains are mediators of both warm and cold ischemic injury in   20
the rat liver(Kohli et al. 1999a). Calpains seem to be activated by raised levels of 
free cytosolic Ca
+2 that accumulates in the liver during ischemia(Arnould et al. 
1992). 
 
Although the basic mechanisms of I/R injury after warm and cold liver ischaemia 
are similar, there are also significant differences. In liver transplantation the liver 
undergoes  cold  ischemic  storage  followed  by  rewarming  ischaemia  and 
reperfusion.  Cold  ischemia  is  associated  with  marked  ATP  depletion  and 
increased glycolysis (Churchill et al. 1994). Cold ischaemia causes Kupffer cell 
stimulation,  while  warm  ischemia  leads  to  oxidative  stress  and  mitochondrial 
dysfunction (Baumann et al. 1989; Mochida et al. 1994). It is the hepatocytes 
which are most susceptible to warm ischaemia(Gujral et al. 2001; Kohli et al. 
1999c), whereas, nonparenchymal cells (Kupffer, endothelial cells, and Ito cells) 
are more susceptible to cold I/R than hepatocytes (Ikeda et al. 1992).. It has 
been shown in the 1980s that cold ischaemia specifically caused injury in the 
sinusoidal endothelial cells (EC)(Caldwell-Kenkel et al. 1988; Otto et al. 1984; 
McKeown et al. 1988; Momii and Koga 1990). On exposure to cold ischaemia the 
EC get detached, lose cytoplasmic processes, become rounded as a result of 
alteration  of  the  extracellular  matrix  and  cytoskeleton  and  sloughed  into  the 
sinusoidal lumen(Caldwell-Kenkel et al. 1988; Holloway et al. 1990; McKeown et 
al.  1988).  The  degree  of  EC  detachment  has  been  shown  to  correlate  with 
duration  of  cold  ischaemia(Clavien  et  al.  1991;  Caldwell-Kenkel  et  al.  1988; 
Holloway et al. 1990). Despite these structural changes most ECs remain viable   21
during the cold ischaemic period but rapidly die on reperfusion(Imamura et al. 
1997; Miyagawa et al. 2002). The resultant disruption of endothelium results in 
leukocyte(Clavien  et  al.  1991;  Clavien  et  al.  1993;  Jaeschke  et  al.  1990; 
Jaeschke and Farhood 1991a; Takei et al. 1991) and platelet adhesion(Cywes et 
al. 1993; Sindram et al. 2000), which induces microcirculatory disturbances(Marzi 
et al. 1991) in the reperfusion phase. Leukocytes  and  platelets synergistically 
exacerbate EC injury by induction of apoptosis(Sindram et al. 2001). Kupffer cells 
play  a  contributive  role  in  the  EC  injury  along  with  platelets  and 
leukocytes(Sindram et al. 2001). 
 
Increased  activities  of  non-lysosomal  proteases  preferentially  in  anoxic 
hepatocytes may play a causal role. Inhibition of non-lysosomal proteolysis by 
acidosis  or  glycine  protects  against  anoxic  hepatocyte  death  (Nichols  et  al. 
1994).  
 
1.1.2 Reperfusion Injury 
Although  ischemia  causes  significant  injury  to  tissue  and  cells,  reperfusion 
results in an escalation of organ and cellular damage. Reperfusion injury occurs 
in a biphasic manner(Jaeschke and Farhood 1991a). 
1.1.2.1 Early phase: This occurs within 1-4 hours following reperfusion and is 
characterized  by  Kupffer  cell  (KC)  and  polymorphonuclear(PMN)(Cutrin  et  al. 
1998)  cell  activation,  increased  production  of  NO  by  liver  mitochondria  and 
KCs(Kurose  et  al.  1996;  Stephenson  et  al.  1997),  activation  of  complement   22
cascade and production of C5a by proteolytic cleavage(Jaeschke et al. 1994) 
and generation of reactive oxygen species (ROS)(Jaeschke and Farhood 1991a; 
Bailey and Reinke 2000; Liu et al. 1995; Shiratori et al. 1994). This early phase 
injury  is  mediated  by  ROS  generation(Fan  et  al.  1999a;  Jaeschke  1998; 
Lichtman and Lemasters 1999; Muller et al. 1996). During this phase the main 
event  is  the  activation  of  Kupffer  cells(Jaeschke  and  Farhood  1991b).The 
activation starts during ischemia but becomes more evident during the onset of 
reperfusion. This effect occurs after no-flow ischemia (major liver resections with 
Pringle  maneuver,  transplantation)  but  not  after  low  flow  ischaemia 
(haemorrhagic  shock)(Jaeschke  and  Farhood  2002).  Complement  activation, 
recruitment  and  activation  of  CD4
+  T-cells  are  the  factors  responsible  for  the 
activation of Kupffer cells(Fondevila et al. 2003; Jaeschke 2003a). Kupffer cell 
activation  and  the  subsequent  vascular  inflammation  can  be  enhanced  by 
extrahepatic mechanisms. The most important  event is the  priming  of Kupffer 
cells  by  endotoxin(McCuskey  et  al.  1996;  van  Goor  et  al.  1994).  Endotoxin 
translocates  across  the  gut,  most  likely  as  a  consequence  of  intestinal 
congestion due to portal vein clamping at the time of surgery.  Kupffer cells are 
the main source of formation of vascular reactive oxygen species (ROS) during 
the  initial  reperfusion  period.  Other  sources  of  ROS  formation  are  xanthine 
oxidase(Jaeschke  2002)  and  mitochondria(Jassem  et  al.  2002).    Activation  of 
Kupffer cells leads to activation of neutrophils and production of cytokines (like 
TNFα, IL-1 and IL-12)(Lentsch et al. 2000). The production of TNF-α induces the 
expression of adhesion molecules on vascular endothelial cells and stimulates   23
the  production  and  release  of  neutrophil-attracting  chemokines  (like  CINC-
1)(Hisama et al. 1996). The final result is the recruitment of neutrophils within the 
late phase. 
 
1.1.2.2 Late phase:  This occurs 4-24  hours after onset  of reperfusion and is 
characterized by PMN influx into the post ischaemic liver and organ injury(Fan et 
al. 1999a; Jaeschke 1998; Jaeschke and Smith 1997a; Simpson et al. 1997). 
PMNs  accumulate  in  the  liver  vasculature  in  response  to  the  exposure  to 
inflammatory mediators such as TNF-α, IL-1, CXC chemokines [ IL-8, CINC-1, 
macrophage inflammatory protein-2 (MIP-2)], activated complement factors and 
platelet  activating  factors (PAF)(Jaeschke  2003a;  Jaeschke  and  Smith  1997b; 
Okaya  and  Lentsch  2003).  These  mediators  increase  the  expression  of 
CD11b/CD18,  a member of  the  β2-integrin  family  of  adhesion  molecules, and 
other receptors on the surface of neutrophils by causing fusion of the secretory 
vesicles within the neutrophils to cell membrane(Jaeschke 2006). ICAM-1 is also 
transcriptionally  induced  in  endothelial  cells  and  hepatocytes(Farhood  et  al. 
1995; Bell et al. 1997). Selectins(Sawaya, Jr. et al. 1999) and β2-integrin-ICAM-
1(Rentsch  et  al.  2000;  Vollmar  et  al.  1995a)  interactions  are  involved  in 
neutrophil  rolling  and  adhesion,  respectively,  in  post  sinusoidal  venules.  β1-
integrin have also been implicated in leukocyte rolling/adhesion(Fox-Robichaud 
and  Kubes  2000).  There  is  however,  little  evidence  of  transmigration  of 
neutrophils  from  the  venules(Vollmar  et  al.  1994b).  In  contrast  sinusoids  are 
identified as a site of major extravasation(Chosay et al. 1997). Extravasation is   24
considered a prerequisite for hepatocyte damage by neutrophils(Chosay et al. 
1997). There is no experimental evidence for involvement of adhesion molecules 
in neutrophil accumulation in sinusoids(Rentsch et al. 2000; Vollmar et al. 1995a; 
Fox-Robichaud and Kubes 2000). However, the extensive vascular injury during 
reperfusion damages the sinusoidal endothelial barrier and allows direct access 
for the neutrophils to the hepatocytes(McKeown et al. 1988; Caldwell-Kenkel et 
al. 1991). Once extravasated the neutrophils adhere to hepatocyte by β2-integrin-
ICAM-1 interactions with the ICAM-1 expressed on hepatocytes)(Nagendra et al. 
1997).  The  adherence  to  the  target  induces  degranulation  of  neutrophils  with 
release of proteases and formation of ROS. Some of the ROS can diffuse into 
the  hepatocytes  and  can  cause  intracellular  oxidant  stress  resulting  in 
mitochondrial  dysfunction  and  cell  death(Jaeschke  and  Smith  1997b). 
Intracellular  oxidant  stress  leads  to  oxidation  of  pyridine  nucleotides, 
accumulation  of  calcium  in  mitochondria,  and  superoxide  formation  by 
mitochondria,  which  ultimately  leads  to  opening  of  membrane  permeability 
transition pores and breakdown of mitochondrial membrane potential(Jaeschke 
and Smith 1997b; Nieminen et al. 1997a). Some of the proteases (cathepsin G, 
elastase) increase the hepatocyte damage, whereas others generate more pro 
inflammatory mediators(Jaeschke and Smith 1997b).  
 
1.1.3 The role of reactive oxygen species in I/R injury 
A radical is any atom or biomolecule that contains unpaired electrons(Halliwell B 
and Gutteridge JMC 1999). These unpaired electrons alter the chemical reactivity   25
by  making  the  radical  more  reactive  than  the  corresponding  non-radical.  The 
most biologically relevant  radicals  are the superoxide anion (O2
.-) and  hydroxyl  
(HO
.) (Halliwell 1994). Under normal conditions around 1-3 % of the oxygen that 
is metabolized in the body is converted to superoxide (Nohl et al. 2003).  Another 
important radical is nitric oxide (NO
.). Some other species are intermediate in the 
metabolism of O2 or NO
. but are not radicals as they do not contain unpaired 
electrons.  These  intermediate  species  along  with  radical  species  are  called 
reactive oxygen species and reactive nitrogen species (RNS) respectively. The 
most representative examples of non radical ROS are hydrogen peroxide (H2O2) 
and  hypochlorous  acid  (HOCl).  The  most  representative  of  the  RNS  is 
peroxynitrite  (ONOO
-)(Ischiropoulos  et  al.  1992).  Peroxynitrite  is  a  toxic 
substance that is formed when there is simultaneous production of    nitric oxide 
with superoxide anion: 
 
NO
.      +     O2
.-       ONOO
. (1) 
 
Superoxides  damage  cells  by  their  direct  reactivity  with  numerous  biological 
molecules including lipids, DNA, RNA, catecholamines and steroids, and from its 
dismutation to form H2O2(Cuzzocrea et al. 2001). Trace amounts of metals ions 
(principally iron or Copper) can react with H2O2 in what is known as the Fenton 
reaction to produce the  toxic hydroxyl radical (Sutton and Winterbourn 1989). 
This  radical  can  cleave  covalent  bonds  in  proteins  and  carbohydrates  and 
destroy cell membranes.   26
The burst of ROS generated after reperfusion may contribute to the initiation of 
postischemic liver injury and to the subsequent inflammatory activation. Although 
the  exact  subcellular  sources  of  ROS  generation  in  I/R  are  still  under 
investigation, both the xanthine /xanthine oxidase system and mitochondria have 
been suggested to play important roles (Fan et al. 1999b). Although xanthine 
oxidase was regarded as the principal source of post ischemic oxidant stress in 
the  liver,  recent  evidence  suggests  that  xanthine  oxidase  plays  a  minor  role 
compared  to  mitochondria(Jaeschke  2002).  Mitochondria  are  the  site  of  the 
production of large amounts of superoxide, under conditions of oxidative stress. It 
is  this    stress  that  finally  leads  to  the  formation  of  membrane  permeability 
transition pores and the  breakdown of the mitochondrial membrane potential that 
can cause cellular death (Nieminen et al. 1997b). 
 
Intracellular production of ROS can activate signal transduction pathways and  
regulate gene expression. Two of the systems that are believed to be affected by 
ROS  are  the  nuclear  factor-kappa  B  (NF-kB)  and  activator  protein  1  (AP-1) 
pathways. Both of these  affect cell growth and apoptosis(Palmer and Paulson 
1997).  There  is  evidence  that  extracellular  ROS,  such  as  superoxide  radicals 
produced  by  activated  neutrophils,  may  act  on  redox-sensitive  membrane 
receptors  to  initiate  intracellular  ROS  production.  Through  this  mechanism 
extracellular ROS lead to necrotic cell death. 
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Although ROS have  a significant role in hepatic I/R injury, they also have  an 
essential  role  in    the  defence  function  of  phagocytes  and  are  involved  in  the 
production of mediators regulating liver blood flow and regeneration(Nakatani et 
al. 1997; Pannen 2002). In summary, ROS are important cytotoxic and signalling 
mediators in the pathophysiology of liver I/R injury. A list of ROS properties and 
roles in liver I/R injury is given in table 1. 
 
1.1.4 The role of nitric oxide in liver I/R injury 
NO
. is a  radical synthesized via the oxidation of L-arginine by NO
.   synthetase 
(NOS)(Moncada and Higgs 1993). There are two major isoforms of NOS in the 
liver, endothelial NOS (eNOS) and inducible NOS (iNOS). eNOS is expressed 
constitutively and its activity is dependent on  Ca
++  and Calmoduline(Vasquez-
Vivar et al. 1998). eNOS is expressed only in sinusoidal endothelial cells, whilst 
iNOS is induced by extracellular stimuli such as cytokines and lipopolysacharide 
(LPS), leading to the production of much higher levels of NO
.. iNOS is produced 
by  endothelial  cells,  hepatocytes  and  Kupffer  cells  and  its  activity  is  Ca
++ 
independent.  All  NOS  isoforms  can  be  inhibited  to  varying  degrees  with  N-
substituted  L-arginine  analogs.  Many  of  the  biological  actions  of  NO
.  are 
mediated through the guanylyl cyclase/cyclic GMP system. NO
.  is a lipophilic 
biomolecule  that  diffuses  to  adjacent  cells  and  enters  the  cytosol,  where  it 
activates  soluble  guanylyl  cyclase  by  binding  to  the  iron  in  the  heme  center 
resulting  in  an  intracellular  increase  of  cGMP  levels(Schmidt  et  al.  1993). 
Triggering the cyclic GMP cascade has different effects in different cells that it is   28
produced(Cottart  et  al.  2003).  In  the  sinusoidal  endothelial  cells  it  offers 
cytoprotection  as  well  as  inhibits  platelet  aggregation  and  infiltration  of 
PMNs(Cottart et al. 2003). In hepatocytes, through mechanism regulated by p38 
mitogen activated kinase (p38 MAPK) it causes cytoprotection by preservation of 
pH,  Na+  and  Ca++  homeostasis,  preservation  of  mitochondrial  functions, 
reduced production of ROS and preservation of cytoskeleton(Carini and Albano 
2003). NO can also bind to non-heme  iron in the iron-sulphur centers of a variety 
of enzymes, thus altering their biological activity (Nathan 1992).  
Under physiologic conditions only constitutive eNOS is present in the liver and 
the low level of NO
.  produced regulates hepatic perfusion, preventing platelet 
adhesion, thrombosis and polymorphonuclear cell (PMN) accumulation(Mittal et 
al. 1994).  NO
.  also  induces vasodilation at the level of the sinusoid and at 
presinusoid sites(McCuskey 2000; Ming et al. 1999); and plays an important part 
in keeping a balance with  vasoconstrictors such as  endothelins (Pannen 2002). 
It has also been reported that NO
. inhibits leukocyte-endothelial cell adhesion 
and prevent leukocyte secretion of inflammatory mediators(Gauthier et al. 1994).   
 
Induction of iNOS may have either toxic or protective effects. The effects are 
dependent  on  the  type  of  insult  to  the  tissue,  the  tissue  type,  the  level  and 
duration  of  iNOS  expression  and  the  simultaneous  production  of  superoxide 
anion (Cuzzocrea et al. 2001).  
   29
In liver I/R iNOS is  expressed 5 hours after the ischaemic insult(Hur et al. 1999). 
The literature concerning the effect of iNOS in liver I/R injury is still ambivalent. 
Some  studies  suggest    that  iNOS  expression  can  have  detrimental 
effects(Meguro et al. 2002; Serracino-Inglott et al. 2003) in liver function whilst 
others that it is beneficial(Hsu et al. 2002; Wang et al. 1998) and yet in others  no 
effect(Hines  et  al.  2002;  Rivera-Chavez  et  al.  2001).  One  study  with  mice 
deficient in iNOS showed a moderate reduction in reperfusion injury.  
 
The toxic effects are linked with the production of peroxynitrite which can cause 
cell  injury,  either  by  inhibiting  mitochondrial  enzymes  and  thus  mitochondrial 
respiration or through the formation of nitrotyrosine and nitrosylation which can 
cause DNA damage.  
 
1.1.5 Oxidative stress and antioxidant system  
The  body  has  developed  major  antioxidant  defense  mechanisms  to  protect  it 
from  free  radicals.  The  definition  of  an  antioxidant  is  quite  difficult.  A  broad 
definition  is  that  an  antioxidant  is  any  substance  that  when  present  at  low 
concentrations  compared  with  those  of  an  oxidizable  substrate,  significantly 
delays or prevents oxidation of the substrate(Gutteridge 1995). These defenses 
can be classified according to the site of action as: intracellular; membrane and 
extracellular. 
Another  classification  is  according  to  the  mode  of  action.  There  are  four 
mechanisms:    30
a.  Catalytical  removal  of  ROS.  Enzymes  such  as  superoxide  dismutase, 
catalase,  peroxidases  and  thiol-specific  antioxidants  act  through  this 
mechanism. 
b.  Chelation  of  prooxidants  such  as  iron  ions,  copper  ions  and  haem. 
Proteins like transferrins, haptoglobins, haemopexin, metallothionein and 
caeroloplasmin are examples. 
c.  Protection of biomolecules against oxidative damage. In this category are 
the heat shock proteins.  
d.  Scavenging  of  ROS  and  RNS.  Examples  are  low-molecular-mass 
antioxidants such as glutathione, a-tocopherol, ascorbic acid, bilirubin, uric 
acid. 
 
 
1.1.5.1 Intracellular antioxidant defences 
Intracellular  antioxidant  defences  include:  the  superoxide  dismutase  (SOD); 
catalase; glutathione peroxidase and reductase enzymes, thioredoxine and other 
peroxidases such as Cytochrome c, NADH, horseradish peroxidase. 
 Superoxide  dismutases  catalyse  the  dismutation  of  superoxide  to  hydrogen 
peroxide and oxygen: 
 
2O2
.-      +   2H
+                      H2O2   +      O2  (2) 
Three  forms  of  SOD  exist  with  different  subcellular  localizations.  Those 
containing  copper  and  zinc  (Cu/ZnSOD)  are  located  in  cytosol,    manganese   31
(MnSOD) in the mitochondria (Ho and Crapo 1988) and the third form is secreted 
into the extracellular environment. 
The  product  of  reaction  (2),  hydrogen  peroxide,  is  a  weak  oxidant  and  is 
relatively stable. However unlike superoxide, H2O2 can rapidly diffuse across cell 
membranes and in the presence of transition metal ions it can be converted to 
hydroxyl radicals via Fenton chemistry:  
 
Fe
+2    +   H2O2                       Fe
+3   +    
.OH +  OH
- (3) 
 
Two enzymes can break down H2O2 . 
One of them is the hemoprotein catalase. Catalase is present in all major body 
organs  being  especially  concentrated  in  liver.  It  catalyzes  the  breakdown  of 
hydrogen peroxide in oxygen and water:   
2 H2O2                            O2       +      2H2O (4) 
 
The  second  is  the  system  consists  of  glutathione  peroxidases.  This  group 
includes four different isoforms(Dufaure et al. 1996). They are located in cytosol 
and  mitochondria  and  have  a  major  role  in  removing  hydrogen  peroxide 
generated by superoxide dismutase with the oxidation of glutathione (GSH): 
2 GSH   +  H2O2                   GSSG  +  2H2O (5) 
Glutathione reductase is also an important enzyme in this system. It expresses 
its action through the regeneration of GSH from GSSG using NADPH(Meister 
1988). 
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GSH scavenges 
.OH, OHCl, peroxynitrite, carbon centred radicals and singlet 
oxygen  (
1O2).  GSH  is  involved  in  many  other  metabolic  processes,  including 
chelation of Copper ions, and prevention of oxidation of protein –SH groups.  
 
Thioredoxin is a polypeptide being especially concentrated in the endoplasmic 
reticulum but some is also found on the cell surface. Thioredoxin contains two 
adjacent –SH groups in its reduced form that are converted to a disulphide in 
oxidized thioredoxin. It can undergo redox reactions with multiple proteins. 
 
1.1.5.2 Extracellular antioxidant defences 
Major  extracellular  antioxidant  defences  include  the  metal-binding 
proteins(Betteridge 2000). It is well known that the free metals iron and copper 
can promote free radical damage, accelerating lipid peroxidation and catalyzing 
hydroxyl  radical  formation.  The  body  is  protected  against  these  potentially 
adverse  effects  by  binding  proteins  (transferrin,  lactoferrin  and  ceruloplasmin) 
which ensure that these metals are maintained in a nonreactive state(Halliwell 
and  Gutteridge  1990).  Similarly  haptoglobins,  hemopexin  and  albumin  bind 
haemoglobin and haem.  Haemoglobin and myoglobin are normally intracellular 
proteins. When these proteins are exposed to a large amount of oxidative stress 
(e.g. large amounts of H2O2) they are degraded releasing both haem and iron 
ions that can stimulate lipid peroxidation.  
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1.1.6 Role of Hemoxygenase in IR 
Hemoxygenase is an enzyme found in the endoplasmic reticulum that catalyses 
the first and rate limiting step of degradation of haem to yield equimolar amounts 
of biliverdin, carbon  monoxide (CO)  and free divalent iron(Wunder  and Potter 
2003).  Biliverdin  is  subsequently  reduced  to  bilirubin  while  the  iron  is 
sequestered by ferritin. 
 
 
Figure 1.1 
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Three  isoforms  of  HO  have  been  identified.  HO-1  also  known  as  heat  shock 
protein  32,  is  highly  inducible  in  all  cells.  HO-2  is  a  constitutively  expressed 
36kDa protein which is unresponsive to stimuli increasing HO-1 expression. HO-
3 is a 33 kDA protein which is a weak catalyst for haem degradation and is non 
inducible(Maines 1988; McCoubrey, Jr. et al. 1992; McCoubrey, Jr. et al. 1997). 
HO-2  is  most  abundant  in  hepatocytes,  sinusoidal  endothelial  cells,  hepatic 
stellate cells and Kupffer cells(Bauer et al. 1998). In normal physiological states,   34
Kupffer cells are the only cells which constitutively express HO-1(Bauer et al. 
1998). In conditions of stress such as hypoxia, I/R, hyperthermia, oxidative or 
cytotoxic stress HO-1 is upregulated primarily in the parenchymal cells(Wunder 
and Potter 2003; Bauer et al. 1998). Endogenous HO activity within the liver was 
shown to preserve microcirculatory dysfunction and prevent cell injury following 
I/R injury(Kobayashi et al. 2002; Coito et al. 2002; Kato et al. 2001; Redaelli et al. 
2002).  The  exact  mechanism  of  the  protective  role  although  not  known,  CO, 
biliverdin  and  ferritin  are  thought  to  be  responsible  for  it(Wunder  and  Potter 
2003). 
 
1.1.6.1 Carbon Monoxide (CO) 
CO released during haem oxidation by HO functions as a second messenger in a 
fashion similar to NO(Verma et al. 1993; Maines 1997). CO has a stimulatory 
effect on soluble guanylate cyclase thereby increasing cyclic GMP, which in turn 
through effect on smooth muscle contractility leads to vasodilatation(Pannen et 
al. 1998; Morita et al. 1995; Sammut et al. 1998). CO has also been shown to 
cause smooth muscle relaxation via activation of calcium dependent potassium 
channels(Wang et al. 1997). CO also influences vascular resistance by inhibiting 
cytochrome  P450  mediated  production  of  endothelin-1(Coceani  et  al.  1996; 
Coceani  et  al.  1997).  It  also  acts  through  mitogen  activated  protein  kinase 
(MAPK)  in  reducing  the  expression  of  TNFα,  IL-1β,  and  macrophage 
inflammatory  protein  (MIP-1)(Otterbein  et  al.  2000).  The  use  of  water  soluble   35
carbon monoxide releasing molecule intravenously in reperfusion phase of I/R 
has been shown to reduce the infarct size in hearts of mice(Guo et al. 2004).  
 
1.1.6.2 Biliverdin and Bilirubin 
Both  bilirubin  and  biliverdin  have  antioxidant  properties(Stocker  et  al.  1987; 
Stocker and Ames 1987) and are known to prevent oxidation of poly unsaturated 
fatty acids(Neuzil and Stocker 1994). Bilirubin protects cells from oxidative stress 
by scavenging ROS(Snyder and Baranano 2001). Administration of bilirubin to 
rats has been shown to modulate the expression of P-selectin and E-selectins 
which suggests that bilirubin has anti inflammatory properties(Vachharajani et al. 
2000). 
 
In addition to the major protective role of the metal-binding proteins, various low-
molecular-weight  molecules  that  are  synthesised  in  vivo  have  antioxidant 
properties(Ames  et  al.  1981;  Frei  et  al.  1988;  Layton  et  al.  1996).  The  most 
important of these substances are bilirubin, melatonin, lipoic acid, Coenzyme Q, 
Uric acid and Melanin. 
        
In  clinical  settings  where  liver  I/R  injury  occur,  the  endogenous  antioxidant 
system  can  be  depleted  and  a  serious  imbalance  between  production  of 
ROS/RNS and antioxidant defence can happen. This imbalance called oxidative 
stress leads to cell, tissue and organ injury. In these situations the replacement 
of the antioxidants that have been depleted could have a therapeutic role.    36
Figure 1.2 
Schematic Representation of Pathophysiology of Liver I/R injury 
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Figure 1.3 Antioxidant defences against Ischaemia reperfusion injury 
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Table 1.1 
 
 Role of ROS in liver IR injury 
1. Enhance pro-inflammatory gene expression (TNF-a, IL-1, IL-8, cellular 
adhesion 
    molecules) 
2.  Induce  expression  of  the  transcription  factors  NF-kB  and  activator 
protein-1  
3. Direct cellular damage through protein oxidation and degradation, lipid 
     peroxidation and DNA damage 
4. Direct induction and regulation of apoptotic and necrotic cell death 
5. Inactivation of antiproteases 
6. Induction of protective stress genes in hepatocytes 
7. Formation of mediators involved in regulating sinusoidal blood flow and 
liver regeneration 
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Chapter 2 
Bucillamine: A thiol antioxidant 
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2.1 Bucillamine: Introduction 
Bucillamine  [N-  (2-mercapto-2-  methylpropinyl-  L-  cysteine)]  (previously  called 
SA96),  is  structurally  analogous  to  cysteine.  The  compound  contains  two 
donatable  thiol  groups  and  is  more  potent  than  cysteine  and  other  cysteine 
derivatives  containing  only  one  thiol  grouping  ameliorating  the  effects  of 
IR(Amersi  et  al.  2002;  Amersi  et  al.  2002;  Horwitz  and  Sherman  2001). 
Bucillamine  is  fourfold  more  potent  than  NAC  in  in  vitro  studies(Horwitz  and 
Sherman 2001) and in mice 20 mg /kg i.p. of bucillamine had similar effects to a 
16-fold greater dose of NAC (320 mg/kg i.p.) in models of cardiac I/R(Whitekus et 
al.  2002).  .  As  an oral formulation it is marketed  in  Japan  and Korea  for  the 
treatment of rheumatoid arthritis(Matsuno et al. 1998). 
 
2.2 Chemistry 
Bucillamine [Molecular Weight 223.3] 
Cysteine is the rate limiting intracellular precursor of glutathione(De et al. 2001). 
Reduced glutathione (GSH) cofactored by glutathione peroxidase gets converted 
to the oxidised form (GSSG) in the presence of peroxides(Ceconi et al. 1988b). It 
serves as a major endogenous defence against oxidative stress. Bucillamine can 
be rapidly transported into the cells by transport protein utilised by cysteine and 
can  restore  intracellular  glutathione  levels.  Bucillamine  is  available  as  a 
lyophilized powder which is highly soluble. It forms an acidic solution with normal 
saline which can be  neutralised with sodium hydroxide for intravenous  use in 
experimental animals.   41
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Figure2.2.1: Chemical structure of Bucillamine 
 
 
 
 
 
 
 
 
 
                                           O   
 
 
 
              NH2             CH              C           OH 
 
 
 
                           CH2SH 
 
Figure2.2.2: Chemical structure of Cysteine 
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Figure2.2.3: Chemical structure of Bucillamine metabolite SA 981 which has a structural 
similarity to D- Penicillamine 
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Figure2.2.4: Chemical structure of Bucillamine metabolite SA672 which has one donatable thiol 
group 
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2.3 Pharmacology 
The blood concentration of Bucillamine reaches a peak of 20µg/ml after oral 
administration of 50mg/kg with a half life of just under 1hour in rats. The half life 
after intravenous administration is about 24 minutes (Figure 2.3.1). Bucillamine 
enters erythrocytes rapidly and hence precise measurement of bioavailability 
requires whole blood measurements. This can be done using high performance- 
liquid chromatography- mass spectrometry technique(Beaudry et al. 2004). In 
humans the bioavailability and half life is almost similar to animal 
models(Sugawara et al. 1985a; Sugawara et al. 1985b; Horwitz 2003). 
After absorption Bucillamine is metabolised in the liver into three metabolites SA 
981, SA 679 and SA 672, of which, SA 981 has a disulfide compound. These can 
be detected in serum and urine in humans, dogs and rats(Horiuchi et al. 1985; 
Takashina et al. 1985; Matsuno et al. 1998).  
In Phase I human studies in normal volunteers, bucillamine at a dose up to 
25mg/kg/h i.v. for 3 hours elicited no serious toxicity(Horwitz 2003). On the basis 
of the pharmacokinetic assessment of blood levels during these studies it was 
concluded that bucillamine infused i.v. at doses ≥ 10 mg/kg/h for 3 hours in 
humans could be therapeutically beneficial in I/R injury(Horwitz 2003).  
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Figure 2.3.1 
 
(Taken  From: Sugawara, S, Ishigama, M, and Kageyama, T. Phase I study of N-(Mercapt-2-
methlpropionyl)-L-cysteine (SA96). (I) Single administration study. Rinsho Yakuri 16(3), 611-620. 
1985.) 
   
2.4 Bucillamine in Rheumatoid arthritis 
Rheumatoid  arthritis  is  a  chronic  inflammatory  process  associated  with 
inflammatory synovial hyperplasia. Cytokines ( including TNF- α, IL-1, IL-6, IL-8, 
interferon-γ  and  GM-CSF)  are  involved  in  the  pathogenesis  of  Rheumatoid 
arthritis(Arend and Dayer 1995). TNF-α and IL-1 stimulate the gene expression 
of  these  cytokines  and  cell  adhesion  molecules  (CAM)  through  a  signal 
transduction pathway leading to NF-κB activation in human synovial cells (Arend 
and Dayer 1995; Ledebur and Parks 1995). Bucillamine has been shown to block   45
the NF-κB activation cascade, leading to decrease in cytokine production and  
attenuation of Rheumatoid arthritis(Aono et al. 1996; Fujisawa et al. 1996; Tsuji 
et al. 1999). Bucillamine is a more potent inhibitor of NF-κB than NAC(Tsuji et al. 
1999).  Treatment  with  Bucillamine  for  long  duration  either  on  its  own  or  in 
combination  with  other  drugs  has  shown  clinical  benefit  in  patients  with 
rheumatoid  arthritis  along  with  lowering  of  IgG,  IgA  and  rheumatoid 
factor(Nagashima et al. 2006; Goto et al. 1992; Isozaki et al. 1992; Kashiwazaki 
and Shiokawa 1987; Kim et al. 1996). 
 
2.5 Adverse Effects 
Incidence  of  adverse  effects  with  Bucillamine  is  very  low  with  most  adverse 
effects being reported as case reports in patients who were receiving treatment 
for  a  few  months.  The  common  side  effects  with  Bucillamine  treatment  are 
pruritus  rash,  stomatitis,  proteinuria,  nausea,  anorexia  and  abnormal  liver 
function  tests(Goto  et  al.  1992;  Isozaki  et  al.  1992;  Yoshida  et  al.  1991; 
Nagahama  et  al.  2002).  Most  of  these  developed  on  chronic  usage  and 
disappeared on stopping the drug. Sakai et al have also reported giant mammary 
hyperplasia in a young women(Sakai et al. 2002). Other adverse effects reported 
are interstitial pneumonia, myasthenia gravis and agranulocytosis(Nakashima et 
al. 1995; Sawa et al. 1999; Miwa et al. 2002). 
 
2.6 Studies Involving use of Bucillamine in IR injury: 
These have been tabulated below (Table 2.1):   46
Model  Organ  Ischaemia 
Type 
Duration  Route of 
administration 
Bucillamine 
Dose 
Outcome Measures  First 
author 
(Year) 
Tissue  Cardiac 
Myocytes 
Oxidative 
stress -
H2O2 
44 hours  Incubation  0, 125, 250, 
500µM 
Dose dependent ↓ in LDF 
levels 
Horwitz 
LD 
(2001)  
Canine  Cardiac  Warm 
ischaemia 
90 min 
ischaemia 
48 hour 
reperfusion 
I. V. during 3hr 
reperfusion 
11 mg/kg/hr, 
22mg/kg/hr 
Dose dependent 
improvement in (Infarct 
size)/(region at risk) ratio 
Horwitz 
LD 
(2001) 
Rat  Normal 
Liver ex 
vivo 
Cold 
ischaemia 
24 hour  Intraportal  10mg at 
harvest, 90mg 
in perfusate 
↑ portal venous flow, ↑ 
bile production, ↓SGOT, 
↑ Liver GSH, ↓ Liver 
GSSG, ↑ Blood perfusate 
GSH, ↓ Blood perfusate 
GSSG, Histology 
Amersi 
F (2002)  
Rat  Steatotic 
Liver ex 
vivo 
Cold 
ischaemia  
24 hour  Intraportal  10mg at 
harvest, 90mg 
in perfusate 
↑ portal venous flow, 
↑bile production, ↓SGOT, 
↑ Liver GSH, ↓ Liver 
GSSG, ↑ Blood perfusate 
GSH, ↓ Blood perfusate 
GSSG, Histology 
Amersi 
F (2002)  
Rat  Liver in 
Vivo OLT 
Cold 
ischaemia 
24 hour  Intraportal 
 
 
Intravenous 
15mg/kg 
before 
reperfusion 
10mg/kg 
30min after 
reperfusion 
Improved survival, 
↓serum GOT levels, 
histology 
Amersi 
F (2002)  
Table2.1  47
 
2.7 Probable mechanism of action in IR 
1.  Bucillamine  has  been  shown  to  preserve  high  concentrations  of 
glutathione in an ex vivo liver cold ischaemia model(Amersi et al. 2002; 
Matsuno et al. 1998).  Its anti oxidant activity could hence be primarily 
related  to  replenishment  of  endogenous  reduced  glutathione  by  the 
donated thiol groups.  
2.  The  fully  oxidised  metabolite  of  Bucillamine  SA  981  has 
immunomodulating effect.  It is more potent in suppressing IL-6 production 
in cultured synovial cells than bucillamine itself(Matsuno et al. 1998). 
3.  Bucillamine and SA 981 increase glutathione biosynthesis in both human 
and  murine  hepatoma  cell  lines(Wielandt  et  al.  2006).However,  the 
increase in biosynthesis was seen after 24 hours and is unlikely to be the 
mechanism of action in early phase of I/R injury.  
4.  Bucillamine  is  a  chelating  agent  which  may  retard  iron  mediated 
generation of free radicals(Mazor et al. 2006). 
 
Bucillamine  has  also  been  found  to  act  as  a  pro-  oxidant  at  low 
concentrations(Kladna  et  al.  2006)  and  induces  apoptosis  through  enhanced 
generation of ROS in the presence of copper ions(Sawada et al. 1997). High 
doses of Bucillamine (150mg/kg- 400mg/kg) given intraperitoneally is known to 
deplete liver GSH in mice and cause oxidative damage(Yeung 1991). 
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2.8 Hypothesis 
The effect of bucillamine in warm ischaemia reperfusion model in liver has not 
been studied as yet. We hypothesize that bucillamine would protect against warm 
ischaemia reperfusion injury through its antioxidant and anti-inflammatory effects. 
 
2.9 Aim 
To use a well described model of Liver ischaemia reperfusion to determine the 
effect of Bucillamine administration on liver function, liver microcirculation and 
apoptosis. 
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Chapter 3 
Materials and Methods 
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3.1 Animals and surgical preparation for lobar IR model 
The drug was evaluated in an in vivo lobar liver ischaemia reperfusion model as 
previously described(Koo et al. 1992; Koti et al. 2005). The study was conducted 
under a project license from the Home Office in accordance with the Animals 
(Scientific Procedures) Act 1986. Male Sprague –Dawley rats, weighing 270-
330gms were used. Animals were kept in a temperature controlled environment 
with a 12 hour light-dark cycle and allowed tap water as well as standard rat 
chow pellets ad libitum. Animals were anaesthetised with 4% Isoflurane and 
maintained with 2.0% Isoflurane. They were allowed to breathe spontaneously 
through a concentric mask connected to an oxygen regulator and monitored with 
a pulse oximeter (Ohmeda biox 3740 pulse oximeter, Ohmeda, Louisville, USA). 
 
Polyethylene catheters (Portex 2 Fr) were inserted into the carotid artery (right or 
left) for monitoring of mean arterial blood pressure and the right jugular vein for 
administering normal saline (1ml /100gm body weight/hour) to compensate for 
intraoperative fluid loss. 
 
Laparotomy was carried out through a midline incision. The ligamentous 
attachments of the liver were cut and the liver exposed. All animals were given 
heparin 20 units /kg body weight and partial hepatic ischaemia of the left lateral 
and median lobes of (70% of liver) was induced by clamping the corresponding 
vascular pedicle with an atraumatic microvascular clamp for 45 minutes in the 
control and Bucillamine groups. This model prevents splanchnic congestion by   51
allowing flow through the remaining liver(Koo et al. 1992; Koti et al. 2005). 
Animals in the Sham group did not have any vascular clamping. Animals were 
monitored for 3 hours in the reperfusion period. Animals were randomly allocated 
to the following groups:   
 
3.1.1 Experimental groups (n=6 in each group) 
Group1 - (Sham) – laparotomy and mobilisation of liver but no occlusion of the 
vascular pedicle. 
Group2- IR- 45 minutes of partial hepatic ischaemia followed by 3 hrs of 
reperfusion. 
Group3- Bucillamine 15mg/ kg/hr intravenously + IR followed by 3 hrs of 
reperfusion. 
Group4- (SB) - Sham + Bucillamine infusion 15mg/kg/hr (SB) 
Group5- IR24- 45 minutes ischaemia followed by 24 hour reperfusion 
Group6- B24- 45 minutes ischaemia + Bucillamine 15mg/ kg/hr intravenously for 
3 hours followed by 24 hour reperfusion 
Subjects in the bucillamine group were administered an infusion of bucillamine 
(15mg/kg/hr) over the operative period (preischaemia, ischaemia and 3 hour post 
reperfusion). Bucillamine was supplied by Santen pharmaceuticals, Osaka, 
Japan. Animals in the Sham, SB and I/R groups were given an equivalent volume 
of saline up to 3 hours of reperfusion (or equivalent period in case of sham 
operated animals). Temperature of the animals was monitored and maintained at 
36-38
oC by means of a heated platform (Harvard Apparatus, Kent, UK). The   52
experiments were terminated by exsanguination and serum and plasma samples 
were collected by spinning the blood at 3000rpm for 10 minutes and stored in 
aliquots of 0.2 mls at -80
o C. Liver tissue was stored in formalin for 
histopathology and immunohistochemistry. Liver tissue was also frozen 
immediately on termination of the experiment in liquid nitrogen and stored at -80
o 
C for further analysis.  
 
3.1.2 Recovery experiments 
In the recovery experiments (Group 5 and 6) the animals were given Bucillamine 
15 mg/kg/hr or equivalent volume of saline for 3 hours intravenously following the 
ischaemia, the abdominal wound was closed with 4-0 vicryl and the neck line was 
removed after the period of infusion and the neck wound closed using 4-0 Vicryl 
continuous suture. The animals were recovered, administered adequate 
analgesia (Buprenorphine 0.15mg/kg subcutaneously)  and kept in a temperature 
controlled environment with a 12 hour light-dark cycle and allowed tap water as 
well as standard rat chow pellets ad libitum. After 24 hours the animals were re-
anaesthetised with 4% Isoflurane and maintained with 2.0% Isoflurane (Abbott 
Laboratories Ltd., Kent, UK). They were allowed to breathe spontaneously 
through a concentric mask connected to an oxygen regulator and monitored with 
a pulse oximeter (Ohmeda biox 3740 pulse oximeter, Ohmeda, Louisville, USA). 
The right carotid artery was cannulated with a polyethylene catheter (0.40-mm 
inner diameter, Portex, Kent, UK) for administering fluorochromes. The abdomen 
was re-opened through the previous incision. The left lobe of liver was mobilised   53
gently and placed under the intravital microscope for visualisation of the hepatic 
microcirculation. Following this experiments were terminated by exsanguination 
and samples were collected as above. 
 
3.1.3 Preparation of Bucillamine 
Bucillamine was kindly provided by Santen Pharmaceutical, Osaka, Japan, as a 
lyophilized powder. This dissolves in normal saline readily to form an acidic 
solution. Bucillamine solution was freshly prepared just before each experiment 
(1.5 mg/ml in normal saline [concentration adjusted in dosing experiments]). The 
pH of the solution was then adjusted to 7.4 by titrating with NaOH solution. 
 
3.1.4 Blood collection in lobar IR model 
Blood samples were collected from the IVC at the end of reperfusion. Samples 
were heparinised and centrifuged at 3000 RPM for 10 minutes at room 
temperature to sediment the erythrocytes.  The plasma supernatant was 
removed and stored at –80 °C until required for assay of plasma F2 isoprostanes. 
Sample was also collected in serum gel tube (BD Vacutainer Systems, Plymouth, 
UK) and allowed to stand for 2 hours, following which sample was spun down at 
3000RPM for 10 minutes and supernatant serum removed and stored in -80
o C 
until required for assay for Alanine transaminase and Aspartate transaminase 
and serum CINC-1 levels.   54
3.1.5 Tissue collection 
At termination of reperfusion phase, sections of liver were (1) freeze clamped in 
liquid nitrogen (for determination of tissue glutathione, tissue F2 isoprostanes and 
immediately stored [at –80
0 C] for western blotting), and (2) fixed in 10% formalin for 
histological study.  
 
 
3.2 Intravital microscopy 
3.2.1 Introduction 
The first intravital fluorescent microscope (IVFM) was made by Ellinger and Hirt 
in  Germany , which was a modified version of the fluorescence microscope 
(developed in the early 20
th century [1929]) to allow tissues to be 
examined(Kasten 1993). The IVFM can be divided into two separate measuring 
systems. The first represents the microscope alone, with the light source, lenses, 
filters and fluorescence acting as the functional elements (Fig 3.2.1). 
 
Figure 3.2.1. Intra-vital fluorescence microscope – instrumental 
components. 
Light through eye 
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The second system begins with the image seen from the microscope being 
converted via the CCD camera, passing through the frame grabber and onto the 
computer monitor display (Figure 3.2.2) 
 
Figure3.2.2. Image recording system in the intravital microscope 
 
The IVFM used for this study was a custom built Nikon Epi-illumination system 
with filter block set suitable for Texas Red, FITC and DAPI dyes as detailed in 
table 3.2.1 
Table 3.2.1.The filter set details for the Nikon Epi-illumination system. 
Fluorochrome  Excitation 
(nm) 
Emission 
(nm) 
Colour  Type of label 
DAPI  360  450  Blue  Nuclear Stain 
FITC  495  525  Green  Protein 
Conjugation 
Texas Red  596  620  Red  Protein 
Conjugation 
 
Microprocessor in 
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converts the binary 
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the combined array 
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Frame 
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Serial register 
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Output buffer. 
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reads images 
and stores as 
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CCD Camera 
Images from 
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microscope 
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Figure 3.2.3.The complete intravital microscopy setup. 
 
3.2.2 Principles 
Fluorescence is the inherent property of some atoms and molecules to absorb 
light of a particular wavelength and, after a brief interval (the fluorescent lifetime) 
re-emit light at a longer wavelength.  
 
These atoms and molecules (chromophores) are excited by an external light 
source. They absorb the light energy and pass into an excited energy state. After 
entering the higher energy state, the molecules undergo internal changes.  The 
electrons in certain molecules instead of returning to the ground state enter a 
metastable state. When the molecules pass down to the ground state they emit 
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the excess energy as electromagnetic radiation (Sykes et al. 1991) which is seen 
as fluorescence. The energy between the metastable and ground states is less 
than the energy absorbed during excitation, so the emission wavelength will be of 
longer wavelength than the absorbed or excitation light(Sykes et al. 1991). 
The light from the epi-illumination light source (which is usually a mercury arc or 
xenon lamp in standard IVFM setups) first passes through an excitation or short-
pass (SP) filter allowing only the excitation waves through. These are then 
passed onto a chromatic beam splitter (dichromatic mirror) where wavelengths 
below a certain value are reflected onto the specimen while any above the 
wavelength value are passed through and dissipated. The light hitting the 
specimen then activates the chromophore which emits light of a particular 
wavelength.  
A dichromatic mirror allows passage of certain values of excitation and emission 
wavelengths. The dichromatic mirror is designed to allow the transmission of 
longer emission wavelengths and reflect the shorter excitation wavelengths. The 
three filters are usually contained within a filter box as illustrated in figure 3.2.4. 
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Figure 3.2.4 Schema of Filter Block  
 
 
After passing through the dichromatic beam splitter the excitation wavelength 
then passes through a barrier filter that removes any light of shorter wavelength 
that may have passed through the dichromatic beam splitter. This emission 
wavelength then passes into a detector that sends the signals to the eye pieces 
for operator observation or into a video camera for image recording.  
 
3.2.3 Components 
3.2.3.1 Light source 
The light of the IVFM is a fluorescent mercury arc lamp, which is protected in a 
lamp-house. Since the development of epi-illumination, microscope optics has 
developed with the incorporation of laser light sources increasing the resolution 
of the image and improving the signal-to-noise ratio. A rheostat or ballast alters 
the current applied to the lamp to control the intensity of the light produced. In a 
gas discharge, such as a fluorescent lamp, current causes resistance to 
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decrease. This is because as more electrons and ions flow through a particular 
area, they bump into more atoms, which frees up electrons, creating more 
charged particles.  
 
3.2.3.2 Objective lenses 
IVFMs usually use water immersion objectives as these reduce the refractive 
index in living in vivo imaging .The water immersion objective delivers contrast 
and resolution values nearly equivalent to the theoretical limits, and maintains its 
performance when water layers of 80 and 153 µm are added between the target 
specimen and cover slip, a simulation of the situation encountered in imaging 
deep within aqueous material such as living cells or tissue.  
 
There are four types of filters in the intra-vital fluorescence microscope system, 
neutral density (ND) filters, an excitation filter, an emission filter and a multi-band 
pass filter. 
 
Special neutral density (ND) filters are built in the light path to block 90-95% of 
the incidence light passing into the microscope to prevent damage to the eye as 
well as reduce overexposure of fluorescence in specimens(Nikon 2004). There 
are three neutral density filters which are placed in front of the optical light path to 
reduce illumination without altering the colour balance.  
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The excitation filter passes only a selected range of wavelengths of light to cause 
the fluorescently labelled specimen to fluoresce and filters the rest. The 
bandwidth of a filter determines the brightness of the fluorescent image. If the 
bandwidth is narrow then the image appears dark but minimal auto-fluorescence 
and photo-bleaching occur. With a wide bandwidth, although the image appears 
bright, autofluorescence may also be detected with the added disadvantage of 
photo-bleaching(Nikon 2004). 
 
The emission or barrier filter allows only light wavelengths that have been emitted 
from the specimen. These are usually longer according to Stoke's law. In older 
epi-illumination microscopes only a dichromatic beam splitter is present allowing 
use of one fluorescent dye at a time. However newer developed models have a 
multi-band pass filter or a polychromatic beam splitter that can allow visualisation 
of three different coloured fluorescent dyes. 
 
3.2.3.3 CCD Camera  
The image obtained from the IVFM is then recorded by a charged coupled device 
(CCD) camera. For this study a JVC TK-C1360B colour video camera was used 
(JVC video camera, JVC, Osaka, Japan). CCD sensors are light integrating 
devices that accumulate photo charges until image readout. The CCD chip in the 
camera contains an array of pixels that transform light (wavelength 400nm to 
1000nm) into a charge, which during readout is transformed into a voltage. 
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Once photo charges are shifted to the storage area, images are erased from the 
CCD light sensing area(Cinelli 1998). New photo charges can not pile up on top 
of the previous images. 
 
The photo charges are shifted in block from the sensing area to the storage area, 
then each line is individually read to the serial registers and finally photo charges 
are transferred to the output buffers. Each readout cycle is initiated by a vertical 
sync pulse (vertical blanking sync) which activates the parallel driver and triggers 
the shift block of photo charges accumulated in the sensing area to the CCD 
storage area. 
Exposure time is the main factor that determines the sensitivity of CCD cameras. 
Long exposure times improve camera sensitivity and reduce the noise levels of 
the images, since the accumulation of the photo charge in the CCD sensor is 
proportional to the duration of the exposure period .The analogue video images 
are digitised at varying resolutions typically around 8 bits resolution by a frame 
grabber board. 
 
3.2.3.4 Frame Grabber 
The Matrix Meteor II/Standard frame grabber used in this study allows image 
acquisition at 25 frames per second. The main parts of the frame grabber are the 
low-pass filter, the decoder, the trigger and the image coding components. The 
low pass filter reduces the high frequency noise and aliasing effects from the 
analogue CCD signals and passes the refined signals to the video decoder. This   62
is the component of the frame grabber that performs the actual analogue to 
digital conversion of the component (Y/C) analogue video signals. 
 
3.2.3.5 Image Analysis Software 
Adjusting the output image can enhance the resolution and contrast of the image. 
Light intensity and colour are represented in numbers between 0 (black) and 255 
(white). Converting the image into binary form means it is converted into a black 
and white image. This is done by assigning threshold values which determine the 
distribution of the pixels into two populations either of value 0 or 255.  
 
An image can be transformed into binary form using many different types of 
software packages. 
Laboratory Universal Computer Image Analysis (LUCIA) is a multi-spectral image 
analysis software developed specifically for image processing independently on 
red, green and blue components and then combining them together into the RGB 
image at the same time. Most Nikon microscopes are supplied with Lucia 
software and there are many versions available denoted by the letter following 
Lucia. Lucia G is the top of the range package that allows 24-bit colour image 
analysis with the function to allow user to create specialized macros which was 
used in this study.  
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3.2.4 Preparation of Fluorescent Dyes 
In order to measure the parameters RBCs were labelled with fluorescein 
isothiocyanate (FITC) and leukocytes were labelled with Rhodamine 6G. At the 
end of each experiment the amount of cellular damage was assessed by labelling 
with propidium iodide. 
   
3.2.4.1 Labelling of RBCs 
An animal was sacrificed by exsanguination and RBCs were labelled using the 
following protocol(Zimmerhackl et al. 1983): 
Protocol for Fluorescence Labelling Of RBC 
 
Stock Solution 1 (adjust to pH 7.4) 
Barbital Sodium   2.55 g 
1M HCl     10 ml 
NaCl       6.8 g 
Bring to     0.5 L 
 
Stock Solution 2:- 
MgSO4.7H2O 24.6 g 
100ml distilled water makes 1M solution 
 
Stock Solution 3(0.03M CaCl2): 
CaCl2.2H2O      4.41 g 
100ml distilled water makes solution. 
 
Note: Stock solutions can be kept for around a month in a fridge at 4
0C. 
 
Working Solution (glucose saline buffers) 
Stock 1  50 ml   
Stock 2  0.1 ml 
Stock 3  0.1 ml 
Glucose  4.2 g  
Make up to 200ml with distilled water 
 
FITC for red blood cells:- 
40mg of FITC 
2ml of glucose saline buffer   64
 
Labelling cells: 
1. Collect approx 8ml blood in heparinised tube or as much as you need.  
2. Centrifuge blood at 400g or 2000r.p.m for 10mins  
3. Remove plasma + buffy coat  
4. Wash cells with glucose saline buffer 5 times  
5. 1ml of washed red cells are added to 1ml of buffer and 0.4ml of FITC  
6. Leave for 1.5 to 2hrs at room temp  
7. Labelled cells are washed 3 times until no colouring is left in supernatant  
8. Suspend in glucose saline buffer in 1:2 dilution. 
 
RBCs which were labelled could be stored at 4
0 C for 3-4 days. 
 
3.2.4.2 Leukocyte labelling 
Leukocyte were labelled in vivo with rhodamine 6G-(Sigma, Rodermark, 
Germany) 0.3 mg/kg by administering the dye intra- arterially(Wunder et al. 2002)
 
through the carotid artery at 150 minutes post reperfusion. Rhodamine 6G 
accumulates in the mitochondria of the leukocytes. Intrarterial or intravenous 
injection results in labelling of circulating leukocytes(Dunn et al. 2002). In Vivo 
labelling of leukocytes requires using freshly prepared rhodamine solution 
dissolved in normal saline. 
 
3.2.4.3 Detection of hepatocellular death in vivo. 
Irreversible injury in anoxic hepatocytes results in abrupt increase in plasma 
permeability which results in uptake of Propidium Iodide fluorescent dye stains 
nuclei of cells that are lethally damaged(Herman et al. 1988). Propidium iodide 
solution 0.05mg per ml of saline was prepared and 0.05 mg/kg was injected at 
the end of 3 hours of reperfusion.   65
3.2.5 Measurement of Parameters by Intravital microscopy 
Pictures taken at Intravital microscopy were recorded on computer (25 frames 
per second) and off line microcirculatory analysis performed at a later time. 
 
3.2.5.1 Measurement of RBC velocity 
RBC velocity was determined by using 40x magnification. Ten sinusoids were 
randomly selected at each time point in each animal and RBC velocity was 
calculated by frame by frame analysis as previously described by Kelly et al(Kelly 
et al. 1998). RBC velocity was calculated by measuring the distance travelled by 
a RBC by frame by frame analysis as shown in figure 3.2.5. RBC velocity was 
then calculated as: 
RBC Velocity = (distance travelled/ n-1) x 25 in µ/sec 
Where n is the number of frames. 
Mean value was calculated for each time point.   66
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.5 Frame by Frame analysis of measuring red blood cell velocity. 
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3.2.5.2 Sinusoidal diameter 
Sinusoidal diameter was measured in ten randomly selected sinusoids at each 
time point in each animal and mean was calculated. 
 
3.2.5.3 Sinusoidal perfusion  
Five randomly chosen non overlapping Rappaport acini were observed for more 
than a minute with recording from representative areas for 2 seconds with the 
JVC video camera (25 frames per second) on the computer for each time point. 
Perfusion was established by studying the ratio of perfused to total visible 
sinusoids after administration of FITC labelled RBC. Perfused sinusoids 
described as continuously perfused (continuous perfusion for > 1 min) (Nc) or 
interrupted (intermittent perfusion for 1 min. period) (Ni) or non perfused (Nn).  
Sinusoidal perfusion index was calculated as: 
Perfusion index= (Nc + 0.5 Ni ) / (Nc + Ni  + Nn)(Post et al. 1993) and expressed 
as %.  
 
3.2.5.4 Sinusoidal Blood Flow 
Sinusoidal blood flow was calculated using formula for capillary blood flow as 
previously described by Wunder et al in 2002(Wunder et al. 2002). 
Sinusoidal blood Flow= Velocity x ￿ ￿ ￿ ￿ x (d/2)
2 (expressed as pl/sec) 
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3.2.5.5 Leukocyte endothelial interactions 
Ten randomly chosen post sinusoidal venules were visualized for at least 20 
seconds each at 40x magnification, under green filtered light. The number of 
sticking leukocytes were counted and expressed as cells per mm
2 of endothelial 
surface ( length of observed vessel length x diameter x ￿ = stickers per mm
2) as 
previously described(Croner et al. 2006; Wunder et al. 2002). Adherent 
leukocytes were calculated as adherent cells/ mm
2 of liver tissue. 
 
 
 
 
Figure 3.2.6 Venules showing adherent Leukocytes (stained yellow) 
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3.2.5.6 Detection of hepatocellular death in vivo. 
Dead nuclei stained with propidium iodide and were expressed as number of 
cells per mm
2. An average value was taken for each subject after studying at 
least 5 high power fields. 
 
 
 
 
 
 
Figure 3.2.7. Nonviable nuclei stained with propidium iodide. 
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3.3 Histological assessment 
Samples of liver were taken, at the end of the experiment from the left lobe. 
These were fixed in 10 per cent neutral buffered formalin and embedded in 
paraffin; paraffin section 4µm thick were cut using a microtome and mounted on 
slides for haematoxylin and eosin staining. Assessment of liver injury was 
performed with light microscopy by Consultant pathologist who was blinded from 
the study groups, by a scoring system devised by Suzuki et al(Suzuki and 
Toledo-Pereyra 1993) as shown in the table 3.3.1. In this system, sinusoidal 
congestion, hepatocyte ballooning or vacuolation, and necrosis are graded from 
0 to 4. No congestion, vacuolation or necrosis is given a score of 0, while severe 
congestion, vacuolation and necrosis is given a score of 4, as shown in the table. 
 
Table 3.3.1 
Suzuki’s Criteria for Liver I/R 
Numerical 
assessment 
Congestion  Vacuolation   Necrosis 
0  None  None  None 
1  Minimal  Minimal  Single cell 
2  Mild  Mild  <30% 
3  Moderate  Moderate  30 - 60% 
4  Severe  Severe  >60% 
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3.4 Liver Injury Assay  
Blood was sampled from the IVC 3 hours post perfusion and centrifuged at 3000 
rpm for 10 minutes. Serum was analysed on an autoanalyzer (Hitachi 747, 
Hitachi, Tokyo, Japan) using commercially available kits (Boehringer Mannheim, 
Lewes, East Sussex, UK) for serum aspartate transaminase and serum alanine 
transaminase. 
 
3.5 Measurement of Hepatic F2-Isoprostanes  
Approximately 250 mg whole liver tissue was homogenized in a mixture of saline 
and chloroform/methanol solution containing butylated hydroxytoluene (5%) (to 
inhibit ex vivo lipid peroxidation), and centrifuged at 3,000g for 10 minutes. This 
process results in three phases, an upper aqueous phase, separated from the 
lower lipid containing phase by a ring of protein precipitate. The lower lipid layer 
was aspirated and, following the addition of 500 pg of [
2]H4-iso-PGF  (Cayman 
Co., Ann Arbor, MI) as internal standards, was dried down under nitrogen, and 
hydrolyzed in methanolic 15% potassium hydroxide solution (1 hour, 37° C). To 
extract the F2-isoprostanes, the pH was adjusted to 3.0, and the samples were 
extracted  on  a  C18  solid-phase  extraction  cartridge  (Elstree,  Hertsfordshire, 
Waters,  UK)  as  described(Morrow  and  Roberts  1999),  converted  to  the 
pentaflurobenzyl  ester, purified by thin-layer chromatography and analyzed  as 
the  tri-methysilyl  ether.  F2  isoprostane  levels  were  quantified  by  selected  ion 
monitoring  gas  chromatography  negative  ion  chemical  ionization/mass 
spectrometry with monitoring of ions at m/z 569 and 573(Morrow and Roberts   72
1999).  The  levels  of  F2-isoprostanes  were  expressed  as  the  ratio  of  F2-
isoprostanes to mg dried protein in liver tissue homogenates. 
 
3.6 Measurement of Plasma F2-Isoprostanes 
Following the addition of 500 pg of [
2]H4-iso-PGF  (as internal standard) to 500 
µl of rat plasma, the samples were hydrolyzed in methanolic 15% potassium 
hydroxide solution (1 hour, 37°C). To extract the F 2-isoprostanes, the pH was 
adjusted to 3.0, and the samples were extracted on a C18 solid-phase extraction 
cartridge (Elstree, Hertsfordshire, Waters, UK) as described(Morrow and Roberts 
1999), converted to the pentaflurobenzyl ester, purified by thin-layer 
chromatography and analyzed as the tri-methysilyl ether. Detection was 
performed by selected ion monitoring gas chromatography negative ion chemical 
ionization/mass spectrometry with monitoring of ions at m/z 569 and 573. 
. 
3.7 Liver Tissue Glutathione Assay 
Liver tissue Glutathione was measured by modified Tietze method(Baker et al. 
1990; Eyer and Podhradsky 1986; Tietze 1969) using a commercially available 
kit ( Cayman Chemical Company, Ann Arbor, USA). This utilizes a carefully 
optimized enzymatic recycling method, using glutathione reductase, for the 
quantification of GSH. The sulfhydryl group of GSH reacts with 5,5
’ dithiobis-2-
nitrobenzoic acid (DTNB) and produces a yellow coloured compound 5-thio-2-  73
nitrobenzoic acid (TNB). The mixed disulfide that is concomitantly produced is 
reduced by glutathione reductase to recycle the GSH and produce more TNB. 
The rate of production of TNB is directly proportional to this cycling reaction 
which is proportional to the concentration of GSH. GSH and GSSG were 
measured according to manufacturer’s protocol. GSH concentrations of the 
sample, was measured by the kinetic method as described in the protocol to 
avoid interference by other thiol groups. 
 
3.8 Serum CINC-1 assay 
Serum samples were assayed by using CINC-1 assay kit (Quantikine rat CINC-1 
immunoassay, R & D systems, Inc., Minneapolis, USA) using the manufacturers 
recommended protocol. This assay employs the quantitative sandwich enzyme 
immunoassay technique. A polyclonal antibody specific for rat CINC-1 is 
precoated onto a microplate. Standards, controls and samples are micropipetted 
into the wells and any rat CINC-1 gets bound by the antibody. After washing 
away unbound substances, an enzyme linked polyclonal antibody specific for rat 
CINC-1 is added to the wells. The enzyme reaction produces yellow colour the 
intensity of which is measured colorimetrically.   74
 
 
 
 
 
 
 
Chapter 4 
Study of microvascular and biochemical changes in the early 
phase of Liver IR (3 hrs) and the effect of Bucillamine on 
early phase Liver IR 
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4.1  Introduction: 
Liver  I/R  is  known  to  cause  microcirculatory  perfusion  failure,  activate 
polymorphonuclear leukocytes and increase leukocyte-endothelial cell interaction 
which in turn contribute to hepatocellular damage and liver dysfunction(Menger et 
al. 1999; Vollmar et al. 1994a; Vollmar et al. 1996). 
 
The effect of bucillamine in the treatment of liver warm I/R injury has not been 
investigated, furthermore its effect on liver microcirculation are not known. The 
aim of the present study was to use a well described model of Liver ischaemia 
reperfusion injury to determine the effect of Bucillamine administration on liver 
function, liver microcirculation and hepatocyte apoptosis/ necrosis.   76
4.2 Materials and Methods 
 
4.2.1 Animals and surgical preparation 
The study was conducted under a project license from the Home Office in 
accordance with the Animals (Scientific Procedures) Act 1986. Male Sprague –
Dawley rats, weighing 270-330gms were used. Animals were kept in a 
temperature controlled environment with a 12 hour light-dark cycle and allowed 
tap water as well as standard rat chow pellets ad libitum. Animals were 
anaesthetized with 4% Isoflurane and maintained with 2.0% Isoflurane (Abbott 
Laboratories Ltd., Kent, UK). They were allowed to breathe spontaneously 
through a concentric mask connected to an oxygen regulator and monitored with 
a pulse oximeter (Ohmeda biox 3740 pulse oximeter, Ohmeda, Louisville, USA). 
 
Polyethylene catheters (Portex 2 Fr, Portex, Kent, UK) were inserted into the 
carotid artery (right or left) for monitoring of mean arterial blood pressure and the 
right jugular vein for administering normal saline to compensate for intraoperative 
fluid loss (1ml /100gm body weight/hour). 
 
Laparotomy was carried out through a midline incision. The ligamentous 
attachments of the liver were cut and the liver exposed. All animals were 
administered heparin 20 units /kg. Partial hepatic ischaemia of the left lateral and 
median lobes (70% of liver) was induced by clamping the corresponding vascular 
pedicle with an atraumatic microvascular clamp for 45 minutes. This model   77
prevents splanchnic congestion by allowing flow through the remaining liver(Koo 
et al. 1992; Koti et al. 2005). Animals were randomly allocated to the following 
groups:   
 
4.2.2 Experimental groups (n=6 in each group) 
Group1 – Sham 
These animals underwent laparotomy and liver mobilisation under general 
anaesthesia but without clamping of the liver vascular pedicle. 
Group2- IR 
45 minutes of partial hepatic ischemia followed by 3 hrs of reperfusion. 
Group3- Bucillamine (15mg/ kg/hr intravenously) + IR 
Group4- (SB)- Sham + Bucillamine (15mg/kg/hr i.v.) 
 
The Bucillamine group were administered Bucillamine infusion (15mg/kg/hr) over 
the operative period [For 10 minutes prior to ischaemia, during the period of 
ischaemia and for 3 hours in the reperfusion period]. Bucillamine was supplied by 
Santen pharmaceuticals, Osaka, Japan. Animals in the sham and I/R groups 
were given equivalent volume of saline. Temperature of the animal was 
monitored and maintained at 36-38
oC by means of a heating pad (Harvard 
Apparatus Ltd., Kent, UK). 
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4.2.3 Intravital Microscopy 
Intra vital microscopy (IVM) was used to assess the perfusional changes 
associated with I/R and possible alterations with Bucillamine administration. The 
left lobe of the liver was gently mobilised and placed over a specially designed 
platform (Nikon microscope, Nikon, Tokyo, Japan). The surface of the liver was 
moistened with normal saline and visualised through a coverslip. Images (25 
pictures /sec) from the microscope were recorded by camera (JVC video camera, 
JVC, Osaka, Japan) directly on to a computer for further analysis. Off line 
microcirculatory analysis was performed from recorded images to measure RBC 
velocity and sinusoidal diameter using Lucia G software (Laboratory Universal 
Computer Image Analysis, Nikon, Tokyo, Japan). 
 
Red blood cells (from a previously bled rat) were labelled with fluorescein 
isothiocyanate (FITC) using a technique previously described(Zimmerhackl et al. 
1983) and labelled RBCs (0.5ml) were administered via the jugular vein at 30 
minutes reperfusion. The hepatic microcirculation was evaluated after 30, 60,120 
and 180 minutes following reperfusion. Microcirculatory changes were studied in 
sinusoids (periportal, midzonal and pericentral sinusoids) within randomly 
selected acini. The following parameters were studied. 
 
4.2.3.1 Mean RBC velocity 
Mean RBC velocity was determined at 40x magnification. Ten sinusoids were 
randomly  selected  at  each  time  point  in  each  animal  and  RBC  velocity  was   79
calculated  from  frame  by  frame  analysis  as  previously  described(Kelly  et  al. 
1998). Mean value was calculated for each time point. 
 
4.2.3.2 Sinusoidal diameter 
Sinusoidal diameter was measured in ten randomly selected sinusoids at each 
time point in each animal and the mean was calculated. 
 
4.2.3.3 Sinusoidal perfusion  
Five randomly chosen non overlapping rappaport acini were observed for a 
minute and recording made from representative areas for 2 seconds with a JVC 
video camera (JVC TK-C1360B colour video camera, JVC, Osaka, Japan) (25 
frames per second) and stored on the computer for each time point. Perfusion 
was established by studying the ratio of perfused to total visible sinusoids after 
administration of FITC labelled RBC. Sinusoidal perfusion was graded as 
continuously perfused (continuous perfusion for > 1 min) (Nc) or interrupted 
(intermittent perfusion for 1 min. period) (Ni) or non perfused (Nn).  Sinusoidal 
perfusion index was calculated as previously described(Post et al. 1993): 
Perfusion index= (Nc + 0.5 Ni ) / (Nc + Ni  + Nn) and expressed as %.  
 
4.2.3.4 Sinusoidal Blood Flow 
Sinusoidal blood flow was calculated as previously decribed(Wunder et al. 2002). 
Sinusoidal blood Flow= Velocity x ￿ ￿ ￿ ￿ x (d/2)
2 (expressed as pl/sec) 
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4.2.3.5 Leukocyte parameters 
Leukocyte endothelial interactions were studied by labelling leukocytes in vivo by 
administering rhodamine 6G-(Sigma, Rodermark, Germany) 0.3 mg/kg intra- 
arterially(Wunder et al. 2002)
 at 150 minutes post reperfusion. Ten randomly 
chosen postsinusoidal venules were visualized for 20 seconds each under green 
filtered light. The number of adherent leukocytes were counted and expressed as 
cells per mm
2 of endothelial surface ( length of observed vessel length x diameter 
x ￿ = adherent cells per mm
2) as previously described(Croner et al. 2006; 
Wunder et al. 2002). Leukocytes adherence in sinusoids was measured as 
adherent leukocytes per mm
2 of liver tissue. 
 
4.2.3.6 Detection of hepatocellular death in vivo. 
Propidium Iodide fluorescent dye stains the nuclei of cells that are lethally 
damaged(Herman et al. 1988). Propidium iodide (0.05 mg/kg) was injected after 
3 hours of reperfusion. The dead nuclei were identified as those stained with 
propidium iodide. These were counted in each high power field and an average 
value was taken for each subject after studying at least 5 high power fields 
(studying all regions of the acini). The area in each high power field was 
calculated using Lucia G software (Laboratory Universal Computer Image 
Analysis, Nikon, Tokyo, Japan) and results were expressed as number of dead 
cells per mm
2. 
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At the end of the experiment animals were killed by exsanguinations. Serum and 
Plasma samples were collected by spinning the blood at 3000rpm for 10 minutes 
and stored in aliquots of 0.2 mls at -80
o C. A sample of liver tissue was taken 
from the left lobe was stored in formalin for histopathology. 
 
 
4.2.4 Liver Injury assay 
Blood was sampled at the end of the procedure from the IVC 3 hours post 
reperfusion and centrifuged at 3000 rpm for 10 minutes. Serum was analysed on 
an autoanalyzer (Hitachi 747, Hitachi, Tokyo, Japan) using commercially 
available kits (Boehringer Mannheim, Lewes, East Sussex, UK) for serum 
aspartate transaminase and serum alanine transaminase. 
 
 
4.3 Data collection and statistics 
Data was continuously collected for oxygen saturation, blood pressure and mean 
arterial pressure (MAP). Averages for one minute were calculated at 30, 60, 120 
and 180 minutes post reperfusion. Data is expressed as mean± standard error of 
mean (SEM). Analysis of data was done using SPSS 14.0 (SPSS Inc., Chicago, 
Illinois, USA). Differences in data between groups were assessed by using one 
way ANOVA with Bonferroni’s post hoc test. Data was considered statistically 
significant if p< 0.05.   82
4.4 Results: 
There were no procedure related deaths in either group. The model was 
haemodynamically stable (Figure 4.4.1a, 4.4.1b).  There was a statistically 
significant transient fall in oxygen saturation immediately after reperfusion which 
was reduced by Bucillamine therapy. (Figure 4.4.1c)  
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Figure 4.4.1b: 
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Figure 4.4.1c: 
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4.4.2 Biochemistry 
Transaminases were grossly elevated following I/R. The Bucillamine I/R group 
had lower AST and ALT than the IR group [(AST 932±201 vs. 2072.5±512, 
p<0.05), (ALT 862±263 vs. 2079±322, p<0.05)]. (Figure 4.4.2a, 2b).  
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Figure 4.4.2b: 
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4.4.3 Intravital microscopy 
We did not find any difference in the perfusion, leukocyte adhesion, in the 
different sinusoidal regions (periportal, midzonal and pericentral sinusoids) within 
the same group of animals. RBC velocity was taken as average over the entire 
visible length of the sinusoid. Hepatocyte apoptosis/ necrosis were more severe 
in the pericentral region and we studied all the regions to calculate the number of 
nonviable nuclei. 
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4.4.3.1 RBC velocity 
RBC velocity remained stable in the Sham group over the duration of the 
experiment. I/R produced a gradual fall in RBC velocity from baseline which was 
significant vs. sham operated animals at 120 and 180 minutes (p<0.001)). In the 
Bucillamine I/R group the initial fall in the RBC velocity at 60 minutes post 
reperfusion was similar to I/R(299.71±18.15 vs. 244±15.49, not significant) but 
after this the velocities remained steady for the subsequent 2 hours duration. The 
difference in velocity at 180 minutes reperfusion was statistically significant 
between the IR and Bucillamine I/R groups (p<0.05). Velocities were lower in the 
SB group as compared to sham group, but there was no change in the velocities 
over time (Figure 4.4.3.1). 
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Figure 4.4.3.1: Showing gradual fall in RBC velocity on reperfusion after I/R injury. Bucillamine+ IR 
group showing initial fall in RBC velocity with maintenance of RBC velocity. 
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4.4.3.2 Sinusoidal diameter 
There was no statistically significant difference in the sinusoidal diameter in the 
I/R or Bucillamine I/R groups. (Figure 4.4.3.2). 
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Figure 4.4.3.2: showing no change in sinusoidal diameter 
 
4.4.3.3 Sinusoidal Perfusion Index 
Sinusoidal perfusion index was lower in I/R group as compared to SB and sham 
groups at all time points. Bucillamine therapy with I/R increased the sinusoidal 
perfusion although values were not statistically significant. (Figure 4.4.3.3) 
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Figure 4.4.3.3: Showing no statistically significant change   87
4.4.3.4 Sinusoidal Blood Flow 
I/R reduced sinusoidal blood flow over the reperfusion period.  Bucillamine with 
I/R maintained the sinusoidal blood flow, after an initial fall, although, none of 
these changes, however, were statistically significant. (Figure 4.4.3.4) 
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Figure 4.4.3.4: Showing a gradual fall in sinusoidal blood flow after IR. Bucillamine +IR group 
showed initial fall in sinusoidal blood flow which was maintained at same level after 60 minutes 
reperfusion.  
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4.4.3.5 Leukocyte adherence in venules and sinusoids 
I/R injury were associated with adherence of leukocytes in the venules. 
Bucillamine with I/R reduced leukocyte adherence (385.66±142.69) in the 
venules, however this was not statistically reduced when compared with the I/R 
group (Figure 4.4.3.5.2). In the sinusoids I/R group (97.4±7.49) had a significantly 
higher number of adherent leukocytes as compared to sham(3.75±3.75), SB 
(22.48±11.46) and bucillamine groups(29.97±13.81) (p<0.005). (Figure 4.4.3.5.3) 
 
 
Neutrophil adhesion 
 
     
Figure 4.4.3.5.1 Neutrophils stained by rhodamine is seen adherent to post sinusoidal venular 
endothelium.  The number of adherent neutrophils divided by the area of endothelial surface (л×D×L) gives 
the number of neutrophils/ mm2. D= sinusoidal diameter, L= length of segment along adherent neutrophils. 
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Figure 4.4.3.5.2: Showing no significant change 
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Figure 4.4.3.5.3: Statistically significant decreased adherent leukocytes in sinusoids in Bucillamine +IR 
group as compared to IR only group. 
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4.4.3.6 Hepatocellular cell death in vivo 
The number of lethally damaged nuclei was assessed in each group after 3 hours 
of reperfusion. I/R produced significant hepatocellular death (1816±293.09 cells/ 
mm
2) which was significantly reduced with Bucillamine administration at 3 hours 
reperfusion (258.48±46.73 cells/ mm
2, p<0.001). (Figure 4.4.3.6) 
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Figure4.4.3.6: Significantly lesser nonviable nuclei at 3 hours reperfusion in Bucillamine+IR group as 
compared to IR only group (p< 0.001) 
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4.5 Discussion 
This study has shown for the first time that Bucillamine can reduce the effects of 
liver warm ischaemia reperfusion injury. This is also the first study showing effect 
of Bucillamine on liver microcirculation in vivo. The model of partial liver 
ischaemia and reperfusion injury used in this study is stable, reproducible and 
avoids splanchnic congestion found with total liver inflow occlusion(Koti et al. 
2005). Technical manoeuvres such as performing the laparotomy; mobilisation of 
the liver and performing Intravital microscopy did not affect the heart rate, oxygen 
saturation or mean arterial pressure as shown by stable parameters in the sham 
and the SB groups. There was a fall in mean arterial pressure following 
ischaemia reperfusion injury in both the I/R and Bucillamine I/R groups which 
was not statistically significant. Bucillamine administration without I/R has no 
effect on the vital parameters or haemodynamic stability of the animals 
suggesting that it has no direct effect on systemic or portal haemodynamics. 
 
Intravital microscopy has allowed novel insights into hepatic haemodynamics 
following I/R and the effect of Bucillamine administration. Liver I/R is known to 
cause microcirculatory perfusion failure, activate polymorphonuclear leukocytes 
and increase leukocyte-endothelial cell interaction which in turn contribute to 
hepatocellular damage and liver dysfunction(Menger et al. 1999; Vollmar et al. 
1994a; Vollmar et al. 1994c; Vollmar et al. 1996).  Bucillamine administration with 
I/R was shown to maintain RBC velocity, sinusoidal blood flow and sinusoidal   92
perfusion in the reperfusion period. It has also shown to decrease leukocyte 
adhesions in sinusoids and decrease hepatocyte apoptosis/ necrosis.  
 
RBC velocity 
In our experiments there was a gradual drop in the RBC velocity in the I/R group, 
whereas the RBC velocity remained stable after an initial drop in the Bucillamine 
group. This would be consistent with the scavenging of oxygen free radicals by 
Bucillamine. RBC mechanical properties play a key role in tissue 
perfusion(Schmid- Schonbein H 1988; Shiga et al. 1990). RBC velocity can be 
affected by changes in both aggregability and deformability of the RBCs, and 
oxygen free radicals which form as a result of I/R affect RBC aggregation and 
deformability(Lowe GDO and Barbanel JC 1988). Decreased RBC deformability 
is associated with oxygen free radical damage during sepsis and is linked to 
multiorgan failure(Machiedo et al. 1989). Pre-treatment with an oxygen free 
radical scavenger prevents such adverse changes in deformability(Powell et al. 
1989). RBC aggregation also has an impact on blood flow mainly in low shear 
regions(Cabel et al. 1997). Externally generated oxygen free radicals (i.e. outside 
RBCs) in experimental settings increases aggregation of RBCs whereas 
internally generated oxygen free radicals affects the deformability(Baskurt et al. 
1998).  By scavenging oxygen free radicals Bucillamine might be preventing RBC 
aggregation and deformability thus maintaining RBC velocity. After absorption 
Bucillamine enters the RBCs rapidly and is carried within the   93
erythrocytes(Horwitz 2003; Sugawara et al. 1985a; Sugawara et al. 1985b). This 
might be of importance in the beneficial effect of Bucillamine. 
 
Sinusoidal perfusion 
I/R injury decreased the sinusoidal perfusion which is a known consequence of 
severe liver ischaemia reperfusion injury(Vollmar et al. 1994a)and  results in 
significant compromise of hepatic tissue oxygenation and damage and functional 
impairment of parenchymal and non parenchymal cells(Vollmar et al. 1994c; 
Vollmar et al. 1996). The severity of sinusoidal perfusion failure is proportional to 
the ischaemia time(Vollmar et al. 1994a). Bucillamine was shown to reduce the 
perfusion abnormality of I/R with an increased sinusoidal perfusion. This could be 
related to its effect on- 1. RBCs (decreased aggregability or better maintenance 
of deformability) and /or 2. WBC adhesions. Sinusoidal perfusion was also better 
maintained in the SB group, which although, as mentioned earlier had lower RBC 
velocity, had normal liver function, indicating that a combination of better 
perfusion and maintenance of RBC velocity would decrease abnormality in liver 
function.  
 
Sinusoidal diameter 
Changes in sinusoidal diameter by constriction of hepatic stellate cells mediated 
by endothelin-1 are known to influence the hepatic perfusion in 
endotoxaemia(Ring and Stremmel 2000; Croner et al. 2006; Horwitz 2003). Our 
results do not suggest such a role in liver I/R injury. The increase in sinusoidal   94
diameter in Sham group from 30 minutes to 180 minutes post reperfusion could 
be attributed to the effect of anaesthesia. This would suggest that there might be 
a relative decrease in the sinusoidal diameters in the I/R and Bucillamine groups. 
The sinusoidal dilatation in Bucillamine group at 30 minutes could explain the 
better perfusion and cytoprotection. Our results also do not suggest primary 
vasodilator function for Bucillamine as the sinusoidal diameter did not increase in 
the SB group.  
 
Sinusoidal Blood flow 
There was a progressive decrease in sinusoidal blood flow after I/R injury. 
Sinusoidal blood flow was maintained bucillamine administration. Sinusoidal 
blood flow is essentially related to the velocity of flow and diameter and our data 
on sinusoidal flow is similar to that for RBC velocity as there was no significant 
change in the diameter. The sinusoidal blood flow values were lower (although 
not significant as compared to sham) in the SB group demonstrating that the 
maintained blood flow in the group who had I/R with administration of Bucillamine 
was not related to a direct effect of Bucillamine but related to its effect on the 
inflammatory cascade of I/R. 
 
Leukocyte endothelial interactions 
The I/R group showed leukocyte adherence in the sinusoids and post sinusoidal 
venules. Jaeshcke et al first showed that leukocyte infiltration into liver 
parenchyma is associated with the development of liver I/R injury(Croner et al.   95
2006; Jaeschke et al. 1990).  Hepatic I/R induces accumulation, adherence and 
extravasation of leukocytes in both sinusoids and post sinusoidal 
venules(Vollmar et al. 1994c). The increased number of adherent leukocytes in 
venules, but not in sinusoids, is known to correlate  with the extent of liver 
dysfunction(Vollmar et al. 1994c).  Leukocyte adherence in venules is mainly 
mediated by increased expression of ICAM-1(Croner et al. 2006; Vollmar et al. 
1995b; Iwata et al. 1999). Our study showed a decreased leukocyte adherence in 
venules with Bucillamine following I/R. Bucillamine is known to scavenge ROS 
thus decreasing Kupffer cell and leukocyte activation. Leukocyte adhesion in 
sinusoids may decrease perfusion of sinusoids(Vollmar et al. 1994c). However, 
although we could show significantly increased adherent sinusoids in I/R group 
the number of adherent leukocytes were very few to account for no flow/ reduced 
flow in sinusoids by mechanical blockage, which would suggest that the adherent 
leukocytes are not the cause of reduced parenchymal perfusion. They might, 
however, be contributing to the hepatocellular injury and dysfunction by release 
of cytokines and generation of reactive oxygen species. 
 
 Hepatocellular injury/ apoptosis 
The propidium iodide staining confirmed that there was significant hepatocellular 
necrosis  associated  with  I/R  injury  in  this  model.  Bucillamine  administration 
reduced the number of nonviable nuclei by more than 80%. Liver warm I/R is 
associated  with  necrosis  /  apoptosis  of  hepatocytes(Jaeschke  and  Lemasters 
2003).  In  liver  I/R,  oncotic  necrosis  and  apoptosis  share  features  and   96
mechanisms(Gujral et al. 2001; Jaeschke and Lemasters 2003). It is suggested 
that the ability of a necrotic process to be converted to an apoptotic one and vice 
versa  illustrates  that  the  pathways  in  the  two  processes  could  be  shared,  a 
phenomenon  called  necroapoptosis(Lemasters  1999;  Formigli  et  al.  2000). 
Irreversible injury in anoxic hepatocytes is precipitated by an abrupt increase in 
plasma  membrane  permeability  which  results  in  uptake  of  propidium  iodide, 
labelling the nonviable nuclei(Herman et al. 1988). We have used this previously 
used technique to demonstrate nonviable hepatocytes(Herman et al. 1988; Brock 
et al. 1999; Zhang et al. 1994). This study has shown that with better perfusion 
and  decreased  leukocyte  adherence,  Bucillamine  reduces  the  hepatocyte 
damage, which could be related to its effect on scavenging of ROS. 
   
 
4.6  Conclusions:  These  findings  suggest  that  this  agent  may  prove  to  be  a 
useful target in liver protection against I/R injury and could be of clinical benefit in 
the field of liver transplantation or liver resection surgery.  
 
In the subsequent chapter we investigate its effect on liver necrosis /apoptosis as 
assessed histologically and by genetic markers of apoptosis. 
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Chapter 5 
 
The effect of Bucillamine infusion on Bax/ Bcl-2 and 
Histological changes following Liver Warm IR 
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5.1 Introduction: 
 
During  ischaemia  the  cell  is  deprived  of  the  energy  needed  to  maintain  ionic 
gradients and homeostasis.  Failure of enzyme systems inevitably leads to cell 
death(Mathews  et  al.  1994).    Recovery  from  ischaemic injury  is  facilitated  by 
reperfusion  through  the  restoration  of  energy  supply  and  removal  of  toxic 
metabolites(El-Wahsh  et  al.  2004).   However,  post-ischaemic reperfusion  is a 
complex process with potentially damaging effects, giving rise to a phenomenon 
known as ischaemia-reperfusion injury (IRI).   
 
 
Microscopically,  IRI  cell  death  occurs  by  uncontrolled  and  controlled 
mechanisms,  known  as  necrosis  and  apoptosis  respectively.    The  relative 
contributions of these processes are unclear but studies by Teoh et al.(Teoh and 
Farrell 2003), Selzner et al.(Selzner et al. 2003), and Jaeschke et al.(Jaeschke 
2003b)  suggest  an  overlap  in  necrotic  and  apoptotic  pathway  components.  
Additionally, such studies highlight discrepancies in methods used to measure 
apoptosis. 
 
 
It has been shown that apoptosis of sinusoidal endothelial cells and hepatocytes 
is a cardinal feature of reperfusion injury in the cold(Gao et al. 1998) and warm 
ischaemic liver(Kohli et al. 1997; Kohli et al. 1999b; Natori et al. 1999).  Several 
lines of evidence suggest that apoptosis critically contributes to organ viability in 
transplantation models as the number of apoptotic cells is positively correlated 
with  ischaemia  and  animal  survival.    Moreover,  inhibition  of  mediators  of   99
apoptosis such as caspases(Natori et al. 1999) or calpain-like proteases(Kohli et 
al. 1997) ameliorates the effects of IRI(Piot et al. 1997; Vexler et al. 1997).   
 
At  a  genetic  level,  protection  against  apoptosis  ultimately  involves  decreased 
expression of pro-apoptotic genes such as Bax as well as up-regulation of anti-
apoptotic  mechanisms.    Bcl-2  is  a  family  of  mitochondrial  membrane  protein 
which includes the proapoptotic Bax and anti apoptotic Bcl-2 gene. Rentsch et al 
found that induction of apoptosis in rat liver transplantation was associated with 
caspase  3  activation  and  Bax  expression(Rentsch  et  al.  2001).  Warm  liver 
ischaemia  reperfusion  injury  has  also  been  shown  to  increase  Bax 
expression(Ishigami  et  al.  2001).  Increased  apoptosis  following  liver  warm 
ischaemia reperfusion injury  has  also been shown to occur in transgenic Bax 
inhibitor  knock  out  mice  as  compared  to  normal  mice  suggesting  that  the 
proapoptotic    Bax  gene  has  a  role  in  apoptosis  following  warm  ischaemia 
reperfusion injury(Bailly-Maitre et al. 2006). Ablation of Bax has been shown to 
protect against warm ischaemia reperfusion injury in transgenic mice(Ben-Ari et 
al. 2007). 
 
Bcl-2 is the most ubiquitous anti-apoptotic molecule protecting against a variety 
of apoptotic stimuli(Adams and Cory 2007; Reed 1994).  Overexpression of Bcl-2 
in transgenic mice is known to protect liver against I/R injury(Selzner et al. 2002). 
Bcl-2  overexpression  suppresses  cell  apoptosis  mainly  by  normalizing 
mitochondrial membrane permeability, so as to reduce cytochrome c release and 
thus preventing caspase 3 activation(Zamzami et al. 1996; Zhao et al. 2003).   100
 
Thus in simplistic terms Bax stimulates the release of mitochondrial cytochrome 
c(Rentsch  et  al.  2001),  whereas  Bcl-2  inhibits  its  release(Bossy-Wetzel  et  al. 
1998). The release of mitochondrial cytochrome c results in activation of caspase 
3 and fragmentation of DNA resulting in apoptosis(Rudiger et al. 2003). 
 
 
Studies on Liver ischaemia reperfusion injury using antioxidants and 
effects on Bax/ Bcl-2 
Various investigators have investigated effects of antioxidants on Bax and Bcl-2. 
These studies have been summarised in Table 5.1:   101
Table 5.1: Studies on Liver ischaemia reperfusion injury using antioxidants and effects on Bax/ 
Bcl-2 
 
Author  Antioxidant  Model  Findings on 
using 
antioxidant 
Kong, R (Kong et al. 
2009) 
Salvanoic acid B  Rat, 90 min ischaemia, 5 hr 
reperfusion 
↑ Bcl-2 levels  
Jha,S (Jha et al. 2008)  H2S Donor 
(IK1001) 
Mouse, 60 min ischaemia, 5hr 
reperfusion 
↑ Bcl-2 levels 
Duenschede, 
F.(Duenschede et al. 
2007) 
Lipoic Acid  Rat, 90 min ischaemia, 1 hr 
reperfusion 
↓ Bax levels 
Jia, CJ (Jia et al. 2006)  Alanyl-glutamine 
dipeptide 
Rat, 30 min ischaemia, 1hr & 24 
hr reperfusion 
↑ Bcl-2 levels, ↓ 
Bax levels 
Zhang, Y (Zhang et al. 
2005) 
Panax 
Notoginseng 
saponins 
Rat OLTx model, 2 hr, 6hr and 
24 hr reperfusion 
↑ Bcl-2 levels 
Wang, XH (Wang et al. 
2004) 
Hemin  Rat OLTx model, 12 hr 
reperfusion 
↑ Bcl-2 levels 
Jawan, B  (Jawan et 
al. 2003) 
Magnolol  Rat 2 hr ischaemia  ↑ Bcl-xl levels 
Altunkan,A (Altunkan 
et al. 2002) 
Succinyl Gelatine  Rabbit 45 min ischaemia, 45 min 
reperfusion 
↑ Bcl-2 levels, ↓ 
Bax levels 
Ishigami,F (Ishigami et 
al. 2001) 
Tauro 
Ursodeoxycholic 
acid 
Rat 2 hr ischaemia, 6 hr 
reperfusion 
↓ Bax levels 
Singh,AK (Singh et al. 
2000) 
Picroliv  Rat 30 min ischaemia, 2 hr 
reperfusion 
No change in Bax, 
Bcl-2 as 
compared to 
sham. However, 
caspase3 ↓ In the previous chapter we had shown an increase in non viable nuclei following 
ischaemia reperfusion as compared to sham group on Intravital microscopy, 
which was attenuated by bucillamine infusion. This correlated with better 
preservation of liver function as assessed by lesser derangement of liver 
enzymes. In this study we wanted to investigate the effect of Bucillamine on Bax 
and Bcl-2 and if there was any correlation with histological changes. 
 
Studies have shown that the ratio of Bax to Bcl-2 expression is one factor that 
may determine the resistance of hepatocytes to apoptotic stimuli(Lacronique et 
al. 1996; Yamabe et al. 1998).  We measured the levels of Bax and Bcl-2 and the 
ratio of Bax/Bcl-2. Histological assessment was done using modified Suzuki’s 
criteria as described. 
 
Aim- To study if protective effect – 
1.  correlated with histological changes.  
2.  associated with differences in expression of pro and anti apoptotic genes.  103
5.2 HYPOTHESIS 
We hypothesised that Bucillamine infusion would have a protective effect against 
liver I/R by reducing Bax expression and increasing Bcl-2 expression. 
 
Materials and Methods: 
The drug was evaluated in an in vivo lobar liver ischaemia reperfusion model as 
previously described(Koo et al. 1992; Koti et al. 2005). This study was conducted 
under  project  license  from  the  Home  Office  in  accordance  with  the  Animals 
(Scientific Procedures) Act 1986. 
 
5.2.1 Animals and Surgical Procedure 
Male Sprague-Dawley rats weighing 250-300g were used.  The animals were 
kept  in  a  temperature  controlled  environment  with  a  12  hour  light-dark  cycle.  
They were given tap water as well as standard rat chew pellets ad libitum.   
 
Animals were anaesthetized with 4% Isoflurane and maintained with 2.0% 
Isoflurane. They were allowed to breathe spontaneously through a concentric 
mask connected to an oxygen regulator and monitored with a pulse oximeter 
(Ohmeda biox 3740 pulse oximeter, Ohmeda, Louisville, USA). 
 
Polyethylene catheters (Portex 2 Fr, Portex, Kent, UK) were inserted into the 
carotid artery (right or left) for monitoring of mean arterial blood pressure and the   104
right jugular vein for administering normal saline (1ml /100gm body weight/hour) 
to compensate for intraoperative fluid loss. 
Laparotomy was carried out through a midline incision. The ligamentous 
attachments of the liver were cut and the liver exposed. All animals were given 
heparin 20 units /kg and partial hepatic ischaemia of the left lateral and median 
lobes of (70% of liver) was induced by clamping the corresponding vascular 
pedicle with an atraumatic microvascular clamp for 45 minutes in the control and 
Bucillamine groups. This model prevents splanchnic congestion by allowing flow 
through the remaining liver(Koo et al. 1992; Koti et al. 2005). Animals in the 
Sham group did not have any vascular clamping. Animals were monitored for 3 
hours in the reperfusion period. Animals were randomly allocated to the following 
groups:   
 
5.2.2 Experimental groups (n=6 in each group) 
Group1 - (Sham) – laparotomy and mobilisation of liver but no occlusion of the 
vascular pedicle. 
Group2- IR- 45 minutes of partial hepatic ischemia followed by 3 hrs of 
reperfusion. 
Group3- Bucillamine 15mg/ kg/hr intravenously + IR followed by 3 hrs of 
reperfusion. 
Group4- (SB) - Sham + Bucillamine infusion 15mg/kg/hr (SB) 
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Subjects in the Bucillamine group were given Bucillamine infusion (15mg/kg/hr) 
over the operative period (preischaemia, ischaemia and 3 hour post reperfusion). 
Bucillamine was supplied by Santen pharmaceuticals, Osaka, Japan. Animals in 
the Sham and I/R groups were given an equivalent volume of saline up to 3 
hours of reperfusion (or equivalent period in case of sham operated animals). 
Temperature of the animals was monitored and maintained at 36-38
oC by means 
of a heated platform (Harvard apparatus Ltd., Kent, UK). The experiments were 
terminated by exsanguination and serum and plasma samples were collected by 
spinning the blood at 3000rpm for 10 minutes and stored in aliquots of 0.2 mls at 
-80
o C. Liver tissue was stored in formalin for histopathology and 
immunohistochemistry. Liver tissue was also frozen immediately on termination 
of the experiment in liquid nitrogen and stored at -80
o C for further analysis.  
 
 
5.2.3 RNA Extraction 
RNA was extracted from the liver tissue samples that were frozen at -80° C after 
the  surgical  procedure.    Extraction  followed  the  protocol  as  set  out  in  the 
QIAGEN  RNeasy
®  Mini  Handbook  (QIAGEN,  Hilden,  Germany).    All 
centrifugations  were  carried  out  at  room  temperature  (25° C)  and  maximum 
speed (1300 rpm).   
 
A  fraction  of  the  tissue  was  excised  from  the  main  sample  and  placed  in  a 
suitably  sized  vessel.    A  volume  of  550µl  lysis  buffer  RLT  was  added  to  the   106
vessel and the tissue was homogenised using a rotor-start homogeniser.  The 
tissue lysate was then centrifuged for 3 min.  The supernatant was pipetted into a 
new microcentrifuge tube.  550µl of 70% ethanol was then added to the clear 
lysate  and  mixed  immediately  by  pipetting.    From  this,  700µl  was  put  in  an 
RNeasy mini column placed in a 2ml collection tube and centrifuged for 30 s.  
The flow-through was discarded.  700µl of buffer RW1 was then added to the 
RNeasy column to wash it followed by centrifugation for another 30 s.  The flow-
through was ejected once more.  550µl of buffer RPE was subsequently pipetted 
into  the  RNeasy  column  and  centrifuged  for  30  s.    The  flow-through  was 
discarded  and  550µl  of  buffer  RPE  was  added  again.    The  tube  was  then 
centrifuged  for  2  min  and  flow-through  was  thrown.    The  tube  was  then 
centrifuged for a further 1 min.  The collection tube with any further flow-through 
was discarded.  The RNeasy column was placed in a new 1.5ml collection tube.  
To elute the RNA, 40µl of RNase-free water was directly added onto the silica-gel 
membrane of the mini column.  The tube was centrifuged for 1 min.  The RNeasy 
mini column was taken out as the collection tube contained the RNA.  The RNA 
was  then  quantified  as  absorbance  at  260nm  using  a  Gene  Spec 
spectrophotometer (Hitachi Gene systems, Alameda, CA, USA). 
  
5.2.4 Kinetics Study 
The graph shape produced by a polymerase chain reaction is sigmoidal (y axis = 
quantification of electrophoresis gel bands, x-axis = number of PCR cycles).  It is 
therefore  important  to  ensure  that  the  number  of  PCR cycles  chosen  for any   107
particular reaction restricts the amount of product produced to the exponential 
phase of the graph.  More cycles do not guarantee a greater yield as items run 
out  and  start  to  hinder  the  reaction  (for  example,  reduction  in  the  number  of 
deoxynucleotide triphosphates [dNTPs] that are available).  Thus, to determine 
the optimum number of cycles a RNA sample was chosen at random and run for 
20, 30 and 40 cycles with each pair of primers for GAPDH, Bcl-2 and Bax.  The 
amplification products were separated by 2% agarose gel electrophoresis and 
the band patterns quantified (see below).   
 
5.2.5 Reverse-Transcriptase Polymerase Chain Reaction 
Message levels of the genes being investigated in this study were determined 
using  reverse-transcriptase  polymerase  chain  reaction  (RT-PCR).    The 
commercially  available  QIAGEN  OneStep  RT-PCR  Kit  (QIAGEN,  Hilden, 
Germany)  was  used  and  the  protocol  followed  was  of  that  set  out  in  the 
handbook.    This  method  combined  the  reverse  transcription  from  messenger 
RNA (mRNA) to DNA followed by the PCR proper.   
 
Each PCR tube contained 10µl of the 5x QIAGEN OneStep RT-PCR Buffer, 10µl 
of the Q-Solution, 2µl dNTP Mix, 2µl Enzyme Mix, and 0.5µl each of forward and 
reverse primer solutions.  However, these concentrations were all prepared in a 
master mix whose volume was 10% greater than the total number of reactions to 
be performed and 25µl was subsequently added to each individual PCR reaction.  
Having previously quantified the RNA samples the volume needed to make a   108
concentration of 0.5µg/µl was calculated and added to the PCR tube.  A variable 
volume of RNase-free water was then added to make up the PCR tube solution 
to a total of 50µl.  The PCR reactions also included negative controls, i.e. no 
RNA was included and 25µl of RNase-free water was added. 
 
Below is an outline of the PCR conditions and primer sequences: 
Reverse Transcription 
Step 1: T = 50° C for 30 min 
Step 2: T = 95° C for 15 min 
 
 
PCR Proper 
Step 1: T = 94° C for 1 min (denaturation) 
Step 2: T = 58, 58 and 56° C for 1 min - GAPDH, Bcl- 2 and Bax respectively 
(annealing) 
Step 3: T = 72° C for 1 min (extension) 
Step 4: Repeat steps 1-3 with number of cycles -1 (GAPDH = 25, Bcl-2 = 30, Bax 
= 30) 
Step 5: T = 72° C for 10 min (final extension) 
Step 6: Hold at 4° C (if kept overnight) 
 
 
Primer Sequences 
GAPDH 
CCATCACCATCTTCCAGGAG (forward) 
CCTGCTCACCACCTTCTTG (reverse) 
 
Bcl-2 
GCTACGAGTGGGATACTGGAGA (forward) 
AGTCGTCCACAGAGCGATGTT (reverse) 
 
Bax 
AGGATGATTGCTGATGTGGATAC (forward) 
CACAAAGATGGTCACTGTCTGC (reverse) 
 
Product size 
GAPDH   576 base pairs 
Bcl2   446 base pairs 
Bax   300 base pairs 
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5.2.6 Agarose Electrophoresis Gel 
 
Amplification products were resolved by 2% agarose gel electrophoresis, stained 
with  ethidium  bromide  (EtBr)  (Sigma  chemical  Co.,  St  Louis,  MO,USA)  and 
photographed under ultraviolet light.  Each gel was run at 80 volts for 1 hour. 
 
To make the 2% agarose gel, 2g of agarose were added to 100ml 1.0x EDTA 
(TAE)  buffer.    In  a  microwave  oven  the  solution  was  brought  to  the  boil  to 
dissolve the agarose.  Once the solution had cooled down to about 60° C at room 
temperature, 1µl of EtBr was added.  The gel was poured into the gel rack, a 
“comb” was placed in it to create the wells, and the gel was left to set.  After 
some time the gel tank was filled with remaining buffer solution and the ‘’comb’’ 
removed for the loading of the amplification products.   
 
20µl was removed from each PCR tube and put into a new vessel.  To each tube 
4µl of DNA loading dye was added.  One tube containing 20µl of DNA ladder and 
4µl of DNA loading dye was also created.  The gels included DNA markers to 
help resolve the molecular weights of the bands but quantification of individual 
bands was done using the computer software Syngene (Syngene, Cambridge, 
UK). 
 
 
5.2.7 Histological assessment 
Samples of liver were taken, at the end of the experiment from the left lobe. 
These were fixed in 10 per cent neutral buffered formalin and embedded in 
paraffin; paraffin section 4µm thick were cut using a microtome and mounted on   110
slides for haematoxylin and eosin staining. Assessment of liver injury was 
performed with light microscopy by Consultant pathologist who was blinded from 
the study groups, by a scoring system devised by Suzuki et al(Suzuki and 
Toledo-Pereyra 1993). In this system, sinusoidal congestion, hepatocyte 
ballooning or vacuolation, and necrosis are graded from 0 to 4. No congestion, 
vacuolation or necrosis is given a score of 0, while severe congestion, 
vacuolation and necrosis is given a score of 4, as shown in table 5.2.1. 
 
 
 
Table 5.2.1  
Suzuki’s Criteria for Liver I/R 
Numerical 
assessment 
Congestion  Vacuolation   Necrosis 
0  None  None  None 
1  Minimal  Minimal  Single cell 
2  Mild  Mild  < 30% 
3  Moderate  Moderate  30- 60% 
4  Severe  Severe  >60% 
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5.3 Data Collection and Statistical Analysis 
 
As  the  data  was  not  distributed  normally  a  non-parametric  test  was  used  to 
determine  whether  the  means  of  the  groups  were  significantly  different.    The 
Student’s  t  test  was  used  to compare  the  IRI  alone and  Bucillamine  plus IRI 
groups  as  these  were  the  two  groups  of  greatest  relevance.    All  data  are 
expressed as mean values ± standard deviations.  Statistical significance was set 
at p < 0.05.   
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5.4 Results: 
 
GAPDH,  Bcl-2  and  Bax  expression  was  measured  by  agarose  gel 
electrophoresis (Figures 5.4.2, 5.4.3A and 5.4.4A respectively) and the intensity 
of the expression bands compared in the following experimental groups: sham 
operated  versus  IR  alone  versus  Bucillamine  +  IR.    Gels  were  also  run  to 
separate  the  amplification  products  for  Bax  expression  in  the  groups  sham 
operated versus IR alone versus Bucillamine + IR.  The optimum number of PCR 
cycles for GAPDH, Bcl-2 and Bax amplification were determined to be 25, 30 and 
30 respectively (Figure 5.4.1). 
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   GAPDH  Bcl-2  Bax 
20  1.71  0.00  0.00 
30  8.17  0.00  2.84 
40  55.87  16.60  28.97 
 
Figure 5.4.1.  Graphical and tabular representations of kinetic studies to determine the 
optimum number of PCR cycles for GAPDH, Bcl-2 and Bax expression. 
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5.4.2Effect of Bucillamine on Bcl-2 Expression in Rat Liver 
 
There  was  decrease  in  Bcl-2  expression  following  IR  as  compared  to  sham 
group. An increase in mean Bcl-2 expression was demonstrated in the rat livers 
of the Bucillamine + IR group compared to the IR alone group (10720± 7320 vs 
1517±  929,  p<0.05)  (Table  5.4.2).  The  increase  in  mean  Bcl-2  expression  is 
demonstrated graphically in Figure 5.4.3B.   
 
 
5.4.3 Effect of Bucillamine on Bax Expression in Rat Liver 
 
An increase in the Bax expression in the IR alone group was seen as compared 
to the sham group (12312.8±2553.2 vs. 1829.8± 721.51, p, 0.001) (Table 5.4.2). 
In the Bucillamine + IR group the Bax expression was significantly attenuated 
(2036±759, p=0.000468). The increase in mean Bax expression is demonstrated 
graphically in Figure 5.4.4B. 
 
5.4.4 Bax/Bcl-2 ratio 
 
A mean Bax/Bcl-2 expression ratio was calculated for the IR, Bucillamine and 
sham  groups  (Table  5.4.2).    The  ratio  was  higher  in  the  IR  alone  group  as 
compared to the Bucillamine + IR group (10.13±5.12 vs. 0.36±0.33, p=0.013). 
The difference in ratio sizes is demonstrated graphically in Figure 5.4.5. 
Finally, track 2 in each agarose electrophoresis gel (Figures 5.4.2, 3 and 4) was 
blank due to lack of any fragment.  This was to be expected as track 2 acted as a 
negative control with no RNA added to the PCR reaction tube prior to loading. 
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Table 5.4.2 : 
    Quantification Of Bands (Arbitrary Units) 
  Track Number  Bax  Bcl-2  Bax/Bcl-2 Ratio 
IR alone  3  12512  750  16.68 
   4  10351  1500  6.90 
   5  16585  3050  5.44 
   6  10431  1485  7.02 
   7  11685  800  14.61 
MEAN      12312.80  1517  10.13 
±S.D.      2553.20  929.22  5.13 
 
Bucillamine + IR   8  3060  12340  0.25 
   9  2615  3040  0.86 
   10  1385  17680  0.08 
   11  1412  17430  0.08 
   12  1708  3020  0.57 
MEAN      2036  10702  0.36 
±S.D.      759.04  7320.53  0.33 
 
Sham  13  3080  800  3.85 
  14  1412  570  2.48 
  15  1308  10444  0.13 
  16  1563  11251  0.14 
  17  1786  13520  0.13 
MEAN     1829.8  7317  1.74 
±S.D.     721.61  6158.84  1.34 
 
 
Table 5.4.2.  Quantification of Bcl-2 and Bax agarose gel electrophoresis band patterns in the 
following experimental groups: ischaemia-reperfusion injury (IR) alone and Bucillamine + IR.  
Statistical analysis of the two groups (Student’s t-test) was carried out.  Significant increase in 
Bax expression seen in IR group which was attenuated by Bucillamine infusion ( p<0.0005). 
Bucillamine infusion also significantly up regulated Bcl-2 expression as compared to IR only 
group (p<0.005). 
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Figure 5.4.2: 
 
 
 
 
Track Key: Track1- DNA molecular marker, Track2- Negative control 
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Figure 5.4.3A: 
 
Track Key: Track1- DNA molecular marker, Track2- Negative control 
 
Figure5.4.3B:
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Figure 5.4.4 A: 
 
Track Key: Track1- DNA molecular marker, Track2- Negative control 
 
Figure 5.4.4B 
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Figure 5.4.5: 
 
5.4.6 Histology 
I/R injury caused significant periportal congestion with severe necrosis in zones 2 
and 3 (Figure 5.4.6a), with a statistically significant rise in the Suzuki score as 
compared to sham group (p < 0.001). The Bucillamine I/R group showed less 
damage with a statistically significantly lower Suzuki score as compared to I/R 
only group (p < 0.05). Portal as well as central venous congestion was seen but 
there  was  no  significant  spill  out  into  the  surrounding  parenchyma.  The  only 
change  appeared  to  be  some  degenerative  changes  in  the  perivenular 
hepatocytes (Figure 5.4.6b). The SB group had well preserved architecture and 
the sham group revealed minimal changes (Figure 5.4.6c and d). No apoptotic 
changes were seen on histology at 3 hours reperfusion.   119
Table  5.4.6: 
  Sham  IR  Bucillamine + 
I/R 
Sham+ 
Bucillamine 
Suzuki score  4.6 ± 0.68  9 ± 0.68  6.57 ± 0.65  1.8 ± 0.2 
 
a.IR group            b.Bucillamine+I/R group   
 
 
c.Sham            d.Sham+ Bucillamine 
 
Figure 5.4.6 Histology a).IR- The HE section shows large areas of necrosis and  
                                        sinusoidal congestion, normal residual hepatocytes noted at   
                                        bottom of the frame 
                                     b).Bucillamine+IR-The HE section shows sinusoidal congestion,     
                                         some hepatocyte vacuolation but no significant necrosis 
                                     c).Sham- The HE section reveals no significant damage. 
                                     d).Sham+Bucillamine- The HE section reveals no significant                                     
change.   120
5.5 DISCUSSION 
Findings in this study 
In this study apoptotic gene expression was measured in a rat hepatic IR model, 
which has shown for the first time a decreased expression of the proapoptotic 
Bax gene and increased expression of Bcl-2 gene after Bucillamine infusion in 
Liver  IR.  Bucillamine  infusion  during  ischaemia  reperfusion  also  showed  a 
protective effect as seen on histology. 
 
Methodology 
RT-  PCR  for  Bax  and  Bcl-2  is  a  very  well  described  and  validated 
technique(Oshiro et al. 2002; Tannuri et al. 2008). Glyceraldehyde-3-phosphate 
dehydrogenase  (GAPDH)  is  an  enzyme  that  catalyses  the  sixth  step  in  the 
glycolytic pathway.  As the gene is required to maintain basic cellular functions, 
an inherent assumption is that the expression of this gene remains constant in all 
cells.  For this reason GAPDH was utilised as an internal standard in this study to 
normalise the gene expression analysis of Bcl-2 and Bax, as a ‘housekeeping’ 
gene.   
 
We used Suzuki criteria for assessing the histological changes as this allows the 
changes occurring to be allocated a score which could be compared between the 
groups(Suzuki  and  Toledo-Pereyra  1993).  All  samples  being  assessed  by  a 
Consultant  Pathologist  who  was  blinded  to  the  sample  allocation.  Other 
investigators  have  used  degree  of  necrosis  as  the  only  histological   121
parameter(Noh et al. 2006) however, the severity of necrosis seen at 3 hours 
reperfusion  is  not  as  marked  with  more  marked  changes  seen  at  24  hours 
following reperfusion. Initial changes in liver IR seen on histology are congestion, 
cytoplasmic  vacuolation,  nuclear  pyknosis,  cytoplasmic  eosinophilia  and 
neutrophil infiltration. Other investigators have used gradations in these changes 
to assess severity of liver injury in early phase of liver IR(Cavalieri et al. 2002; 
Kong et al. 2009). This is the first study on liver warm ischaemia reperfusion 
injury using Bucillamine infusion. In the ex vivo cold ischaemia model Amersi et 
al(Amersi  et  al.  2002)  used  Banff  score(Demetris  et  al.  1996)  for  grading 
histological  changes  and  showed  better  protection  of  cytoarchitecture  with 
Bucillamine. 
 
An  increase  in  Bax  and  decrease  in  Bcl-2  expression  leads  to  increase  in 
mitochondrial permeability resulting in increased release of cytochrome c which 
in turn upregulates caspase 3 activation leading to apoptosis. An increase in Bax 
and decrease in Bcl-2 was seen in the IR group. Bucillamine by its anti oxidant 
effect  seems  to  decrease  the  expression  of  Bax  and  upregulates  the  anti 
apoptotic gene Bcl-2. 
 
Liver warm I/R is associated with necrosis / apoptosis of hepatocytes(Jaeschke 
and Lemasters 2003). In liver I/R, oncotic necrosis and apoptosis share features 
and  mechanisms(Gujral  et  al.  2001;  Jaeschke  and  Lemasters  2003).  It  is 
suggested that the ability of a necrotic process to be converted to an apoptotic   122
one and vice versa illustrates that the pathways in the two processes could be 
shared,  a  phenomenon  called  necroapoptosis(Lemasters  1999;  Formigli  et  al. 
2000).  Our  results  agree  with  this  theory  of  common  phenomenon  of 
necroapoptosis. Liver I/R showed cellular congestion, vacuolation and necrosis 
along with inflammatory changes which are a feature of oncotic necrosis(Majno 
and Joris 1995). However, Liver I/R also showed an increase in Bax/ Bcl-2 ratio. 
Bucillamine ameliorated both the severity of morphological changes as well as 
the  rise  in  Bax/  Bcl-2  ratio.  This  co-related  with  our  earlier  observation  of 
increased non viable nuclei with propidium iodide on intra vital microscopy and its 
attenuation by Bucillamine infusion.  
 
Conclusion: 
This study shows a protective role of Bucillamine infusion in the early phase in 
the  subsequent  chapters  we  concentrate  its  role  in  late  phase  of  IR  and  the 
possible mechanisms. 
 
 
 
 
 
   123
 
 
   
 
 
 
 
Chapter 6 
New insights into the late phase of hepatic IR and the effect 
of Bucillamine on hepatocellular and microvascular changes 
after 24 hrs of reperfusion 
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6.1 Introduction 
The previous chapters have analysed the early phase of liver warm ischaemia 
reperfusion injury and demonstrated the protective hepatocellular and 
microvascular changes associated with Bucillamine in hepatic IR injury. In this 
chapter we have studied the late phase of hepatic IR and the effect of 
Bucillamine on the late phase of IR. In the clinical setting ischaemia reperfusion 
injury in the late phase has a major bearing on patient survival, graft function and 
morbidity. Therefore it is imperative that experimental studies investigate the 
pathophysiology of the late phase, the mechanism of hepatocellular injury 
caused in the late phase of hepatic IR and the effect of protective strategies in 
the late phase of hepatic IR. 
 
 Pathophysiological changes in IR (early and late phase) 
 The key event in the initial phase of reperfusion injury is activation of 
macrophages which are the primary source of extracellular ROS (free radicals). 
Endothelial cells and parenchymal cells are activated leading to release of ROS 
originating from intracellular mitochondria, xanthine oxidase system, NADH 
oxidase system and iron redox system.  There is an imbalance between 
endothelial NO and ROS leading to impairment of protective effects of NO on the 
microvasculature. Free radicals (ROS) are the key initiators of reperfusion injury 
which lead to endothelial injury and further release of pro inflammatory cytokines.  
Simultaneous activation of complement pathway in the early phase serves to 
prime macrophages and neutrophils for  release of ROS(Jaeschke et al. 1993).   125
The complement cascade along with cytokines and chemokines leads to 
recruitment of neutrophils, increased expression of adhesion molecules and 
adhesion of neutrophils to the endothelium in venules. Neutrophils damage 
endothelium, extravasate, adhere to parenchymal cells and plug the local 
microvasculature which along with vasoconstriction due to increased endothelin 
release exacerbates tissue ischaemia. In the late phase of IRI neutrophils 
produce an oxidative burst causing parenchymal injury due to release of free 
radicals and proteases. 
 
 Microvascular, biochemical and histological changes (comparison of early 
and late phase of hepatic IR) 
In the early phase of hepatic IR there is significant impairment of RBC velocity, 
sinusoidal flow, sinusoidal perfusion and significant increase in sinusoidal and 
postsinusoidal venular neutrophil adhesion and hepatocellular death by intravital 
microscopy as demonstrated by the findings in this study and previously by 
Menger and Vollmar(Menger et al. 1999; Vollmar et al. 1994a). In the late phase 
of hepatic IR there is significant impairment of sinusoidal perfusion and 
significantly increased neutrophil adhesion in sinusoids and postsinusoidal 
venules. Neutrophil adhesion is markedly increased as compared to the early 
phase. In both phases there is increased parenchymal cell death and evidence of 
raised hepatic transaminases suggestive of hepatocellular injury. In both phases 
there is histological evidence of apoptosis, necrosis and neutrophilic infiltration 
with these changes being significantly more in the late phase of hepatic IR.   126
Studies involving Bucillamine and other thiol antioxidants in late phase of 
liver I/R 
In the in vivo study of syngeneic OLT in rats Amersi et al have shown a improved 
survival and better preservation of hepatic cytoarchitecture in livers given 
Bucillamine intraportally(Amersi et al. 2002). Our group has previously shown a 
protective role of continuous infusion of N acetylcysteine (NAC) in late phase of 
warm liver I/R(Fusai et al. 2005; Glantzounis et al. 2004). Chavez-Cartaya et al 
however, did not show any beneficial effect with NAC given preoperatively 
intramuscularly at 24 hour reperfusion(Chavez-Cartaya et al. 1999). Data from 
clinical trials in the use of NAC in OLT is unclear(Bromley et al. 1995; Thies et al. 
1997; Steib et al. 1998; Bucuvalas et al. 2001; Weigand et al. 2001). 
Effect of Bucillamine on late phase of warm liver I/R has not been studied. Its 
effect on liver microcirculation in the late phase has also not been studied. We 
hence carried out this study to see if the protective effect of Bucillamine infusion 
could be seen in the late phase of liver I/R. 
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6.2 Materials and Methods 
Animal care and experimental protocols were performed in accordance with the 
Home Office Guidance in the Operation of the Animals (Scientific Procedures) 
Act 1986. Male Sprague-Dawley rats weighing 300- 350g were be used in this 
study. Rats were kept in temperature controlled environment with 12 hours light- 
dark cycle and allowed tap water and standard rat chow pellets ad libitum.  
 
6.2.1 Operative Procedures 
Animals were anesthetized using isoflurane (Baxter, Norfolk, UK) and allowed to 
breathe spontaneously via concentric mask connected to an oxygen regulator. 
The animal’s body temperature was maintained at 36-38 
o C using a heating pad 
(Harvard apparatus Ltd., Kent, UK) and monitored with a rectal temperature 
probe. The arterial oxygen saturation (SaO2) and heart rate (HR) were 
continuously monitored with a pulse oximeter (Ohmeda Biox 3740 pulse 
oximeter, Ohmeda Louisville, Colorado, USA). Polyethylene catheters (Portex 2 
Fr) were inserted into the right or left jugular vein for administering normal saline 
(1ml /100gm body weight/hour) [or Bucillamine reconstituted to same volume 
depending on the experimental group] to compensate for intraoperative fluid loss. 
 
Laparotomy was carried out through a midline incision. The ligamentous 
attachments of the liver were cut and the liver exposed. All animals were given 
heparin 20 units /kg and partial hepatic ischaemia of the left lateral and median 
lobes of (70% of liver) induced by clamping the corresponding vascular pedicle   128
with an atraumatic microvascular clamp for 45 minutes in the control and 
Bucillamine groups. This model prevents splanchnic congestion by allowing flow 
through the remaining liver(Koti et al. 2005). Reperfusion was started by 
releasing the atraumatic clamp. Rats were randomly allocated to 2 study groups 
(n=6/group).  
 
6.2.2 Experimental Protocol 
Group 1.  I/R- 45 minutes ischaemia followed by 24 hour reperfusion 
Group 2.  Bucillamine + I/R 
In the Bucillamine group Bucillamine was given as an infusion through the jugular 
line at a rate of 15mg/kg/hr through the period of ischaemia and for 3 hours after 
reperfusion. Animals in the I/R group received same volume of normal saline. 
Abdomen was closed with 4-0 Vicryl. The neck line was removed after the period 
of infusion and the neck wound closed using 4-0 Vicryl continuous suture. 
 
Rat recovery was closely monitored. Animal behaviour was assessed every hour 
for 4 hours and then at 22 and 24 hours. Signs of poor clinical condition were 
lethargy , ruffled fur and guarding upon abdominal palpation, lack of grooming 
and decreased food intake. 
 
After 24 hours of reperfusion right carotid artery was cannulated with a 
polyethylene catheter (0.40-mm inner diameter, Portex, Kent, UK) for 
administering fluorochromes. The abdomen was re-opened through the previous   129
incision. The left lobe of liver was mobilised gently after dividing filmy adhesions 
that had formed following previous laparotomy and put under the intravital 
microscopy for visualisation. In each group, Intravital microscopy was performed 
to assess RBC dynamics and interactions of leukocyte to the endothelium, prior 
to giving propidium iodide to assess nonviable nuclei.  
 
6.2.3 Intravital Microscopy 
As described previously in Chapter 3 (page 65) 
6.2.3.1 Leukocyte parameters 
As described previously in Chapter 3 (page 68) 
6.2.3.2 Mean RBC velocity 
As described previously in Chapter 3 (page 65) 
6.2.3.3 Sinusoidal diameter 
As described previously in Chapter 3 (page 67) 
6.2.3.4Sinusoidal perfusion  
As described previously in Chapter 3 (page 67) 
6.2.3.5 Sinusoidal Blood Flow 
Sinusoidal blood flow was calculated using formula for capillary blood flow as 
previously described(Rucker et al. 1999). 
Sinusoidal blood Flow= Velocity x π x (d/2)
2 (expressed as pl/sec) 
 
6.2.3.6 Detection of hepatocellular death in vivo. 
As described previously in Chapter 3 (page 69)   130
At the end of the experiment animals were killed by exsanguinations. Serum and 
Plasma samples were collected by spinning the blood at 3000rpm for 10 minutes 
and stored in aliquots of 0.2 mls at -80
o C. Liver tissue was stored in formalin for 
histopathology and immunohistochemistry. Liver tissue was also frozen 
immediately on termination of experiment in liquid nitrogen and stored at -80
o C 
for further analysis. 
 
6.2.4 Biochemical Assay    
Blood samples were collected from the Carotid artery and were centrifuged at 
3000 rpm for 10 minutes and serum was removed and analysed on an 
autoanalyzer (Hitachi 747, Hitachi, Tokyo, Japan) using commercially available 
kits (Boehringer Mannheim, Lewes, East Sussex, UK) for serum aspartate 
transaminase and serum alanine transaminase. 
 
 6.2.5 Histological assessment 
As described previously in Chapter 5 (page 109) 
 
6.3 Data collection and statistics 
All the data is expressed as mean± standard error of mean (sem). Analysis of 
data was done using SPSS 14.0.Differences in data between groups was 
assessed by using one way ANOVA with Bonferroni’s post hoc test. Data was 
considered statistically significant if p< 0.05. 
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6.4 Results: 
There were no procedure related deaths in either group. 
It was found to be difficult to mobilise the liver on account of adhesions and 
tissue oedema as compared to 3 hour reperfusion group (Figure 6.1). Intravital 
microscopy was not possible due to oedema and necrosis in one animal in the 
I/R group and was only possible to get partial data in one animal in the 
Bucillamine group. Complete Intravital microscopy data could be obtained in 5 
animals in both groups. 
 
Biochemistry 
The AST as well as ALT were less raised in the Bucillamine group, though this 
was statistically non significant (AST, 3053±1322.06 vs. 3379±1501.51) (ALT, 
1611±588.12 vs. 1740.67±723.11).  (Figure 6.2 and 6.3) 
 
Intravital microscopy 
RBC velocity 
RBC velocity was higher in the Bucillamine group as compared to the I/R group 
(481.38± 33 vs. 400.47±25.4, p=0.062) (Figure 6.4). 
 
Sinusoidal diameter 
There was no statistically significant difference between the two groups 
(7.37±0.23 vs. 7.27±0.21). (Figure6.5). 
   132
Sinusoidal Perfusion Index 
There was no statistically significant difference between the two groups 
(76.61±5.78 vs. 67.03±7.73, p=0.35). (Figure 6.6) 
 
Sinusoidal Blood Flow 
There was no statistically significant difference between the two groups 
(19.13±2.63 vs. 16.28±1.83, p=0.401). (Figure 6.7) 
 
Leukocyte adherence in sinusoids 
I/R group (176.92±48.68) showed a significant higher number of adherent 
leukocytes in the sinusoids as compared to bucillamine group (43.09±8.42) 
(p<0.05). (Figure 6.9) 
 
Leukocyte adherence in venules 
There were significantly lesser number of adherent leukocytes in the venules in 
the Bucillamine group as compared to I/R group (217.33±50.15 vs. 
737.62±132.52, p < 0.01) (Figure 6.10) 
 
Hepatocellular cell death in vivo 
There was statistically significant difference in the nonviable nuclei between the 
Bucillamine and I/R groups (385.37±49.37 vs. 923.98±116.68, p<0.005). (Figure 
6.11) 
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Figure 6.1: Photograph showing severe necrosis and oedema seen 24 hours post reperfusion 
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Figure 6.2: Showing serum AST levels 24 hours post reperfusion values expressed as Mean ± SEM 
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Figure 6.3: Showing serum ALT levels 24 hours post reperfusion values expressed as Mean ± SEM 
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Figure 6.4:  Velocity of RBC flow in Bucillamine+IR-24 as compared to IR-24.  Values expressed as 
mean + sem.  (No significant difference seen between IR-24 and Bucillamine +IR-24) 
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Figure 6.5: Figure - Sinusoidal diameter- No Significant Difference seen. Values expressed as mean + 
sem.   
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Figure 6.6: Sinusoidal perfusion index – No significant difference seen.  Values expressed as mean +  
sem.  
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Figure 6.7: Sinusoidal flow = V× (D/2)2×л. V is velocity of RBC, D is sinusoidal diameter.  No 
significant difference seen. Values expressed as mean + sem.  
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Figures 6.8: Neutrophils stained by rhodamine are seen adherent to post sinusoidal venular 
endothelium and to hepatic sinusoids.  The number of adherent neutrophils divided by the area of 
endothelial surface (л×D×L) gives the number of neutrophils/ mm2. D= sinusoidal diameter, L= length of 
segment along adherent neutrophils.  
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Fig 6.9:  Significantly reduced venular neutrophil adhesion in Bucillamine (B-24) group compared to IR 
only group (IR-24). Values expressed as mean + sem. † p<0.01 
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Figure 6.10- Significantly reduced sinusoidal neutrophil adhesion in Bucillamine group (B24) compared 
to IR only group (IR24). Values expressed as mean + sem. ‡ p<0.05 
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Figure 6.11- Hepatocellular cell death in Bucillamine group (B-24) is significantly less compared to IR 
only (IR-24) group. Values expressed as mean+ sem. *  p<0.005 
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Hepatocellular death.  
   
 IR-24                                                       Bucilamine+IR-24 
Figure 6.12: Hepatocellular l death in IR by propidium iodide staining (IVM). The dead cells appear 
pink stained by propidium iodide. The number of cells divided by the surface area of the field above gives 
the number of cells/mm2.  
Fig 6.13 - Hepatocellular cell death seen in Bucillamine+IR-24 by propidium iodide staining (IVM). 
 
 
 
 
Histology 
In the IR24 group severe damage with abundant ballooning degeneration and 
necrosis was seen which was reduced by Bucillamine administration (Figure 6.14 
and 6.15). Apoptotic changes were seen in the IR only group. 
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Figure 6.14: IR-24 
 
 
Figure 6.15: B-24 
 
Figure 6.14 &6.15: Very severe injury with abundant ballooning degeneration and necrosis is seen in 
the IR injury group.  Very diffuse and significant neutrophil adhesion is seen in the IR group. Apoptosis is 
evident in the IR group. Bucillamine group shows less injury with some ballooning and degeneration as 
well as neutrophilic infiltration.   140
6.5 Discussion  
Model stability, selection 
The animal model was haemodynamically stable during the period of ischaemia 
and recovery. The animals were resuscitated with intravenous fluids prior to 
closure of laparotomy wound and recovery from anaesthesia. All animals in our 
study received either Bucillamine or normal saline for 3 hours post reperfusion 
only. The effect of this was assessed at 24 hours post reperfusion. This was to 
keep uniformity in the protocol for early phase (Chapter 4) and late phase 
experiments. Furthermore, we wanted to see if the beneficial effect of 
Bucillamine seen in the early phase of liver I/R was maintained in the late phase 
of I/R. Equivocal results with the use of NAC have suggested that the beneficial 
effect of NAC might be lost after the continuous infusion of NAC is 
stopped(Glantzounis et al. 2004). Our results show a beneficial effect with 
Bucillamine in the late phase even after stopping of continuous infusion which 
agrees with the findings of Amersi et al(Amersi et al. 2002). 
 
Microcirculatory changes in hepatic IR injury at 24 hours and comparison 
with early phase (3hrs)  
The velocity of flow and sinusoidal flow in hepatic IR after 24 hours of reperfusion 
are not significantly less in comparison to Bucillamine + IR group in the late 
phase of hepatic IR which is in contrast to the early phase where we found the 
velocity of flow and sinusoidal flow to be significantly lower in the IR group. The 
sinusoidal perfusion in both the early (Chapter 4) and late phase of hepatic IR   141
were found to be lower in the IR group, although this was not statistically 
significant. There was no change in the sinusoidal diameter in early or late phase 
of IR injury in either group. 
 
Neutrophil adhesion in the early and late phase of hepatic IR 
The sinusoidal neutrophil adhesion and postsinusoidal venular neutrophil 
adhesion in both the early and late phase of hepatic IR was significantly more in 
comparison to the sham group. However the number of adherent neutrophils was 
significantly more in the late phase of hepatic IR in comparison to the early phase 
of hepatic IR suggesting that there is increased neutrophil activation and 
adhesion as IR injury progresses over a period of time. Previous intravital studies 
by Menger et al have shown that increased neutrophil adhesion to endothelium is 
responsible for increased endothelial injury and poor sinusoidal 
perfusion(Menger et al. 1999).  
 
Neutrophil adhesion in Bucillamine + IR (3 hrs and 24 hrs)  
The data here clearly demonstrate that Bucillamine markedly attenuates 
neutrophil adhesion to endothelium in the IR injury group in both sinusoids and 
venules and the reduced neutrophil adhesion may account for the improved 
sinusoidal perfusion seen in the Bucillamine + IR group. In the early phase of 
hepatic IR significantly reduces neutrophil adhesion in both sinusoids and 
venules. Previous studies on direct ischaemic preconditioning have 
demonstrated   modulation of sinusoidal perfusion by reduced neutrophil   142
activation and adhesion at 24 hours(Vollmar et al. 1994c). The number of 
adherent neutrophils seen in the sinusoids in our study, however, does not 
suggest a mechanistic role for adherent leukocytes in reducing the sinusoidal 
perfusion by mechanically blocking the sinusoidal flow. Neutrophil activation by 
IR and its amelioration by Bucillamine seem to be an important mechanism of 
action of Bucillamine.  
 
Liver injury and Hepatocellular death in IR and the effect of Bucillamine. 
(3hrs and 24 hrs) 
Hepatic transaminases were used as surrogate markers of liver injury and are 
significantly higher in the IR injury group at 3 hours as compared to the 
Bucillamine group suggesting reduced hepatocellular injury in the Bucillamine 
group. Transaminase levels were also slightly reduced in the late phase of 
hepatic IR although the difference was not statistically significant. However, the 
direct marker of liver injury as assessed by necrotic/apoptotic nuclei stained with 
propidium iodide showed a significant decrease with Bucillamine infusion. 
 
Histological changes in IR -24 and the effect of Bucillamine. (Early and late 
phase) 
Histological findings in this study clearly demonstrate increased parenchymal 
necrosis and neutrophilic infiltration in the IR injury group at 24 hours as 
compared to the Bucillamine group. In the early phase the modified Suzuki score 
was significantly more in IR injury in comparison to Bucillamine+ IR group.   143
However the Suzuki score is an objective score described only for assessing the 
early phase of hepatic IR and cannot be used for describing the late phase 
changes.  
 
6.6 Conclusions 
This is the first study to demonstrate the protective effects of Bucillamine on 
hepatic microcirculation in a recovery model of hepatic IR in rats. The study 
showed that although there was no significant difference in the level of liver 
enzymes which are an surrogate marker of liver injury the protective effect of 
Bucillamine seemed to be preserved as assessed by histology and assessment 
of non viable nuclei on Intravital microscopy which are more direct methods of 
assessing liver injury.  
 In the next chapter we investigated possible mechanisms of action and role of 
Bucillamine in cytokine activation. 
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Chapter 7   
Effect of Bucillamine on Oxidant stress: is mediated by the 
replenishment of intracellular glutathione levels? 
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7.1Introduction: 
Reperfusion of ischaemic tissue generates reactive oxygen species (ROS) which 
have deleterious effects on various cellular functions(Werns and Lucchesi 1990). 
ROS activate cytokines, macrophages and other components of the inflammatory 
pathway(Entman et al. 1991; Jaeschke and Farhood 1991a; Le et al. 1997). 
When generated in large numbers they can also cause direct oxidative damage 
to the cells through iron mediated reactions(Horwitz et al. 1998). Kupffer cells 
become activated during ischaemia(Rymsa et al. 1991)and this is exacerbated 
during reperfusion by complement activation(Jaeschke et al. 1990). Activated 
Kupffer cells generate ROS(Jaeschke and Farhood 1991a). The Kupffer cell 
induced oxidant stress in early reperfusion injury leads to neutrophil activation 
and these activated neutrophils along with Kupffer cells contribute to further 
oxidant stress during the late phase of reperfusion injury(Jaeschke and Farhood 
1991a). In this chapter we investigated if the beneficial effect of Bucillamine could 
be through suppression of oxidant stress. 
 
7.1.1 Lipid Peroxidation assays 
Oxidant stress in tissue and plasma is measured by lipid peroxidation assays. 
Several in vitro markers of oxidative stress are available, but most are of limited 
value in vivo because they lack sensitivity  and specificity or require invasive 
methods(Halliwell 2000). The most widely used test for measurement of oxidative 
stress is measurement of malondialdehyde (MDA), a product of lipid peroxidation 
by a thiobarbituric acid reacting substances assay (TBARS assay)(Del et al.   146
2005). However, the use of this assay has flaws as MDA is not a specific product 
of lipid peroxidation(Gutteridge and Halliwell 1990), and TBARS assay is not 
specific for MDA(Halliwell 2000). Thiobarbituric acid (TBA) reacts with several 
other compounds derived by oxidation(Knight et al. 1988). Moreover, the 
treatment of biological samples to obtain condensation product is carried out at 
high temperatures (around 100
o C) and may result in generation of further 
products of oxidation with obvious overestimation of results(Del et al. 2005).  
Another method of assessing lipid peroxidation in vivo is measurement of 
exhaled volatile alkanes, such as ethane and pentane(Knutson et al. 1999). 
However, these hydrocarbons are minor end-products of peroxidation and their 
concentrations are influenced by the breakdown rates of peroxides(Halliwell 
2000). The accuracy of exhaled pentane as a marker of lipid peroxidation has 
also been questioned(Cailleux and Allain 1993). Lipid hydroperoxides have been 
measured by various methods(Gay and Gebicki 2003), however, this has been 
found to be inconsistent(Halliwell 2000). 
 
7.1.2 The ideal Lipid Peroxidation assay 
The ideal assay of lipid peroxidation should satisfy the following 
conditions(Halliwell 2000): 
1)  It should quantitate a major product of lipid peroxidation 
2)  The coefficient of variance between multiple runs of the same sample 
should be very small in comparison with the differences between subjects. 
3)  It must not be subject to interference by other biomolecules.   147
4)  It must employ chemically robust measurement methods (e.g. mass 
spectrometry or HPLC with good identification methods such as diode array or 
coulometric detectors) or be validated by such methods. 
5)  It must not be confounded by uptake of oxidised lipids present within 
foods. 
6)  It should be able to assess both steady state levels of products of lipid 
peroxidation (i.e. the balance between rate of peroxidation and rates of 
metabolism/ clearance of peroxidation products) and the total rates of ongoing 
lipid peroxidation. 
7)  The parameter measured should be stable on storage and should not be 
formed artefactually in stored samples.  
 
7.2. F2 isoprostanes 
Isoprostanes are prostaglandin like substances that are produced in vivo by free 
radical induced peroxidation of arachidonic acid(Morrow et al. 1990) esterified to 
tissue lipids. They have been detected in a variety of normal animal tissues 
including liver, kidney, testes, heart, brain, skeletal muscle, aorta, ocular lens and 
lungs(Morrow and Roberts 1994). The formation of PG like compound during 
auto oxidation of poly unsaturated fatty acids was reported first in mid 
1970s(Pryor et al. 1976), but isoprostanes were not discovered in vivo until 
1990(Morrow et al. 1990). F2 isoprostanes are a group of 64 compounds isomeric 
in structure to cyclooxygenase derived PGF2α. Other products of the isoprostane 
pathway are also formed in vivo by the rearrangement of labile PGH2 like   148
isoprostane intermediates. These include E2 and D2 isoprostanes(Morrow and 
Roberts 1997), cyclopentenone A2 and J2 isoprostanes(Chen et al. 1999) and 
highly reactive acyclic ketoaldehydes (isoketals)(Brame et al. 1999). Oxidation of 
docosahexaenoic acid ( an abundant unsaturated fatty acid in the central 
nervous system) leads to formation of isoprostane like compounds called 
neuroprostanes(Roberts et al. 1998). 
Isoprostanes are formed in a free radical dependent manner and are chemically 
stable. They are initially generated in cell membranes at the site of free radical 
attack from which they are cleaved presumably by phospholipases, circulate and 
are excreted in the urine(Montuschi et al. 2004). (Figure 7.2.1)   149
Figure 7.2.1 
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F2 isoprostanes: 
1.  are chemically stable(Roberts and Morrow 2000) 
2.  are specific products of peroxidation(Roberts and Morrow 2000) 
3.  are formed in vivo(Roberts and Morrow 2000) 
4.  are present in detectable amounts in all normal tissues and biological 
fluids, thus allowing definition of a normal range(Roberts and Morrow 2000) 
5.  are unaffected by lipid content in the diet(Richelle et al. 1999; Gopaul et 
al. 2000) 
6.  levels are found to increase in animal models of oxidant injury(Morrow et 
al. 1992; Awad and Morrow 1995) 
7.  might provide a sensitive biochemical basis in dose finding studies with 
antioxidants(Roberts and Morrow 2000). 
Roberts et al compared and reviewed various methods of measuring lipid 
peroxidation and found F2 isoprostanes to be the most accurate method(Roberts 
and Morrow 2000). 
 
7.2.1 Biological properties of F2 isoprostanes 
F2 isoprostanes are potent vasoconstrictors and induce their effects through the 
induction of Thromboxane A2 receptors and also through release of products of 
the cyclooxygenase pathway(Cracowski et al. 2001). They have been shown to 
have a vasoconstrictor effect in rat glomerular arteries(Takahashi et al. 1992) 
and cerebral arterioles(Hoffman et al. 1997). F2 isoprostanes also are known to 
mediate rapid neutrophil adhesion through either Thromboxane A2 receptors or   151
specific isoprostane receptors present on neutrophils(Fontana et al. 2001). They 
are also known to cause platelet activation and platelet adhesion(Pratico et al. 
1996; Minuz et al. 1998). All of these effects are known to play a part in 
ischaemia reperfusion injury. 
 
7.2.2 Studies involving ischaemia reperfusion injury: 
Mathews et al studied plasma F2 isoprostanes in Sprague Dawley rats after 45 
minute liver ischaemia and 1, 5 and 24 hours of reperfusion, and showed a 
significant increase in plasma F2 isoprostanes in the reperfusion period with a 
peak rise at 1 hour reperfusion(Mathews et al. 1994). This was accompanied by 
a rise in plasma and liver tissue reduced glutathione (GSH) levels and a rise in 
hydroxyeicosatetraenoic acids. F2 isoprostanes have been found to be increased 
in brain and heart muscle in ischaemia reperfusion models involving cardioplegia  
and reperfusion, in animals(Idris et al. 2005; Xia et al. 2003; Fischer et al. 2003) 
and human subjects(Mehlhorn et al. 2003). They have also been shown to 
increase in lung tissue ischaemia reperfusion model(Becker et al. 1998a). In 
kidneys F2 isoprostanes have been shown to increase during ischaemia and 
reduce in the reperfusion period(Favreau et al. 2004). Increase in urinary F2 
isoprostanes has also been shown in human subjects undergoing percutaneous 
transluminal angioplasty following myocardial infarction(Reilly et al. 1997; Guan 
et al. 2003). All of these studies suggest that F2 isoprostanes could be used as a 
marker of oxidative stress in ischaemia reperfusion injury.  152
Studies on Ischaemia reperfusion injury and F2 isoprostanes Table 7.2.3 
 
First author and year  Organ  F2 isoprostane measurement 
(serum/tissue/urine) 
Observation  Notes 
Matthews(1994)(Mathew
s et al. 1994) 
Rat Liver  Plasma  Significant increase post reperfusion with peak 
rise 1 hr post reperfusion 
↑ Liver GSSG, ↑ Liver 
hydroxyeicosatetranoic acid 
 
Kelly (2008)(Kelly et al. 
2008) 
Human Stroke  Plasma  Increased F2 isoprostane at 6hrs post stroke   
Basu (2007)(Basu et al. 
2007) 
Human renal transplant  Plasma  Increased F2 isoprostane on reperfusion   
Zhang (2007)(Zhang et 
al. 2007) 
Rat Brain  Brain  Increased F2 isoprostane    
Lin (2006)(Lin et al. 
2006) 
Human Sub arachnoid 
haemorrhage 
CSF, Plasma  Increased F2 isoprostane    
Idris (2005)(Idris et al. 
2005) 
Pig Heart  Arterial, Venous, and Brain tissue  Significant increase post reperfusion   
Xia (2003)(Xia et al. 
2003) 
Rat Heart  Heart tissue  Significant increase during ischaemia  Protection by propofol, high dose better 
than lower dose 
Fischer (2003)(Fischer et 
al. 2003) 
Pig Heart  Heart tissue 
immunocytochemistry 
Increased expression of F2 isoprostanes   
Mehlhorn 
(2003)(Mehlhorn et al. 
2003) 
Human heart  Left ventricular biopsy 
immunocytochemistry 
Increased expression of F2 isoprostanes   
Guan W (2003)(Guan et 
al. 2003) 
Human undergoing 
Percutaneous transluminal 
angioplasty(PTCA) 
Urine  Increased F2 isoprostane  No increase in Allopurionol infusion group 
Basu (2001)(Basu et al. 
2001)  
Pig Spine  Urine, Plasma  Increased F2 isoprostane on reperfusion   
Heindl (2001)(Heindl and 
Becker 2001) 
Guinea pig heart  Heart tissue  No significant increase   
Fischer (2000)(Fischer et 
al. 2000) 
Rat Lung transplantation  Lung tissue, Plasma  Increased F2 isoprostane  Decreased F2 isoprostanes with Captopril 
Marin (2000)(Marin et al. 
2000) 
Rat Cerebral ischaemia  Brain tissue  Increased F2 isoprostane   
Basu (2000)(Basu et al. 
2000) 
Pig Heart  Plasma  Increased F2 isoprostane   
Becker (1998)(Becker et 
al. 1998b) 
Ferret lung  Lung tissue  Increased F2 isoprostane   
Reilly (1997)(Reilly et al. 
1997) 
Human PTCA  Urine  Increased F2 isoprostane     153
7.3 Glutathione and Liver I/R: 
Glutathione  (GSH)  is  an  endogenous  molecule  present  in  all  animal  cells,  in 
millimolar  concentrations.  It  has  multifaceted  physiological  functions  such  as 
antioxidant defence, detoxification of xenobiotics, modulation of redox-regulated 
signal  transduction,  regulation  of  cell  proliferation,  synthesis  of  deoxy-
ribonucleotides, regulation of the immune response and regulation of leukotriene 
and  prostaglandin  metabolism.  The  cysteine  sulfhydryl  (-SH)  side  chain  of 
glutathione accounts for most of its physiological properties. 
The antioxidant function of GSH is implicated through two general mechanisms 
of reaction with ROS: direct or spontaneous and glutathione peroxidase (GPX) 
catalysed. As a major by-product of such reactions oxidised glutathione (GSSG) 
is produced (reaction 1).  GSSG, can then be again reduced to GSH with the 
participation of glutathione reductase and NADPH (reaction 2):   
 
) 1 ( 2 2 2 2 2 O H GSSG O H GSH + ¾® ¾ +    
) 2 ( 2 + + ¾® ¾ + + + NADP GSH H NADPH GSSG  
 
In the only other study on Bucillamine in Liver I/R Amersi et al showed increased 
levels of GSH in the liver and decreased levels of oxidized glutathione in both, 
the liver and blood after Bucillamine use and suggested that the beneficial effect 
of  Bucillamine  could  be  due  to  replenishment  of  endogenous  glutathione 
levels(Amersi et al. 2002). 
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Aim of this Study: 
To determine whether the beneficial effect of bucillamine in warm IRI is mediated 
by preservation of intracellular glutathione levels 
Hypothesis: 
We hypothesize that: 
1.  ischaemia reperfusion injury in rat livers there is increased oxidative stress 
and this would result in raised F2 isoprostane levels 
2.  Bucillamine by its anti oxidant property would reduce the rise in the levels 
of F2 isoprostanes. 
3.  Bucillamine would increase the level of tissue glutathione. 
 
7.4 Materials and Methods: 
Animals and surgical preparation 
As described in Chapter 3 page  48 
 
7.4.1 Experimental groups (n=6 in each group) 
Group1 - (Sham) – laparotomy and mobilisation of liver but no occlusion of the 
vascular pedicle. 
Group2- IR- 45 minutes of partial hepatic ischemia followed by 3 hrs of 
reperfusion. 
Group3- Bucillamine 15mg/ kg/hr intravenously + IR (as above) followed by 3 hrs 
of reperfusion. 
Group4- (SB)- Sham + Bucillamine infusion 15mg/kg/hr (SB)   155
Group5- IR24- 45 minutes ischaemia (as above) followed by 24 hour reperfusion 
Group6- B24- 45 minutes ischaemia + Bucillamine 15mg/ kg/hr intravenously for 
3hours followed by 24 hour reperfusion 
   
 
7.4.2 Liver Injury Assay  
As described in Chapter 3 page 71. 
 
7.4.3 Measurement of Hepatic F2-Isoprostanes  
As described in Chapter 3 page 71. 
 
7.4.4 Measurement of Plasma F2-Isoprostanes 
As described in Chapter 3 page 72. 
 
7.4.5 Liver Tissue Glutathione Assay 
As described in Chapter 3 page 72. 
 
7.5 Statistical analysis 
All the data is expressed as mean± standard error of mean (sem). Analysis of 
data was done using SPSS 14.0 (SPSS Inc., Chicago, Illinois, USA). Differences 
in data between groups were assessed by using one way ANOVA with 
Bonferroni’s post hoc test. Data was considered statistically significant if p< 0.05.   156
7.6 Results 
There were no procedure related deaths. The model was haemodynamically 
stable.  There was a transient fall in oxygen saturation immediately after 
reperfusion which was reduced by Bucillamine therapy. There was a transient fall 
in blood pressure following reperfusion in both the I/R only and Bucillamine + I/R 
groups, which were not statistically significant. 
 
7.6.1 Biochemistry 
Transaminases were grossly elevated following I/R. The Bucillamine I/R group 
had lower AST and ALT than the I/R group [ (AST 932±200.81 vs. 
2072.5±511.79, p<0.05), (ALT 861.4±262.63 vs. 2079.3±322.33, p<0.05)]. 
(Figure 4.2.2a & b). The AST as well as ALT were lower in the Bucillamine group 
at 24 hours (B24) as compared to the IR only group at 24 hours (IR24), though 
this was statistically non significant ( AST, 3053±1322.06 vs. 3379±1501.51) 
(ALT, 1611±588.12 vs. 1740.67±723.11). (Figure 6.2 & 6.3)   
 
7.6.2 Hepatic F2-Isoprostanes  
The  I/R  group  and  Bucillamine  groups  had  lower  levels  of  liver  tissue  F2 
isoprostanes than the Sham groups although this difference was statistically not 
significant. ( Figure 7.6.1 & 2) 
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7.6.3 Plasma F2-Isoprostanes 
There was an increase in the plasma F2 isoprostane levels in the I/R group at 3 
hours reperfusion, although this rise was statistically non significant. In the 
Bucillamine + I/R group no rise in the plasma F2 isoprostane levels was seen. 
There was no difference in the levels at 24 hour post reperfusion. (Figure 7.6.3 & 
4) 
 
7.6.4 Liver Tissue Glutathione 
There was no statistically significant difference in the total Glutathione or 
GSH/GSSG ratio in any of the groups. Although the GSH/GSSG ratio seemed to 
better maintained in the Bucillamine group as compared to the I/R group both at 
3 hour and 24 hour reperfusion this was not statistically significant. (Figure 7.6.5-
8)   158
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Figure 7.6.1 
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Figure 7.6.2 
Figure 7.6.1&2: Liver Tissue F2 isoprostane levels showing no significant difference in the groups. 
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Figure 7.6.3 
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Figure: 7.6.4 
 
Figure 7.6.3&4: Plasma F2 isoprostane levels showing no significant difference between groups 
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Figure 7.6.5   
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Figure 7.6.6 
 
 
 
Figure 7.6.5&6: Liver Total Glutathione and GSH/GSSG levels following 45 minutes ischemia and 3 
hours reperfusion showing no significant difference between groups. 
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Figure 7.6.7 
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Figure 7.6.8 
Figure 7.6.7& 8: Liver Total Glutathione and GSH/GSSG levels following 45 minutes ischemia and 24 
hours reperfusion showing no significant difference between groups. 
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7.7 Discussion 
7.7.1 F2 Isoprostanes methodology: 
.The previously published literature would suggest that F2 isoprostanes could be 
used as a marker of oxidative stress in ischaemia reperfusion injury(Becker et al. 
1998a; Gopaul et al. 2000; Idris et al. 2005; Mathews et al. 1994; Mehlhorn et al. 
2003; Morrow and Roberts 1997; Richelle et al. 1999; Roberts and Morrow 2000; 
Xia et al. 2003). We have used a previously well described method to measure 
plasma and liver tissue F2 isoprostane levels(Morrow and Roberts 1997).  Errors 
could arise in measurement of F2 isoprostanes due to generation of these in 
tissue by auto oxidation(Morrow and Roberts 1997). We took care to ensure that  
samples were snap frozen to -80
0 C and used immediately on thawing. Errors 
could arise during homogenisation of tissue, pipetting which were minimised by 
these being carried out by one individual. 
 
7.7.2 Plasma F2 isoprostanes, liver I/R and effect of Bucillamine infusion: 
F2 isoprostanes are present in very small amounts in free form  plasma (in the 
range of 0.02 ng/ml)(Morrow et al. 1995) under normal circumstances. Over 90% 
of F2 isoprostanes present in plasma are carried as lipid esters(Moore 2004). We 
measured esterified concentration of F2 isoprostanes in the plasma. Our results 
showed no significant difference in plasma F2 isoprostane levels in any of the 
groups. In the only previous study of liver I/R and F2 isoprostane Mathews et 
al(Mathews et al. 1994) showed a significant rise in plasma F2 isoprostane levels 
with a peak rise at I hour post reperfusion. In our experiments although in the IR   163
group there appears to be an increase in the levels as compared to the sham 
group, this was not significant. The half life of plasma F2 isoprostanes in rats is 
also very short ( about 20 min)(Moore 2004). Our results could be hence different 
due to different time of sampling. 
 
7.7.3 Liver tissue F2 isoprostanes, liver I/R and effect of Bucillamine 
infusion: 
The levels of F2 isoprostanes in normal liver tissue are 1-10 pg/mg of wet 
tissue(Fernando and Mendis 2001; Harry et al. 1999) . This is the first study on 
liver I/R using liver tissue F2 isoprostane levels. We did not find any increase in 
liver tissue F2 isoprostane levels following I/R. Jaeschke et al had suggested that 
the molecular mechanism of ischaemia reperfusion injury does not seem to be 
due to lipid peroxidation(Jaeschke 2003b) and our results agree with this. There 
was no rise in hepatic F2 isoprostanes which would confirm that lipid peroxidation 
does not play a primary role in ischaemia reperfusion injury.  However, it is 
known that ischaemia reperfusion injury causes an increase in phospholipase 
levels(Caro and Cederbaum 2006). It is suggested that this up regulation of 
phospholipases might be resulting in an increased hydrolysis of F2 isoprostanes  
which could keep the levels of F2 isoprostane within normal range(Moore 2004). 
Hence, Moore et al have suggested that the timing of sample collection  might be 
critical(Moore 2004). This would need to be proved in further studies using 
different time points. Alternatively, Phospholipase levels could be measured in 
future studies.   164
 
7.7.4 Liver tissue Glutathione methodology: 
Liver tissue Glutathione was measured by modified Tietze method(Baker et al. 
1990; Eyer and Podhradsky 1986; Tietze 1969) which utilizes a carefully 
optimized enzymatic recycling method, using glutathione reductase, for the 
quantification of GSH. GSH concentrations of the sample, was measured by the 
kinetic method as described in the protocol to avoid interference by other thiol 
groups. Variability in the assay can arise due to errors in homogenisation of 
tissue, pipetting and, dilution. These were minimised by using standard 
techniques of dilution, assays being done by the same person. Inter assay 
coefficient of variance is 3.6% and intra assay 1.6%. The dynamic range of the 
assay is 0-16 µM for GSH and 0-8 µM for GSSG. 
 
7.7.5 Liver Tissue Glutathione, effect of I/R and effect of Bucillamine 
infusion: 
In our study we did not find any statistically significant difference in any groups. 
In the only other stody on Bucillamine and Liver I/R in an ex vivo liver transplant 
Amersi et al found a significantly increased level of reduced glutathione (GSH) in 
the liver with a significantly decreased level of oxidized Glutathione (GSSG) in 
the liver and blood. Lipid peroxidation was also found to be significantly less in 
this model of cold ischaemia with 2 hour reperfusion(Amersi et al. 2002).These 
differences in results could be due to the different experimental models used. In 
the ex vivo model  the effect of cold ischaemia was studied by storing the livers in   165
24 hour in UW solution(Amersi et al. 2002). Cold storage is known to decrease 
liver tissue glutathione levels(Sumimoto et al. 1996). The effect on liver tissue 
glutathione levels in warm ischaemia using in vivo models of liver partial  
ischaemia ( similar to ours) is variable.  
 
The difference in the result seems to be related to the duration of ischaemia and 
reperfusion used in these models. Some investigators – Stein et al ( partial ischaemia 
45 min and 45 min reperfusion)(Stein et al. 1991), Nagai et al (partial ischaemia 15 min and 60 min 
reperfusion)(Nagai et al. 1991),  Ajamieh et al (partial ischaemia 90 min and 90 min 
reperfusion)(Ajamieh et al. 2004) , Caraceni et al ( partial ischaemia 1 hr and 2 hr 
reperfusion)(Caraceni et al. 2005),  Demir et al ( partial ischaemia 30 min and 20 min reperfusion)(Demir 
and Inal-Erden 1998), Sener et al (partial ischaemia 45 min and 6 hr reperfusion)(Sener et al. 2003), 
Domenicali et al ( partial ischaemia 1 hr and 2 hr reperfusion in fatty liver)(Domenicali et al. 2005), 
Duenschede et al ( partial ischaemia and 1 hr reperfusion)(Duenschede et al. 2007), Dulundu et al 
( partial ischaemia 60 min and 60 min reperfusion)(Dulundu et al. 2007), Saavedra-Lopes et al (60 
min ischaemia and 6hr reperfusion)(Saavedra-Lopes et al. 2008), have shown a decrease in liver 
tissue glutathione levels as compared to sham animals.  
 
Whereas other investigators – Kobayashi et al (partial ischaemia 60 min and 60 min 
reperfusion)(Kobayashi et al. 1992), Schaeur et al ( partial ischaemia, 60, 90  and reperfusion 120 
min)(Schauer et al. 2004), Zumbado et al (75 min ischaemia and 1 hr reperfusion)(Zumbado et al. 
2003), Accatino (30 min ischaemia and 1 hr, 6 hrs, 1 day, 3 days and 7 days reperfusion)(Accatino et al. 
2003), have shown no difference in liver tissue glutathione levels.    166
It has been shown by Jaeschke et al that plasma levels of GSSG increased 
significantly during the reperfusion period(Jaeschke 1991). At the same time 
biliary efflux of glutathione was not enhanced and the increase in plasma GSSG 
was not affected by inhibition of glutathione reductase in the liver. Hepatocytes 
are known to release glutathione into sinusoids in the reduced form with an 
extracellular oxidation in the vasculature(Jaeschke 1991). They also showed that 
stimulation of Kupffer cells by complement pathway and other inflammatory 
mediators not only cased increased generation of ROS but also simultaneously 
increased the sinusoidal GSH efflux(Jaeschke 1992). Increase in plasma GSH 
and GSSG was seen as early as 15 minutes post reperfusion and although both 
plasma GSH and GSSG increased, GSH values increased by 3 to 6 fold whereas 
plasma GSSG increased by 9 to 27 fold as compared to pre ischaemic 
values(Jaeschke and Farhood 1991a). 
 
Oxidation of GSH in vivo was also studied by giving a bolus dose of GSH after 
ligating blood vessels of both kidneys(Jaeschke and Farhood 1991a). The 
injection of GSH in sham animals showed a decrease in plasma GSSG, which 
recovered to a basal level of 24-27% of Total plasma Glutathione in 10-15 
minutes. In contrast animals in the liver IR group showed significantly higher 
plasma GSSG levels which suggested that the high post ischaemic plasma levels 
of GSSG is not due to spontaneous oxidation of GSH in the plasma but reflects a 
higher extracellular oxidant stress. In another study Saito et al showed that the 
tissue ratio of GSH/GSSG decreased significantly in the ischaemic lobe at 60   167
minutes post ischaemia there was a fall in GSH/GSSG levels at 60 min post 
reperfusion which reached pre ischaemia levels by 180 min post 
reperfusion(Saito et al. 1999).  
 
These studies might suggest that the fall in glutathione could be related to the 
length of ischaemic period (i.e. longer the ischaemic period more the decrease in 
glutathione levels) and that glutathione levels in the liver tissue might be getting 
replenished after a certain period of reperfusion. In a study using total liver 
ischaemia, Kirimlioglu et al (total ischaemia 20 min and 22 hr reperfusion) showed a 
significant fall in glutathione levels as compared to sham animals(Kirimlioglu et 
al. 2006). Our results do not support the hypothesis of replenishment of liver 
glutathione as the main mechanism of action of Bucillamine, however, further 
research could be carried out using a different model of warm ischaemia 
reperfusion injury before we could rule this out. Future studies could look at 
plasma GSSG and GSH levels in addition to the liver tissue GSH and GSSG 
levels. Furthermore, newer more accurate methods of GSSG and GSH levels in 
vivo could be used to avoid interference by Bucilamine and other thiol 
groups(Jones and Liang 2009; Shaik and Mehvar 2006). 
 
Bucillamine has also been shown to stimulate glutathione synthesis(Wielandt et 
al. 2006). Our results however, do not suggest this to be the mechanism of action 
either. In a model of partial warm ischaemia reperfusion injury, Kurokawa et al 
showed a fall in total liver tissue glutathione at 60 min post reperfusion after 120   168
minutes of ischaemia. This was accompanied by a significant fall in mitochondrial 
GSH in the ischaemia period and a significant rise in mitochondrial GSH levels at 
60 minutes reperfusion suggesting that endogenous GSH might be transported 
into mitochondrial matrix from the cytosol in the reperfusion period to 
compensate for the fall in mitochondrial GSH in the ischaemic period(Kurokawa 
et al. 1996). Further research into the mechanism of action of Bucillamine could 
also look at mitochondrial GSH levels. 
 
 
7.8 Conclusion 
This study shows that the hepato protective effect of Bucillamine in warm Liver 
ischaemia reperfusion injury is not by direct replenishment of Glutathione level. 
We have shown in the previous chapters the beneficial effect of Bucillamine and 
its effect on reducing leukocyte endothelial interaction. In the next chapter we 
investigate if this is related to any changes in cytokine activation which could 
explain its mechanism of action. 
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Chapter 8 
Modulation of Neutrophil activation by Bucillamine induced   
inhibition of Cytokine-induced neutrophil chemoattractant in 
the early and late phase of hepatic IR. 
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Introduction: 
IR injury   is associated with increased venular and sinusoidal neutrophil 
adhesion seen by intravital microscopy and histologically in both the phases of 
hepatic IR. Bucillamine reduced   neutrophil adhesion in both phases of hepatic 
IR and this was associated with preservation of liver cytoarchitecture and 
improved liver function and decreased apoptosis/ necrosis.  
 
What is CINC-1? 
Cytokine induced neutrophil chemoattractant (CINC-1) is an 8kd polypeptide that 
was originally identified in the conditioned media of IL-1β- stimulated rat 
glomerular epithelial cells(Watanabe et al. 1989a). It consists of 72 amino acids 
having similar amino acid sequence to human peptides with gro/melanoma 
growth stimulatory activities, indicating that rat CINC belongs to the IL-8 family of 
cytokines(Watanabe et al. 1989b; Watanabe et al. 1992). Cells known to express 
CINC-1 include hepatocytes(Planaguma et al. 2002; Spitzer and Zhang 1996), 
kupffer cells(Hisama et al. 1996; Spitzer and Zhang 1996), macrophages(al-
Mokdad et al. 1998; Hisama et al. 1996; Mitsui et al. 2002; Shibata et al. 1998), 
mast cells(Ramos et al. 2003), neurons(Sakamoto et al. 1996), fibroblasts(Huang 
et al. 1992), type II greater alveolar cells(Crippen et al. 1995) and cardiac 
muscles(Seino et al. 1995). 
 
CINC-1 is a major neutrophil chemoattractant and activator(al-Mokdad et al. 
1998; Nakagawa et al. 1994; Ramos et al. 2003; Shibata et al. 2000; Suzuki et   171
al. 1994). CINC-1 is induced by IL-1β, TNF-α and bacterial products and 
promotes both neutrophil rolling and adhesion, most probably through 
upregulation of surface integrins(Aoki et al. 1997; Davenpeck et al. 1998; Dolecki 
and Delarco 1994; Mitsui et al. 2002; Nakagawa et al. 1994; Suzuki et al. 1994). 
It is also reported to stimulate neutrophil activity by promoting cathepsin G 
release from azurophilic granules(Shibata et al. 2000). Relative to CINC-2 and 
CINC-3, CINC-1 seems to be equal in chemotactic activity but less efficient in 
inducing calcium mobilization. It is also induced earlier in macrophages than 
CINC-2 and -3 and declines more quickly in expression(Shibata et al. 2000). The 
significance of this is unclear. 
 
Hisama et al have shown in an ischaemia reperfusion model of the liver an 
increase in serum CINC-1 levels which peaked at 6 hours post reperfusion and 
gradually came down to normal levels after 24 hours(Hisama et al. 1996).  They 
also showed that CINC production has at least two factors involved: 1. activation 
of coagulation system and 2. Kupffer cell activation(Hisama et al. 1996). 
Thrombin and Factor Xa have been shown to enhance production of CINC in 
liver ischaemia reperfusion injury(Yamaguchi et al. 2000). Production of CINC by 
Kupffer cells has been shown to be attenuated by calcium channel 
blockers(Liang et al. 2000). It has also been shown to be attenuated by 
antithrombin presumably by increased production of PGI2 by endothelial 
cells(Harada et al. 1999). CINC production has also been shown to be 
attenuated by xanthine oxidase inhibition(Matsumura et al. 1998).    172
Aim of this study 
The aim of this study was   to   investigate the effects of Bucillamine on CINC 
levels in hepatic IR and correlate with microcirculatory data from the previous 
chapters. In this study the effect of Bucillamine on the inflammatory response of 
I/R has been evaluated. Measurement of CINC-1 has been used to determine 
cytokine activation. We measured neutrophil adhesion with sinusoids by intravital 
microscopy as a measure of leukocyte-endothelial interaction and inflammatory 
cell infiltration. 
 
8.2 Materials and Methods: 
Animals and surgical procedures 
As detailed in the chapter on methodology, page 50. 
Experimental groups (n=6 in each group) 
Group1 - (Sham) – laparotomy and mobilization of liver but no occlusion of the 
vascular pedicle. 
Group2- IR- 45 minutes of partial hepatic ischemia followed by 3 hrs of 
reperfusion. 
Group3- Bucillamine 15mg/ kg/hr intravenously + IR followed by 3 hrs of 
reperfusion. 
Group4- (SB) - Sham + Bucillamine infusion 15mg/kg/hr (SB) 
Group5- IR24- 45 minutes ischemia followed by 24 hour reperfusion 
Group6- B24- 45 minutes ischaemia + Bucillamine 15mg/ kg/hr intravenously 
followed by 24 hour reperfusion   173
 
CINC Elisa 
Elisa for quantification of CINC was done as described in chapter 3, page 73. 
Intravital microscopy 
As described in chapter 3, page 54. 
 
8.3 Data collection and statistics 
All the data is expressed as mean± standard error of mean (SEM). Analysis of 
data was done using SPSS 14.0.Differences in data between groups was 
assessed by using one way ANOVA with Bonferroni’s post hoc test. Data was 
considered statistically significant if p< 0.05.  174
8.4 Results 
There were no procedure related deaths in either group. The model was 
haemodynamically stable. 
Effect of IR on CINC-1   in the early and late phase of hepatic IR 
Hepatic IR injury produced a high serum CINC level in comparison to sham 
animals in the early phase of hepatic IR (2247.67 + 237.86 vs. 5936.3 + 727.06). 
The serum CINC levels were significantly high in the late phase of hepatic IR 
(15306+ 1222.04). (Fig 8.1, 8.2) 
 
Effect of Bucillamine on CINC-1 in the early and late phase of hepatic IR 
Bucillamine reduced CINC -1 level in both the early (3409.73 + 755,2, ns) and 
late phase (183.95 + 28.44, p< 0.001) of hepatic IR in comparison to IR only. 
 
Correlation of CINC-1 with intravital findings on neutrophil adhesion 
I/R produced a significant increase in the number of adherent leukocytes in the 
venules at the end of 180 minutes of reperfusion between the I/R and sham 
groups (769.05±87.481 vs. 195.79±90.79 leukocytes per mm
2, p<0.05). 
Bucillamine group showed less number of adherent leukocytes (385.66±142.69) 
however, there was no statistically significant difference with either the IR or 
sham groups (Figure 4.4.3.5.1). I/R group (97.4±7.49) showed a significant 
higher number of adherent leukocytes in the sinusoids as compared to   175
sham(3.75±3.75), SB (22.48±11.46) and bucillamine I/R groups(29.97±13.81) 
(p<0.005). (Figure 4.4.3.5.2) 
In the recovery group there were significantly lesser number of adherent 
leukocytes in the venules in the Bucillamine group (B-24) as compared to I/R (IR-
24)group (217.33±50.15 vs. 737.62±132.52, p < 0.01) (Figure 6.9) I/R (IR-24) 
group (176.92±48.68) showed a significant higher number of adherent leukocytes 
in the sinusoids as compared to bucillamine (B-24)group(43.09±8.42) (p<0.05). 
(Figure 6.10) 
 
Correlation of   Hepatocellular death with CINC-1 
Increased hepatocellular death on propidium iodide staining was observed in IR 
injury in both phases of hepatic IR in comparison to animals in the Bucillamine 
infusion group (Chapter 4 and 5).  
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Figure 8.1 Modulation of CINC in early phase of hepatic IR 
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Figure 8.2   Modulation of CINC in late phase of hepatic IR*p<0.001   
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8.5 Discussion 
Assay, controls and variability 
If samples generate values higher than the highest standard, samples were 
further diluted with the Calibrator Diluent and the assay was repeated. Any 
variation in operator, pipetting technique, washing technique, incubation time or 
temperature, and kit age can cause variation in binding. This assay is designed 
to eliminate interference by soluble receptors, binding proteins and other factors 
present in biological samples.  
 
 
Reliability of technique and validity cross reactions, sensitivity and 
specificity. 
Twelve assays were evaluated and the minimum detectable dose (MDD) of rat 
CINC-1 ranged from 0.7 - 1.3 pg/mL. The mean MDD was 1.1 pg/mL. 
The MDD was determined by adding two standard deviations to the mean optical 
density value of twenty zero standard replicates and calculating the 
corresponding concentration. This assay recognizes both recombinant and 
natural rat CINC-1. Several factors were prepared at 50 ng/mL in  Calibrator 
Diluent RD5-4 and assayed for cross-reactivity. No significant cross-reactivity or 
interference was observed 
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Findings in this study 
Serum CINC-1 levels in hepatic IRI and correlation with intravital findings of 
neutrophil adhesion and hepatocellular death. 
The serum CINC-1 levels in the early phase of hepatic IR were higher compared 
to sham animals. Liang et al have shown that CINC transcript expression in the 
liver peaks at 3 hours following hepatic IR and serum CINC levels peak at about 
6 hours(Liang et al. 2000). Oxidative stress due to ROS results in increased NF-
кB   production and NF-кB    stimulates CINC production by kupffer cells. CINC-1 
is known to increase neutrophil infiltration which can be reduced by giving anti 
CINC-1 antibody as shown by Hisama et al. In this study increased CINC levels 
correlate with increased neutrophil adhesion and hepatocellular death in the early 
and late phase of hepatic IR.  
 
Effect of Bucillamine on CINC levels in hepatic IR and correlation with 
intravital findings of neutrophil adhesion, hepatocellular death (early and 
late phase).  
Bucillamine   reduced CINC-1 in the early phase of hepatic IR and in the late 
phase of hepatic IR (24hrs). The serum CINC-1 levels correlate with reduced 
neutrophil adhesion and hepatocellular death. This suggests that the beneficial 
effect of Bucillamine could be through modulation of CINC-1 and neutrophil 
activation in hepatic IR. This needs to be clarified in future studies.  
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Conclusion: 
This study shows that the hepato protective effect of Bucillamine in warm Liver 
ischemia reperfusion injury could be through the modulation of CINC-1 levels and 
the resultant decreased neutrophil activation and recruitment.   180
 
 
 
 
 
 
 
Chapter 9 
   
Discussion of the Thesis 
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9.1 Chapter 1 Introduction 
This chapter was a review of the published literature on the mechanism of Liver 
ischaemia reperfusion injury highlighting the changes occurring in the early and 
late  phase  of  Liver  ischaemia  reperfusion  injury.  The  central  role  of  reactive 
oxygen  species  in  IR,  the  role  of  nitric  oxide  and  the  interplay  between  the 
antioxidant  protective  mechanisms  and  oxidative  stress  was  discussed.  Both 
intra and extracellular defence mechanisms are important in protection against 
IR. Reactive oxygen species (ROS) have a central role to play in Ischaemia –
Reperfusion injury (IR)(Waxman 1996). 
 
ROS activate cytokines, macrophages and other components of the inflammatory 
pathway(Entman  et  al.  1991;  Jaeschke  and  Farhood  1991a;  Le  et  al.  1997). 
When generated in large amounts they can also cause direct oxidative damage 
to the cells through iron mediated reactions(Horwitz et al. 1998). Thiol donors are 
antioxidants  which  can  interrupt  redox  signalling  pathway  and  thereby  reduce 
cytokine and macrophage activation(Sano et al. 2001). In addition, thiol donors 
can protect against oxidative injury by replenishing intracellular glutathione and 
other endogenous thiol compounds(Ceconi et al. 1988a). 
 
9.2 Chapter 2 Bucillamine 
In this chapter we have given an introduction of Bucillamine, its pharmacological 
properties, its uses and adverse effects and the current available literature on the 
effect of Bucillamine in IR injury.    182
 
Bucillamine  is  a  low  molecular  weight  thiol  donor  that  is  capable  of  rapidly 
entering cells. As an oral formulation it is marketed in Japan and Korea for the 
treatment of rheumatoid arthritis(Matsuno et al. 1998). 
 
Similar to other cysteine derivatives such as N- acetylcysteine (NAC), bucillamine 
has  the  ability  to  replenish  intracellular  GSH(Amersi  et  al.  2002).  These 
compounds  can  directly  scavenge  peroxides,  but  less  efficiently  than  the 
glutathione/  glutathione  peroxidase  system.  Bucillamine  preserves  a  high 
concentration of oxidized glutathione, which may be its primary action.  
 
Bucillamine has two donatable thiol groups and is fourfold more potent than NAC 
in  preventing  ischaemia  reperfusion  injury  in  in  vitro  studies(Horwitz  and 
Sherman  2001)  and  16-fold  more  potent  in  vivo  study(Whitekus  et  al.  2002). 
Bucillamine is metabolised to SA 969 which has one donatable thiol group and 
SA  981  which  has  a  structural  similarity  to  D-  Penicillamine  and  ha  a 
immunomodulating effect. 
 
Bucillamine has undergone some preliminary investigations in experimental 
studies of IR. In cardiac I/R injury Horwitz and Sherman(Horwitz and Sherman 
2001) demonstrated in isolated rat cardiac myocytes that bucillamine is a potent 
antioxidant. Bucillamine (125-500 microM) prevented lactate dehydrogenase 
(LDH) release in cardiac myocytes exposed to hydrogen peroxide or a   183
xanthine/xanthine oxidase system. Further, in dogs subjected to 90 min of 
coronary artery occlusion and 48 h of reperfusion, bucillamine, administered 
during reperfusion decreased myocardial infarct size by 41%(Amersi et al. 2002).  
 
In  the  only other  study of  effect  of  Bucillamine  in Liver IR injury,  Amersi and 
colleagues(Amersi et al. 2002) studied Bucillamine and I/R in a rat ex vivo liver 
transplantation model. Bucillamine decreased liver IR injury with increased levels 
of GSH in the liver and decreased levels of oxidized glutathione in both the liver 
and  blood.  Thus  on  the  basis  of  these  ex  vivo  experiments  replenishment  of 
glutathione was thought to be the mechanism of action. Bucillamine was also 
shown to improve survival in a separate group of rat liver transplantations. 
 
The study by Amersi et al suffers from few criticisms. No studies trying to confirm 
mechanism  of  action  were  performed  in  the  animals  that  underwent  the 
transplants. Furthermore, cold storage (as in their ex vivo model) is known to 
decrease  liver  tissue  glutathione  levels(Sumimoto  et  al.  1996).  The  dose  of 
Bucillamine used was also much higher than the dose used in our study (10 mg 
intraportally at the time of liver retrieval and 90 mg in 90 ml of blood perfusate). 
Furthermore, added thiols cause interference in estimation of GSH levels and no 
mention is made in the study about what precautions were taken to prevent this 
and what method (end point/ kinetic method) was used for estimation of GSH 
levels. The effect on liver tissue glutathione levels in warm ischaemia using in   184
vivo models of liver partial ischaemia (similar to ours) is variable (as discussed in 
Chapter 7).   
  
From previous studies bucillamine seems to be an agent which could be used to 
reduce liver IR injury. The effects of bucillamine in the treatment of liver warm I/R 
injury has not been investigated before, furthermore its effect on liver 
microcirculation was not known. The mechanism of action has also not been fully 
studied. This formed the basis of studying the effect of Bucillamine in warm liver 
IR. 
 
 
9.3 Chapter 3 Methodology 
Adequacy of model 
The model of partial liver ischaemia and reperfusion injury used in this study is 
stable, reproducible and avoids splanchnic congestion found with total liver inflow 
occlusion(Koti et al. 2005). Technical manoeuvres such as performing the 
laparotomy; mobilisation of the liver and performing intravital microscopy did not 
affect the heart rate, oxygen saturation or mean arterial pressure as shown by 
stable parameters in the sham and the SB groups. There was a fall in mean 
arterial pressure following ischaemia reperfusion injury in both the I/R and 
Bucillamine I/R groups which was not statistically significant. Bucillamine 
administration without IR has no effect on the vital parameters or haemodynamic 
stability of the animals suggesting that it has no direct effect on systemic or portal   185
haemodynamics. Liver I/R is known to cause microcirculatory perfusion failure, 
activate polymorphonuclear leukocytes and increase leukocyte-endothelial cell 
interaction which in turn contribute to hepatocellular damage and liver 
dysfunction(Vollmar et al. 1994a; Vollmar et al. 1994c; Vollmar et al. 1995b; 
Vollmar et al. 1996; Menger et al. 1999). We hence used intravital microscopy to 
study the microcirculatory changes in IR and the effect of Bucillamine. 
 
Transplant vs. partial hepatic IR model, global IR vs. lobar IR. 
Since this study was limited to investigating the effects of warm IR and the 
effects of Bucillamine in warm IR a partial hepatic IR model was chosen as 
against a transplant model. Global hepatic IR would result in congestion of   
intestine and   release of cytokines resulting in confounding results. To avoid this, 
a portosystemic shunt is needed in a global IR model. This was another reason 
to use a partial ischaemia reperfusion model in our study. Partial liver ischaemia 
avoids the intestinal congestion and resulting release of cytokines(Koti et al. 
2005). It is a stable model and previously well described(Koti et al. 2005). 
 
Correlation of the model with other animal models and human IR 
The rat was selected as the experimental animal due to its resistance to surgical 
trauma and infection, the advantage of size and the liver microvascular anatomy 
which makes the technical procedure possible, compared with other laboratory 
animals; the availability and the relative economy of maintenance. Sprague   186
Dawley is a very docile out bred albino rat (Rattus norvergicus), originated in 
Madison, Wisconsin in 1925, by R. Dawley. The original colony was closed 
shortly after its development and no new stock has been introduced since then, 
producing stable colonies which are descended directly from the original stock.  
The rat model of hepatic ischaemia and reperfusion is a useful procedure for the 
study of the local and systemic effects of ischaemia and reperfusion injury. This 
model offers a well defined volume of tissue that can be easily rendered 
ischaemic with no significant alteration of systemic haemodynamics.  
 
In vivo fluorescent microscopy (Intra vital Microscopy) 
 In vivo microscopy of the liver allows assessment of the hepatic microvascular 
perfusion, the analysis of dynamic processes such as changes in diameters of 
blood vessels, interactions between leukocytes and endothelium. 
For the purposes of in vivo microscopic assessments, a plane organ surface is 
necessary to provide clear and sharp images without inducing trauma to the 
tissue under the objective. The anaesthetized animals were placed on the stage 
of a Nikon custom built microscope (Nikon, Japan) with an integrated heating 
system where the temperature was maintained at 37˚C. The whole set up was 
placed on a pneumatic vibration isolation workstation (Newport, USA) to 
minimise vibration. The liver was exteriorised by adequate mobilisation and 
division of the hepatic ligaments and mounted on a plane glass surface. The liver 
was continuously irrigated with saline to wet the surface of the liver and prevent 
drying as dryness of the liver would aggravate hepatic ischaemia. This procedure   187
was easily tolerated by the animals and allowed the tissue to be exteriorised with 
minimum trauma. This method of exteriorisation of the liver also eliminated the 
respiratory movements in the tissue. Liver microcirculation could be affected by 
exteriorisation and handling of the liver and great care and precaution was taken 
in performing the manoeuvre. During the experiments, the animal’s abdomen 
was covered with a plastic wrap (Saran wrap®, Dow Chemical, Michigan, USA) 
to prevent fluid evaporation. The liver was carefully handled, as mechanical 
trauma induces disturbances in microcirculation.  In order to obtain clear images, 
it was necessary to match the concentration of fluorescent dyes with the filter 
systems, the light intensity and the magnification. Off line microcirculatory 
analysis was performed from recorded images to measure RBC velocity and 
sinusoidal diameter using Lucia G software (Laboratory Universal Computer 
Image Analysis, Nikon, Tokyo, Japan). This software allows measurement of 
length and area seen in the image, which allows the parameters studied to be 
measured. Intravital microscopy has the advantage of allowing changes to be 
visualised in real time in vivo. It however, gives only a 2 dimensional view of what 
is essentially 3 dimensional liver anatomy, this however, is the limitation of the 
equipment currently available. Only peripheral tissue upto a limited depth can be 
visualised. Furthermore, liver mobilisation and handling is required which in itself 
could contribute to liver injury. 
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Serum liver enzymes  
Blood levels of intracellular enzymes are a way of estimating tissue damage: 
tissue or organ specific enzyme levels provide valuable information about related 
tissues. Transaminases released from the damaged liver during ischaemia enter 
the circulation during reperfusion and their blood levels increase. ALT and AST 
are indicators of major alterations of liver integrity, and were utilized in this study 
as a marker of hepatocellular injury. Measurement of liver enzymes as surrogate 
markers of liver injury has its limitations. They do not give any indication of sub-
lethal cell injury. They also do not provide any information about the mechanism 
of injury and there is poor correlation with ability for liver to recover. 
 
 
9.4 Chapter 4- The effect of Bucillamine infusion on microvascular changes 
in liver warm IR 
Intravital microscopy has allowed novel insights into hepatic haemodynamics 
following I/R and the effect of Bucillamine administration. Liver I/R is known to 
cause microcirculatory perfusion failure, activate polymorphonuclear leukocytes 
and increase leukocyte-endothelial cell interaction which in turn contribute to 
hepatocellular damage and liver dysfunction(Vollmar et al. 1994a; Vollmar et al. 
1994c; Vollmar et al. 1995b; Vollmar et al. 1996; Menger et al. 1999).  
Bucillamine administration with I/R was shown to maintain RBC velocity, 
sinusoidal blood flow and sinusoidal perfusion in the reperfusion period. It has   189
also shown to decrease leukocyte adhesions in venules and decrease 
hepatocyte apoptosis/ necrosis. After absorption Bucillamine enters the RBCs 
rapidly and is carried within the erythrocytes(Horwitz 2003; Sugawara et al. 
1985a; Sugawara et al. 1985b). The effect of bucillamine on RBC velocity may 
be secondary to its rapid uptake by RBCs which may reduce oxygen free radical 
mediated deformability and aggregation(Baskurt et al. 1998; Cabel et al. 1997; 
Lowe GDO and Barbanel JC 1988; Machiedo et al. 1989; Powell et al. 1989). 
 
This might be of importance in the beneficial effect of Bucillamine. Bucillamine 
was shown to reduce the perfusion abnormality of I/R with a significantly 
increased sinusoidal perfusion. This could be related to its effect on- 1. RBCs 
(decreased aggregability or better maintenance of deformability) and /or  2. WBC 
adhesions; 3. Decreased platelet aggregability/ fibrin deposition. Sinusoidal 
perfusion was also better maintained in the SB group, which although, as 
mentioned earlier had lower RBC velocity, had normal liver function, indicating 
that a combination of better perfusion and maintenance of RBC velocity would 
decrease abnormality in liver function. Furthermore, Bucillamine was also shown 
to reduce apoptosis/necrosis following Liver IR. Apoptosis of sinusoidal 
endothelial cells following liver IR could give rise to decreased sinusoidal 
perfusion due to endothelial cellular congestion(Vollmar et al. 1996). Bucillamine 
seems to attenuate these changes.  
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We were unable to measure the portal venous flow simultaneously as this would 
interfere with the Intravital microscopy equipment set up. Further manipulation of 
the liver for setting up venous Doppler or laser Doppler also would have affected 
the liver microcirculation. Hence we could not correlate our findings with changes 
in portal venous and hepatic arterial haemodynamics. Bucillamine enters 
erythrocytes rapidly and hence precise measurement of bioavailability requires 
whole blood measurements. This can be done using high performance- liquid 
chromatography- mass spectrometry technique(Beaudry et al. 2004).  
Unfortunately we could not perform whole blood Bucillamine measurement and 
this could be undertaken in future studies. Further studies could also concentrate 
on changes in blood viscosity and RBC deformability by Bucillamine. 
 
 
9.5 Chapter 5- Effect of Bucillamine infusion on Bax/ Bcl-2 and histological 
changes seen after liver IR. 
In Chapter 4 it was shown that Bucillamine administration can reduce the 
microcirculatory failure associated with severe IR and that this results in a 
reduced hepatocellular injury as indicated by lowered serum transaminases. 
However the mechanism was not investigated. In this chapter the histology of the 
resected livers was examined in detail with particular regard to the degree of 
hepatocyte necrosis or apoptosis.  
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Histology 
Light microscopy examination allows excellent appraisal of degree of tissue 
injury. In the liver the end points of necrosis, vacuolation, sinusoidal congestion 
and neutrophil infiltration were chosen as histological markers, realizing that 
more detailed ultrastructural studies may be useful either to confirm or to explain 
histological findings in some cases. In this study, clear differences were found 
between groups, and histology was of great help to understand the nature of 
ischaemic injury. An objective scoring system using modified Suzuki’s criteria 
was used to assess histological changes in the early phase of hepatic IR. 
Bucillamine infusion during ischaemia reperfusion also showed a protective effect 
as seen on histology.  
 
In the early phase of liver IR changes seen on gross haematoxylin and eosin 
staining are subtle and difficult to quantify in descriptive terms only. Furthermore 
there could be observer variation. All samples being assessed by a Consultant 
Pathologist who was blinded to the sample allocation. Other investigators have 
used degree of necrosis as the only histological parameter(Noh et al. 2006) 
however, the severity of necrosis seen at 3 hours reperfusion is not as marked 
with more marked changes seen at 24 hours following reperfusion. All scoring 
systems that are used however, suffer from the fact that they are semi 
quantitative in nature and there could be interobserver variations. Furthermore 
there could be sampling errors in spite of best precautions. 
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In view of our histological findings we measured the level of the Bcl-2 gene family 
which are known to have a vital role in programmed cell death.  Liver IR is known 
to increase the expression of the proapoptotic Bax gene(Bailly-Maitre et al. 2006; 
Ben-Ari et al. 2007; Ishigami et al. 2001) and decrease the expression of anti 
apoptotic Bcl-2 gene. In this study apoptotic gene expression was measured in a 
rat hepatic IR model, which has shown for the first time a decreased expression 
of the proapoptotic Bax gene and increased expression of Bcl-2 gene after 
Bucillamine infusion in Liver IR. These findings co-related with our earlier 
observation of increased non viable nuclei with propidium iodide on intra vital 
microscopy and its attenuation by Bucillamine infusion. 
 
9.6 Chapter 6- The effect of Bucillamine infusion on late phase of liver IR 
The introductory chapter has highlighted the previous studies which have 
demonstrated a two phase response to IR injury with an early phase 
characterised by Kupffer cell activation, activation of complement cascade and 
production of C5a by proteolytic cleavage (Jaeschke et al. 1994) and generation 
of reactive oxygen species (ROS) (Jaeschke and Farhood 1991a; Bailey and 
Reinke 2000; Liu et al. 1995; Shiratori et al. 1994), and a late phase 
characterised by influx of polymorpho nuclear cells and organ injury. Drugs 
influencing the early phase of IR may not necessarily have a prolonged effect 
into the late phase or indeed influence the long term viability of the liver. 
A late phase IR model was therefore established. 
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Our results show a beneficial effect with Bucillamine in the late phase even after 
stopping of continuous infusion after 3 hours. The sinusoidal neutrophil adhesion 
and postsinusoidal venular neutrophil adhesion in the late phase of hepatic IR 
was significantly more in comparison to the Bucillamine + IR group. The direct 
marker of liver injury as assessed by necrotic/apoptotic nuclei stained with 
propidium iodide showed a significant decrease with Bucillamine infusion. 
Histological findings in this study also demonstrated increased parenchymal 
necrosis and neutrophilic infiltration in the IR injury group at 24 hours as 
compared to the Bucillamine group. 
 
Our model unfortunately necessitates a second general anaesthetic and 
relaparotomy which could contribute to the liver injury. Intravital microscopy was 
not possible in one animal in the Bucillamine +IR group at 24 hr reperfusion on 
account of oedema and adhesions making it impossible to mobilise the left lobe 
of liver onto the slide. It was also impossible to perform intravital microscopy in 
one animal in the IR only group on account of severe necrosis. Histological 
changes at 24 hours reperfusion are also more marked and Suzuki’s score does 
not give objective score for comparison. 
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9.7 Chapter 7- The effect of Bucillamine on oxidant stress: is mediated by 
glutathione replenishment? 
In the only other study of Bucillamine in liver IR in an ex vivo liver transplant 
model  Amersi et al found a significantly increased level of reduced glutathione 
(GSH) in the liver with a significantly decreased level of oxidised Glutathione 
(GSSG) in the liver and blood(Amersi et al. 2002). In view of these findings they 
concluded that Bucillamine could be acting by replenishing the tissue reduced 
glutathione levels. The effect on liver tissue glutathione levels in warm ischaemia 
using in vivo models of partial liver ischaemia (similar to ours) is variable. This 
variability could be due to different duration of ischaemia and the different time 
after reperfusion studied in the various studies as discussed in Chapter 7. Our 
study shows no significant decrease in glutathione levels at 45 minutes 
ischaemia followed by 3 hour and 24 hour reperfusion. Our results hence do not 
support the hypothesis of replenishment of liver glutathione as the main 
mechanism of action; however, further research could be carried out using a 
different model of warm ischaemia reperfusion injury before we could rule this 
out. 
 
Bucillamine has also been shown to stimulate glutathione synthesis(Wielandt et 
al. 2006). Our results however, do not suggest this to be the mechanism of action 
either. In a model of partial warm ischaemia reperfusion injury, further research 
could also look at the mitochondrial GSH levels to investigate the mechanism of 
action.   195
 
In this study oxidant stress in tissues and plasma was measured by measuring F2 
isoprostane levels. F2 isoprostanes measurement  is the most accurate method 
of measuring lipid peroxidation(Roberts and Morrow 2000).  This is the first study 
on liver I/R using liver tissue F2 isoprostane levels. We did not find any increase 
in liver tissue F2 isoprostane levels following I/R. Jaeschke et al had suggested 
that the molecular mechanism of ischaemia reperfusion injury does not seem to 
be due to lipid peroxidation(Jaeschke 2003b) and our results agree with this. 
There was no rise in hepatic F2 isoprostanes which would confirm that lipid 
peroxidation does not play a primary role in ischaemia reperfusion injury.  
However, it is known that ischaemia reperfusion injury causes an increase in 
phospholipase levels(Caro and Cederbaum 2006). It is suggested that this up 
regulation of phospholipases might resulting in an increased hydrolysis of F2 
isoprostanes  which could keep the levels of F2 isoprostane within normal 
range(Moore 2004). Hence, Moore et al have suggested that the timing of 
sample collection  might be critical(Moore 2004). This would need to be proved in 
further studies using different time points. 
 
We also studied plasma F2 isoprostane levels. Our results showed no significant 
difference in plasma F2 isoprostane levels in any of the groups. In the only 
previous study of liver I/R and F2 isoprostane Mathews et al(Mathews et al. 1994) 
showed a significant rise in plasma F2 isoprostane levels with a peak rise at I 
hour post reperfusion. In our experiments although in the IR group there appears   196
to be an increase in the levels as compared to the sham group, this was not 
significant. The half life of plasma F2 isoprostanes in rats is also very short (about 
20 min)(Moore 2004). Our results could be hence different due to different time of 
sampling. 
 
 
9.8 Chapter 8- Cytokine studies (CINC-1 levels) 
In Chapter 7 we showed that the hepato protective effect of Bucillamine in warm 
Liver ischaemia reperfusion injury is not by direct replenishment of Glutathione 
level. We have shown in the study previous chapters the beneficial effect of 
Bucillamine and its effect on reducing leukocyte endothelial interaction. In this 
study we investigated if this is related to any changes in cytokine activation which 
could explain its mechanism of action. 
 
Cytokine induced neutrophil chemoattractant (CINC-1) which is secreted by 
kupffer cells induces activation of neutrophils in IR injury. CINC belongs to the IL-
8 cytokine family which mediates the recruitment of neutrophils into sites of 
inflammation. Quantification of CINC-1 by Elisa is a well described technique 
(Nakagawa et al). A sensitive enzyme–linked immunosorbent assay for rat CINC 
using biotin-conjugated anti-CINC rabbit immunoglobulin has been established. 
The biotin-streptavidin sandwich enzyme-linked immunosorbent assay detects 
CINC at concentrations of 3 pg/ml to 30ng/ml. Bucillamine reduced CINC-1 levels 
in the early phase of hepatic IR and in the late phase of hepatic IR (24hrs). The   197
serum CINC-1 levels correlate with reduced neutrophil adhesion and 
hepatocellular death. This suggests that the beneficial effect of Bucillamine could 
be through modulation of CINC-1 and neutrophil activation in hepatic IR. 
 
 
9.9 Overall conclusion and Future studies 
This study has shown for the first time that Bucillamine can reduce the effects of 
liver warm ischaemia reperfusion injury. This is also the first study showing effect 
of Bucillamine on liver microcirculation in vivo. The protective effect of 
Bucillamine was also seen at late phase of reperfusion injury. This study also 
showed that Bucillamine up regulates Bcl-2, and down regulates the expression 
of Bax gene, this is accompanied by decreased leukocyte endothelial interaction 
seen in liver sinusoids and post sinusoidal venules, decreased levels of CINC-1 
levels and better preservation of the liver cytoarchitecture. We also showed that 
the mechanism of action might not be related to replenishment of glutathione 
levels; however, further studies could be carried out using a different model and 
different time points to assess this further. 
 
Our study however, is open to criticism.  We used a model of partial ischaemia 
and reperfusion for the reasons given (page 185). A model of total ischaemia 
reperfusion however, mimics the conditions encountered in clinical practice and 
further studies could be carried out using this model. As this was an experimental 
study we had not performed a sample size calculation and hence there is a   198
likelihood of Type II errors and using more animals in the experiments might 
have given us statistically significant results which should be borne in mind when 
performing further studies. We also did not have a sham group and a sham + 
Bucillamine group in our recovery experiments. 
 
We were also unable to perform Laser Doppler flow measurements or direct 
portal flow measurements as this would have interfered with our set up of 
Intravital microscopy. Our data of nonviable nuclei, etc could have been 
measured more objectively by measuring the fluorescence, which unfortunately 
could not be done due to the limitations of the available software (LUCIA G). We 
would have liked to study ultrastructurally changes with electron microscopy to 
correlate with the Intravital microscopy findings.  
 
Although we showed that the protective effect of Bucillamine was preserved in 
the late phase by Intravital microscopy and histology there was no difference in 
the liver enzymes which suggests the possibility that Bucillamine might be 
delaying the inflammatory response rather than reducing it and studies at later 
time points could be undertaken to investigate this further. 
 
Further studies looking at the mechanism of action of Bucillamine could look at 
its effect on mitochondrial redox potential. Using Intravital microscopy Sun et al 
measured the fluorescence intensity of Rhodamine(Rh) 123 as a marker of 
mitochondrial redox potential and showed that a change in mitochondrial   199
membrane potential is the key mechanism in early warm liver IRI(Sun et al. 
2005). A statistically significant fall in fluorescence in Rh123 was seen as early 
as 15 minutes post reperfusion which correlated with liver injury markers. This 
model could be used for assessing the effect of Bucillamine. NADH 
autofluorescence also has be used as a measure of mitochondrial redox 
state(Chance et al. 1962). Using oxygen sensitive fluorescent dye tris(1,10-
phenanthroline)ruthenium(II) chloride hydrate [Ru(phen)3
2+], the activity of which 
is directly dependent on the tissue PO2, is another approach to study the 
metabolic state of liver using Intravital microscopy(Vollmar and Menger 2009). 
Changes in the levels of tissue and serum glutathione and F2 isoprostanes could 
also be looked at in the study at earlier time points (for e.g 15 min., 30 min and 
60 min. post reperfusion). Alternatively, mitochondrial GSH and tissue 
phospholipases levels as marker of lipid peroxidation could be looked at.  
Inflammatory process and its modulation also affects liver regeneration(Devey et 
al. 2009; Jaeschke 2006; Silva et al. 2008) and a liver resection model studying 
the effect of Bucillamine on liver regeneration could also be undertaken. 
 
The findings of our study suggest that this agent may prove to be a useful target 
in liver protection against IR injury and could be of clinical benefit in the field of 
liver transplantation or liver resection surgery. In phase I human studies in 
normal volunteers, bucillamine at doses up to 25 mg/kg/h i.v. for 3 h elicited no 
serious drug related adverse effects(Horwitz 2003). Bucillamine is however, not   200
available for use in intravenous form at present. We had to freshly prepare 
Bucillamine solution prior to each experiment. 
 
In a recent review post resectional liver failure was found to have an incidence of 
0.7-9.1% in all patients undergoing liver resections(van den Broek et al. 2008) 
with an incidence of 9.1 % in patients undergoing major liver resections (>3 
segments). Patients with post resectional liver failure have a mortality risk of 
59%(van den Broek et al. 2008). Liver IRI directly contributes to development of 
post resectional liver failure(van den Broek et al. 2008). Hence, post resectional 
liver failure would be clinically the most relevant end point for studying any effect 
on modulation of liver IR.  We calculate that a clinical trial involving patients 
undergoing major liver resections (> 3 segments) using incidence of post 
resectional liver failure as an clinical end point would require 383 patients in each 
arm to achieve a 50% reduction in incidence with a p value of <0.05 and a power 
of 80%. This would require a multicentre study with care being taken to match 
other risk factors evenly between the study groups (remnant liver volume, blood 
loss, pre existent liver disease, age of patient, etc). A pilot study using surrogate 
markers (ICG clearance, serum LFT levels, etc) could however, be undertaken 
with smaller numbers.    201
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Appendix – abstracts and publications arising from the thesis 
 
Abstracts 
 
1.  Bucillamine ameliorates liver warm ischaemia reperfusion injury in a rat model 
SP Junnarkar, N Tapuria, W- X Yang, B Fuller, AM Seifalian, BR Davidson
 
 
Introduction- Liver transplantation and resection surgery involve a period of ischaemia and 
reperfusion to the liver which initiates an inflammatory cascade resulting in liver and remote organ 
injury. Bucillamine is a low molecular weight thiol antioxidant that is capable of rapidly entering 
cells. The effect in liver warm ischaemia reperfusion injury has not been studied. 
 
Hypothesis-  Bucillamine would protect against warm ischaemia reperfusion injury through its 
antioxidant and anti-inflammatory effects. 
 
Aim- To use a well described model of liver ischaemia reperfusion to determine the effect of 
Bucillamine administration on liver function, liver microcirculation and hepatocyte apoptosis. 
 
Materials and Methods- Effect of bucillamine was studied in a rat model of liver ischaemia- 
reperfusion injury with 45 minutes partial(70%) ischaemia and 3 hours reperfusion. Liver injury 
was assessed by serum Transaminases (AST and ALT) and by assessing sinusoidal blood flow 
and staining of apoptotic hepatocytes by propidium iodide on intravital microscopy. 
 
Results-  Liver injury was significant lesser in Bucillamine group as compared to Control group as 
assessed by serum AST (932±200.8 vs 2072.5±511.79, p<0.05) and serum ALT ( 861.4±262.63 
vs 2079.25±322.33, p<0.05). The number of apoptotic cells at the end of 3 hours of reperfusion 
was also significantly lesser in the Bucillamine group (p >0.001). There also was better perfusion 
of sinusoids in the Bucillamine group at the end of 3hours of reperfusion ( RBC velocity 
242.66±16.86 vs 181.11±17.59). 
 
Conclusions- Bucillamine protects hepatocytes from ischaemia- reperfusion injury through its 
anti inflammatory and anti oxidant effect. 
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2.  Attenuation of Liver ischaemia reperfusion injury by the thiol antioxidant 
Bucillamine 
SP Junnarkar, N Tapuria, B Fuller, AM Seifalian, BR Davidson
 
 
Introduction- Liver transplantation and resection surgery involve a period of ischaemia and 
reperfusion to the liver which initiates an inflammatory cascade resulting in liver and remote organ 
injury. Bucillamine is a low molecular weight thiol antioxidant that is capable of rapidly entering 
cells. Its effect in liver warm ischaemia reperfusion injury has not been studied. 
 
Hypothesis- Bucillamine would protect against warm ischaemia reperfusion injury through its 
antioxidant and anti-inflammatory effects. 
 
Aim- To use a well described model of liver ischaemia reperfusion to determine the effect of 
Bucillamine administration on liver function, microcirculation and cytokine production. 
 
Materials and Methods- Effect of bucillamine was studied in a rat model of liver ischaemia- 
reperfusion injury with 45 minutes partial(70%) ischaemia and 3 hours reperfusion. Liver injury 
was assessed by serum transaminases (AST and ALT) and propidium iodide staining of apoptotic 
hepatocytes intravital microscopy. Liver microcirculation sinusoidal perfusion and leukocyte 
adhesions. Cytokine response was assessed by measuring serum CINC-1 levels. 
 
Results-  The model produced a significant liver injury with elevated Transaminases and an 
acute inflammatory response. Bucillamine reduced the liver injury as indicated by a reduced 
AST(932±200.8 vs 2072.5±511.79, p<0.05) and ALT ( 861.4±262.63 vs 2079.25±322.33, 
p<0.05). The number of apoptotic cells at the end of 3 hours of reperfusion was also significantly 
lesser in the Bucillamine group (p >0.001). Serum CINC-1 levels were found to be lesser in 
animals given Bucillamine with a very significant difference at 24 hours post reperfusion 
(p<0.001). There also was better perfusion of sinusoids in the Bucillamine group at the end of 
3hours of reperfusion. 
 
Conclusions- Bucillamine therapy reduces the deranging effects of warm ischaemia reperfusion 
injury 
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3.  Bucillamine inhibits neutrophil activation and decreases liver warm ischaemia 
reperfusion injury 
SP Junnarkar, N Tapuria, AR Mani, B Fuller, AM Seifalian, BR Davidson
 
 
Introduction- Liver transplantation and resection surgery involve a period of ischaemia and 
reperfusion to the liver which initiates an inflammatory cascade resulting in liver and remote organ 
injury. Bucillamine is a low molecular weight thiol antioxidant that is capable of rapidly entering 
cells. Our previous studies have shown that bucillamine reduces warm ischaemia reperfusion 
injury in liver. 
 
Hypothesis- Bucillamine may reduce warm ischaemia reperfusion injury by reducing neutrophil 
activation. 
 
Aim- To use a well described model of liver ischaemia reperfusion to determine the effect of 
Bucillamine administration on neutrophil adhesions and cytokine production. Neutrophil activation 
is explored as possible mechanism. 
 
Materials and Methods- Effect of bucillamine was studied in a rat model of liver ischaemia- 
reperfusion injury with 45 minutes partial (70%) ischaemia and 3 hours reperfusion. Liver injury 
was assessed by serum transaminases (AST and ALT) and propidium iodide staining of apoptotic 
hepatocytes on intravital microscopy. Leukocyte adhesions were assessed on Intravital 
microscopy. Cytokine response was assessed by measuring serum CINC-1 levels. 
 
Results- The model produced a significant liver injury with elevated Transaminases and an acute 
inflammatory response. Bucillamine reduced the liver injury as indicated by a reduced AST 
(932±200.8 vs. 2072.5±511.79, p<0.05) and ALT (861.4±262.63 vs. 2079.25±322.33, p<0.05). 
The number of apoptotic cells at the end of 3 hours of reperfusion was also significantly lesser in 
the Bucillamine group (p >0.001). Serum CINC-1 levels were found to be lesser in animals given 
Bucillamine with a very significant difference at 24 hours post reperfusion (p<0.001). There also 
was significantly lesser neutrophil adhesion in the Bucillamine group at the end of 3hours of 
reperfusion. 
 
Conclusions- Bucillamine therapy reduces the deranging effects of warm ischaemia reperfusion 
y inhibiting neutrophil activation. 
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Abstract 
Liver transplantation and resection surgery involve a period of ischaemia and reperfusion to the 
liver which initiates an inflammatory cascade resulting in liver and remote organ injury. 
Bucillamine is a low molecular weight thiol antioxidant that is capable of rapidly entering cells. 
The effect of bucillamine was studied in a rat model of liver ischaemia- reperfusion injury with 45 
minutes partial (70%) liver ischaemia and 3 hours reperfusion and at 24 hours reperfusion. 
Controls included ischaemia reperfusion (I/R) only, sham and bucillamine alone (without 
ischaemia reperfusion). Liver injury was assessed by serum Transaminases (AST and ALT). 
Sinusoidal blood flow and hepatocyte apoptosis measured by Intravital microscopy. 
The hepatocellular injury of I/R produced a markedly elevated serum AST which was reduced 
with bucillamine (2072.5±511.79 vs. 932±200.8, p<0.05) at 3 hours reperfusion. Bucillamine 
treatment with I/R also increased parenchymal blood flow (RBC velocity 242.66±16.86 vs. 
181.11±17.59, at the end of 3 hours reperfusion) and reduced hepatocyte necrosis/apoptosis at 
3hours as well as 24 hours(p>0.001). Bucillamine reduces the hepatocellular injury of liver 
ischaemia reperfusion and improves parenchymal perfusion. 
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Abstract: 
Background- Liver transplantation and resection surgery involve a period of ischaemia and 
reperfusion to the liver which initiates an inflammatory cascade resulting in liver and remote organ 
injury. Bucillamine is a low molecular weight thiol antioxidant that is capable of rapidly entering 
cells. We hypothesised that Bucillamine may act by replenishing glutathione levels and hence 
reduce neutrophil activation, modulate Bax/ Bcl-2 expression thus attenuating effects of liver 
warm ischaemia reperfusion injury. 
 
Methods- Effect of bucillamine was studied in a rat model of liver ischaemia- reperfusion injury 
with 45 minutes partial (70%) liver ischaemia and 3 hours reperfusion. Liver injury was assessed 
by measuring serum transaminases (AST and ALT) and liver histology. Oxidative stress was 
quantified by measuring F2 isoprostane and glutathione levels. Leukocyte adhesion was 
assessed by Intravital microscopy and inflammatory Cytokine response by measuring serum 
CINC-1 levels. Bax and Bcl-2 expression was measured by RT-PCR. 
 
Results- The model produced a significant liver injury with elevated transaminases and an acute 
inflammatory response. Bucillamine reduced the liver injury as indicated by reduced AST 
(932±200.8 vs. 2072.5±511.79, p<0.05). Bucillamine reduced Bax expression, serum CINC-1 
levels and neutrophil adhesion; and upregulated Bcl-2. However, Bucillamine did not affect tissue 
glutathione levels nor the levels of oxidative stress as measured by plasma and hepatic F2 
isoprostane levels. 
 
Conclusions- Bucillamine reduces liver warm ischaemia reperfusion by inhibiting neutrophil 
activation and modulation of Bax/Bcl-2 expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accepted for Publication: J Gastroenterol Hepatol Feb 2010 